Maryland
|
Physicians Realty Trust
|
|
46-2519850
|
Delaware
|
(Physicians Realty L.P.)
|
|
80-0941870
|
(State of Organization)
|
|
(I.R.S. Employer Identification No.)
|
|
|
|
|
|
309 N. Water Street, Suite 500
|
|
53202
|
|
Milwaukee,
|
Wisconsin
|
|
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
Registrant
|
|
Title of each class
|
|
Trading Symbol
|
|
Name of each exchange on which registered
|
Physicians Realty Trust
|
|
Common Shares, $0.01 par value
|
|
DOC
|
|
New York Stock Exchange
|
Physicians Realty Trust
|
Large accelerated filer ☒ Accelerated filer ☐ Non-accelerated filer ☐ Smaller reporting company ☐ Emerging growth company ☐
|
Physicians Realty L.P.
|
Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ Smaller reporting company ☐ Emerging growth company ☐
|
•
|
a combined report enhances investors’ understanding of the Trust and the Operating Partnership by enabling investors to view the business as a whole in the same manner as management views and operates the business;
|
•
|
a combined report eliminates duplicative disclosure and provides a more streamlined and readable presentation, as a substantial portion of the Company’s disclosure applies to both the Trust and the Operating Partnership; and
|
•
|
a combined report creates time and cost efficiencies through the preparation of one combined report instead of two separate reports.
|
•
|
the market for registrant’s common equity, related stockholder matters and issuer purchases of equity securities in Item 5 of this report;
|
•
|
selected financial data in Item 6 of this report;
|
•
|
the consolidated financial statements in Item 8 and Item 15 of this report;
|
•
|
certain accompanying notes to the consolidated financial statements, including Note 14 (Earnings Per Share and Earnings Per Unit) and Note 16 (Quarterly Data);
|
•
|
controls and procedures in Item 9A of this report; and
|
•
|
the certifications of the Chief Executive Officer and the Chief Financial Officer included as Exhibits 31 and 32 to this report.
|
|
Page
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
•
|
general economic conditions;
|
•
|
adverse economic or real estate developments, either nationally or in the markets where our properties are located;
|
•
|
our failure to generate sufficient cash flows to service our outstanding indebtedness, or our ability to pay down or refinance our indebtedness;
|
•
|
fluctuations in interest rates and increased operating costs;
|
•
|
the availability, terms and deployment of debt and equity capital, including our unsecured revolving credit facility;
|
•
|
our ability to make distributions on our common shares;
|
•
|
general volatility of the market price of our common shares;
|
•
|
our increased vulnerability economically due to the concentration of our investments in healthcare properties;
|
•
|
our geographic concentration in Texas causes us to be particularly exposed to downturns in the Texas economy or other changes in Texas market conditions;
|
•
|
changes in our business or strategy;
|
•
|
our dependence upon key personnel whose continued service is not guaranteed;
|
•
|
our ability to identify, hire, and retain highly qualified personnel in the future;
|
•
|
the degree and nature of our competition;
|
•
|
changes in governmental regulations or interpretations thereof, such as real estate and zoning laws and increases in real property tax rates, taxation of REITs, and similar matters;
|
•
|
defaults under or non-renewal of leases by tenants;
|
•
|
decreased rental rates or increased vacancy rates;
|
•
|
difficulties in identifying healthcare properties to acquire and completing acquisitions;
|
•
|
competition for investment opportunities;
|
•
|
any adverse effects to the business, financial position or results of operations of CommonSpirit Health, or one or more of the CommonSpirit Health-affiliated tenants, that impact the ability of CommonSpirit Health-affiliated tenants to pay us rent;
|
•
|
the impact of our investments in joint ventures we have and may make in the future;
|
•
|
the financial condition and liquidity of, or disputes with, any joint venture and development partners with whom we may make co-investments in the future;
|
•
|
cybersecurity incidents could disrupt our business and result in the compromise of confidential information;
|
•
|
our ability to operate as a public company;
|
•
|
changes in healthcare laws or government reimbursement rates;
|
•
|
changes in accounting principles generally accepted in the United States (GAAP);
|
•
|
lack of or insufficient amounts of insurance;
|
•
|
other factors affecting the real estate industry generally;
|
•
|
our failure to maintain our qualification as a REIT for U.S. federal income tax purposes;
|
•
|
limitations imposed on our business and our ability to satisfy complex rules in order for us to qualify as a REIT for U.S. federal income tax purposes; and
|
•
|
other factors that may materially adversely affect us, or the per share trading price of our common shares, including:
|
•
|
the number of our common shares available for future issuance or sale;
|
•
|
our issuance of equity securities or the perception that such issuance might occur;
|
•
|
future debt;
|
•
|
failure of securities analysts to publish research or reports about us or our industry; and
|
•
|
securities analysts’ downgrade of our common shares or the healthcare-related real estate sector.
|
Year
|
|
Portfolio Lease Expirations
|
MTM (1)
|
|
0.6%
|
2020
|
|
2.5%
|
2021
|
|
4.3%
|
2022
|
|
4.7%
|
2023
|
|
4.5%
|
2024
|
|
6.3%
|
2025
|
|
7.9%
|
2026
|
|
26.0%
|
2027
|
|
9.5%
|
2028
|
|
9.9%
|
2029
|
|
4.4%
|
Thereafter
|
|
19.4%
|
Total
|
|
100.0%
|
(1)
|
“MTM” means month-to-month. This line also includes 9 leases which expired on December 31, 2019, representing 0.2% of leased square feet.
|
•
|
medical office buildings (“MOB”);
|
•
|
outpatient treatment and diagnostic facilities;
|
•
|
physician group practice clinics;
|
•
|
ambulatory surgery centers; and
|
•
|
specialty hospitals and treatment centers.
|
•
|
creditworthiness of the tenants, especially whether the property is anchored by a financially-sound healthcare delivery system or whether tenants have strong affiliation to a healthcare delivery system;
|
•
|
the performance of the local healthcare delivery system and its future prospects;
|
•
|
property location;
|
•
|
demand for medical office buildings and healthcare related facilities, current and future supply of competing properties, and occupancy and rental rates in the market;
|
•
|
population density and growth potential;
|
•
|
ability to achieve economies of scale with our existing medical office buildings and healthcare related facilities or anticipated investment opportunities; and
|
•
|
existing and potential competition from other healthcare real estate owners and operators.
|
•
|
We seek to invest in properties occupied by healthcare systems with dominant market share, high credit quality and those who are investing capital into their campuses. In particular, we seek to acquire off-market or selectively marketed assets with attractive demographics, economic growth, and high barriers to entry. We seek to own well occupied properties that we believe are critical to the delivery of healthcare and which are off-campus from a hospital.
|
•
|
We emphasize ensuring an appropriate and balanced mix of tenants to provide synergies within both individual buildings and the broader health system campus. Our primary tenants are healthcare systems, academic medical centers, and leading physician groups. These groups typically have strong and stable financial performance. We believe this helps ensure stability in our rental income and tenant retention over time.
|
•
|
We seek to maintain a core, critical portfolio of properties and to build our reputation as a dedicated leading MOB owner and operator.
|
•
|
We seek to maintain or increase our average rental rates, focus on actively leasing our vacant space, and reduce leasing concessions.
|
•
|
Seek to maintain a high level of liquidity, including borrowing availability under our unsecured revolving credit facility.
|
•
|
Maintain access to multiple sources of capital, including private debt issuances, public bond offerings, public equity offerings, unsecured bank loans, and equity from joint venture partners.
|
•
|
Periodically review our portfolio to consider the potential dispositions of lower quality properties to reinvest the proceeds into higher quality properties.
|
•
|
Closely monitor our existing debt maturities, average interest rates, and look for refinancing opportunities.
|
•
|
For the full year 2019, we completed acquisitions of 12 operating healthcare properties located in 6 states for an aggregate purchase price of approximately $128.2 million. In addition, the Company purchased a newly-constructed addition to an existing building owned by the Company in Tennessee for $4.3 million and funded $132.7 million of other investments, including real estate and construction loans, earn-out agreements, and buyouts of noncontrolling interests in existing properties owned by the Company. The Company also acquired membership interests in 2 joint ventures for approximately $64.9 million resulting in total consolidated investments of $330.1 million.
|
•
|
During 2019, we sold 6 medical office buildings located in 5 states for approximately $86.3 million and recognized a net gain of approximately $31.3 million.
|
•
|
During the fiscal year-ended December 31, 2019, we issued and sold pursuant to the 2016 ATM Program (as defined herein) 5,673,639 common shares at a weighted average price of $17.98 per share, resulting in net proceeds to us of approximately $101.0 million. During the fiscal year ended December 31, 2019, we issued and sold pursuant to the 2019 ATM Program (as defined herein) 1,617,500 common shares at a weighted average price of $18.84 per share, resulting in net proceeds to us of approximately $30.2 million. See to Note 1 (Organization and Business) to our accompanying consolidated financial statements for further detail.
|
•
|
Risks related to our business;
|
•
|
Risks related to the healthcare industry;
|
•
|
Risks related to the real estate industry;
|
•
|
Risks related to financings;
|
•
|
Risks related to our portfolio and structure; and
|
•
|
Risks related to our qualification and operation as a REIT.
|
•
|
our joint venture partners may make decisions with which we disagree or that are not in our best interest;
|
•
|
we may be prevented from taking actions that are opposed by our joint venture partners;
|
•
|
our ability to transfer our interest in a joint venture to a third party may be restricted;
|
•
|
our joint venture partners might become bankrupt or fail to fund their share of required capital contributions which may delay construction or development of a healthcare related facility or increase our financial commitment to the joint venture;
|
•
|
our joint venture partners may have economic or business interests or goals with respect to the healthcare related facility or the joint venture that conflict with our business interests and goals which could increase the likelihood of disputes regarding the ownership, management or disposition of the healthcare related facility or the joint venture may compete with us for property acquisitions;
|
•
|
disputes may develop with our joint venture partners over decisions affecting the healthcare related facility or the joint venture which may result in litigation or arbitration that would increase our expenses and distract our officers and/or trustees from focusing their time and effort on our business and possibly disrupt the daily operations of the healthcare related facility; and
|
•
|
we may suffer losses as a result of the actions of our joint venture partners with respect to our joint venture investments.
|
•
|
we may not be able to obtain financing for development projects on favorable terms or at all;
|
•
|
we may not complete development projects on schedule or within budgeted amounts;
|
•
|
we may encounter delays in obtaining or fail to obtain all necessary zoning, land use, building, occupancy, environmental and other governmental permits and authorizations, or underestimate the costs necessary to develop the property to market standards;
|
•
|
development or construction delays may provide tenants the right to terminate preconstruction leases or cause us to incur additional costs;
|
•
|
volatility in the price of construction materials or labor may increase our development costs;
|
•
|
hospitals or health systems may maintain significant decision-making authority with respect to the development schedule;
|
•
|
we may incorrectly forecast risks associated with development in new geographic regions;
|
•
|
tenants may not lease space at the quantity or rental rate levels projected;
|
•
|
demand for our development project may decrease prior to completion, including due to competition from other developments; and
|
•
|
lease rates and rents at newly developed properties may fluctuate based on factors beyond our control, including market and economic conditions.
|
•
|
The Medicare Access and CHIP Reauthorization Act of 2015 (“MACRA”) reforms Medicare payment policy for services paid under the Medicare physician fee schedule and adopts a series of policy changes affecting a wide range of providers and suppliers. MACRA repeals the sustainable growth rate formula effective January 1, 2015, and establishes a new payment framework which may impact payment rates for our tenants, including long-term care hospitals (“LTCH”).
|
•
|
The Bipartisan Budget Act of 2013 establishes new payment limits for Medicare patients discharged from an LTCH who do not meet specified criteria. For any Medicare patient who does not meet the new criteria, the LTCH will be paid a lower “site-neutral” payment rate, which may impact the financial condition of tenants affected by the lower payment rate. Additionally, new rules may cause all discharges from LTCHs to be paid at the site-neutral rate if the number of discharges for which payment is made under the site-neutral payment rate is greater than 50% of the total number of discharges from the LTCH.
|
•
|
The 2015 BBA provides changes to the requirements for providers who seek HOPD reimbursement under Medicare. The 2015 BBA generally requires providers who seek to qualify for HOPD to be located on the campus of the hospital that seeks such HOPD, which generally is higher than reimbursement for providers that do not qualify as HOPD providers. The 2015 BBA specifically grandfathers HOPD providers in existence as of November 2, 2015 and does not change such HOPD providers’ eligibility for HOPD reimbursement.
|
•
|
The Affordable Care Act instituted a market basket payment adjustment to LTCHs. In fiscal years 2017 through 2019, the market basket update will be reduced by 0.75%. The Affordable Care Act specifically allows these market basket reductions to result in a less than 0% payment update and payment rates that are less than the prior year. MACRA sets the annual update for fiscal year 2018 at 1% after taking into account the market basket payment reduction of 0.75% mandated by the Affordable Care Act.
|
•
|
The Bipartisan Budget Act of 2018 (Pub. L. 115-123) makes numerous changes to Medicare payment to physicians under the Medicare Part B program. These changes include, for example, the removal of certain restrictions on payment for telehealth services associated with clinical assessments for end-stage renal dialysis patients and acute stroke patients. This legislation also repealed the payment caps for certain physical therapy and speech language therapy services, while reducing payment for these services if provided by therapy assistants. The Bipartisan Budget Act of 2018 amended policies related to the Merit-based Incentive Payment System (MIPS) which, as part of the CMS Quality Payment Program, is intended to tie payments to quality and cost-efficient care, drive improvement in care processes and health outcomes, increase the use of healthcare information, and reduce the cost of care.
|
•
|
Every year, the CMS adjusts payment levels and policies for physician services through rulemaking, in compliance with statutory requirements, and other budget decisions by the Executive Branch. On November 15, 2019, CMS issued a final rule for the Medicare physician fee schedule effective for 2020. Among other things, the final rule increases payment levels during 2020 for many physician services, although payment for some procedures may be reduced based on recalculations of the practice expense component of the physician relative value units. Medicare payment for certain drugs may be reduced from 6% to 3% of the wholesale acquisition cost, if an average sales price is not available. Among other things, the final physician fee schedule rule recognizes a broader scope of Medicare coverage for opioid addiction treatment services.
|
•
|
On November 21, 2018, the Secretary issued a final rule, effective January 1, 2019, that eliminated the higher, Outpatient Prospective Payment System reimbursement rate for evaluation and management services provided by Grandfathered HOPD locations. The Secretary, instead, would only reimburse for evaluation and management services at the lower, Medicare Physician Fee Schedule rate that new non-grandfathered off-campus HOPD locations receive. The AHA and a number of hospitals sued the Secretary in federal court to enforce the plain meaning of Section 603 of the BBA and restore the right to Grandfathered HOPD reimbursement rates. On September 17, 2019, a federal district judge ruled in favor of the AHA. The court stated that CMS did not have the authority to lower payments for off-campus hospital-based departments that were grandfathered under the BBA.CMS challenged this ruling, asking for a stay, which the court denied on October 21, 2019. On November 12, 2019, CMS issued its final rule updating the hospital outpatient prospective payment system, effective 2020. In that final rule, CMS required prior authorizations for five services, intending to slow the performance of these services in the hospital outpatient setting.
|
•
|
changes in the demand for and methods of delivering healthcare services;
|
•
|
changes in third party reimbursement methods and policies;
|
•
|
consolidation and pressure to integrate within the healthcare industry through acquisitions, joint ventures, and managed service organizations;
|
•
|
increased scrutiny of billing, pricing, referral, and other practices by U.S. federal and state authorities;
|
•
|
competition among healthcare providers; and
|
•
|
increased scrutiny of control over release of confidential patient medical information.
|
•
|
vacancies or our inability to rent space on favorable terms, including possible market pressures to offer tenants rent abatements, tenant improvements, early termination rights, or tenant-favorable renewal options;
|
•
|
inability to collect rent from tenants;
|
•
|
competition from other real estate investors with significant capital, including other real estate operating companies, REITs, and institutional private equity or other investment funds;
|
•
|
reductions in the level of demand for healthcare properties and changes in the demand for certain healthcare-related properties;
|
•
|
increases in the supply of medical office space;
|
•
|
increases in expenses associated with our real estate operations, including, but not limited to, insurance costs, third party management fees, energy prices, real estate assessments, and other taxes and costs of compliance with laws, regulations and governmental policies, and restrictions on our ability to pass such expenses on to our tenants; and
|
•
|
changes in, and changes in interpretation or enforcement of, laws, regulations, and governmental policies associated with real estate, including, without limitation, health, safety, environmental, real estate and zoning and tax laws, increases in real property tax rates and taxation of REITs, governmental fiscal policies, and the ADA.
|
•
|
our cash flow may be insufficient to meet our required principal and interest payments;
|
•
|
we may be unable to borrow additional funds as needed or on favorable terms, including to make acquisitions;
|
•
|
we may be unable to refinance our indebtedness at maturity or the refinancing terms may be less favorable than the terms of our original indebtedness;
|
•
|
because a portion of our debt bears, or is expected to bear, interest at variable rates, an increase in interest rates could materially increase our interest expense;
|
•
|
we may fail to effectively hedge against interest rate volatility;
|
•
|
we may be forced to dispose of one or more of our properties, possibly on disadvantageous terms if we are able to do so at all;
|
•
|
our leverage could place us at a competitive disadvantage compared to our competitors who have less debt;
|
•
|
we may experience increased vulnerability to economic and industry downturns, reducing our ability to respond to changing business and economic conditions;
|
•
|
we may default on our obligations and the lenders or mortgagees may foreclose on our properties that secure their loans and receive an assignment of rents and leases;
|
•
|
we may violate financial covenants contained in our various loan documents which would cause a default on our obligations, giving lenders various remedies, including increased interest rates, foreclosure, and liability for additional expenses;
|
•
|
we may inadvertently violate non-financial restrictive covenants in our loan documents, such as covenants that require us to maintain the existence of entities, maintain insurance policies and provide financial statements, which would entitle the lenders to accelerate our debt obligations; and
|
•
|
our default under any of our mortgage loans with cross-default or cross-collateralization provisions could result in default on other indebtedness and result in the foreclosures of other properties.
|
•
|
“business combination” provisions that, subject to limitations, prohibit certain business combinations between us and an “interested shareholder” (defined generally as any person who beneficially owns 10% or more of the voting power of our shares or an affiliate or associate of ours who was the beneficial owner, directly or indirectly, of 10% or more of the voting power of our shares at any time within the two-year period immediately prior to the date in question) or an affiliate thereof for five years after the most recent date on which the shareholder becomes an interested shareholder, and thereafter imposes certain minimum price and/or supermajority shareholder voting requirements on these combinations; and
|
•
|
“control share” provisions that provide that holders of “control shares” of our Trust (defined as shares that, when aggregated with all other shares controlled by the shareholder, entitle the shareholder to exercise one of three increasing ranges of voting power in electing trustees) acquired in a “control share acquisition” (defined as the direct or indirect acquisition of ownership or control of issued and outstanding “control shares,” subject to certain exceptions) have no voting rights with respect to their control shares, except to the extent approved by our shareholders by the affirmative vote of at least two-thirds of all the votes entitled to be cast on the matter, excluding all interested shares.
|
•
|
redemption rights;
|
•
|
a requirement that the Trust may not be removed as the general partner of the Operating Partnership without our consent;
|
•
|
transfer restrictions on OP Units;
|
•
|
the Trust’s ability, as general partner, in some cases, to amend the partnership agreement and to cause the Operating Partnership to issue units with terms that could delay, defer, or prevent a merger or other change of control of the Trust or the Operating Partnership without the consent of the limited partners; and
|
•
|
the right of the limited partners to consent to direct or indirect transfers of the general partnership interest, including as a result of a merger or a sale of all or substantially all of our assets, in the event that such transfer requires approval by our common shareholders.
|
•
|
we would not be allowed a deduction for dividends paid to shareholders in computing our taxable income and would be subject to U.S. federal income tax at regular corporate rates;
|
•
|
we could possibly be subject to increased state and local taxes; and
|
•
|
unless we are entitled to relief under certain U.S. federal income tax laws, we could not re-elect REIT status until the fifth calendar year after the year in which we failed to qualify as a REIT.
|
State
|
|
Number of Properties
|
|
GLA (1)
(square feet)
|
|
Percent of GLA
|
|
Annualized Base Rent (2)
(thousands)
|
|
Percent of Annualized Base Rent
|
||||||
Alabama
|
|
8
|
|
|
332,162
|
|
|
2.4
|
%
|
|
$
|
7,991
|
|
|
2.7
|
%
|
Arizona
|
|
13
|
|
|
733,791
|
|
|
5.4
|
%
|
|
15,568
|
|
|
5.3
|
%
|
|
Arkansas
|
|
7
|
|
|
269,800
|
|
|
2.0
|
%
|
|
4,451
|
|
|
1.5
|
%
|
|
California
|
|
5
|
|
|
93,011
|
|
|
0.7
|
%
|
|
2,097
|
|
|
0.7
|
%
|
|
Colorado
|
|
5
|
|
|
129,620
|
|
|
0.9
|
%
|
|
2,880
|
|
|
1.0
|
%
|
|
Connecticut
|
|
2
|
|
|
100,930
|
|
|
0.7
|
%
|
|
2,645
|
|
|
0.9
|
%
|
|
Florida
|
|
20
|
|
|
380,533
|
|
|
2.8
|
%
|
|
10,174
|
|
|
3.5
|
%
|
|
Georgia
|
|
8
|
|
|
1,065,508
|
|
|
7.8
|
%
|
|
25,658
|
|
|
8.7
|
%
|
|
Illinois
|
|
3
|
|
|
139,450
|
|
|
1.0
|
%
|
|
2,827
|
|
|
1.0
|
%
|
|
Indiana
|
|
23
|
|
|
1,092,163
|
|
|
8.0
|
%
|
|
21,372
|
|
|
7.3
|
%
|
|
Kentucky
|
|
12
|
|
|
979,376
|
|
|
7.2
|
%
|
|
16,847
|
|
|
5.7
|
%
|
|
Louisiana
|
|
3
|
|
|
150,777
|
|
|
1.1
|
%
|
|
6,186
|
|
|
2.1
|
%
|
|
Maine
|
|
1
|
|
|
44,677
|
|
|
0.3
|
%
|
|
1,282
|
|
|
0.4
|
%
|
|
Maryland
|
|
3
|
|
|
166,594
|
|
|
1.2
|
%
|
|
4,010
|
|
|
1.4
|
%
|
|
Michigan
|
|
6
|
|
|
250,456
|
|
|
1.8
|
%
|
|
6,414
|
|
|
2.2
|
%
|
|
Minnesota
|
|
19
|
|
|
810,301
|
|
|
5.9
|
%
|
|
17,520
|
|
|
6.0
|
%
|
|
Mississippi
|
|
2
|
|
|
97,294
|
|
|
0.7
|
%
|
|
2,403
|
|
|
0.8
|
%
|
|
Missouri
|
|
2
|
|
|
69,184
|
|
|
0.5
|
%
|
|
1,873
|
|
|
0.6
|
%
|
|
Montana
|
|
3
|
|
|
185,085
|
|
|
1.4
|
%
|
|
5,421
|
|
|
1.8
|
%
|
|
Nebraska
|
|
13
|
|
|
982,738
|
|
|
7.2
|
%
|
|
18,052
|
|
|
6.1
|
%
|
|
New Mexico
|
|
2
|
|
|
53,029
|
|
|
0.4
|
%
|
|
1,432
|
|
|
0.5
|
%
|
|
New York
|
|
13
|
|
|
613,520
|
|
|
4.5
|
%
|
|
14,260
|
|
|
4.9
|
%
|
|
North Dakota
|
|
8
|
|
|
434,215
|
|
|
3.2
|
%
|
|
8,057
|
|
|
2.7
|
%
|
|
Ohio
|
|
12
|
|
|
650,319
|
|
|
4.7
|
%
|
|
13,692
|
|
|
4.7
|
%
|
|
Oklahoma
|
|
1
|
|
|
52,000
|
|
|
0.4
|
%
|
|
529
|
|
|
0.2
|
%
|
|
Pennsylvania
|
|
11
|
|
|
403,811
|
|
|
2.9
|
%
|
|
5,494
|
|
|
1.9
|
%
|
|
Tennessee
|
|
8
|
|
|
706,805
|
|
|
5.2
|
%
|
|
12,714
|
|
|
4.3
|
%
|
|
Texas
|
|
29
|
|
|
1,890,267
|
|
|
13.8
|
%
|
|
45,602
|
|
|
15.5
|
%
|
|
Virginia
|
|
1
|
|
|
72,255
|
|
|
0.5
|
%
|
|
1,836
|
|
|
0.6
|
%
|
|
Washington
|
|
9
|
|
|
539,698
|
|
|
3.9
|
%
|
|
9,670
|
|
|
3.3
|
%
|
|
Wisconsin (3)
|
|
6
|
|
|
205,886
|
|
|
1.5
|
%
|
|
4,581
|
|
|
1.7
|
%
|
|
Total
|
|
258
|
|
|
13,695,255
|
|
|
100.0
|
%
|
|
$
|
293,538
|
|
|
100.0
|
%
|
(1)
|
“GLA” means gross leasable area.
|
(2)
|
Annualized base rent is calculated by multiplying (a) base rental payments for the month ended December 31, 2019, by (b) 12.
|
(3)
|
Excludes leases related to the Company’s 108,843 square foot corporate office building.
|
Expiration (1)
|
|
Number of Leases Expiring
|
|
GLA
|
|
Percent of GLA
|
|
Annualized Base Rent
(thousands)
|
|
Percent of Annualized Base Rent
|
|
Annualized Base Rent Leased per Square Foot (2)
|
||||||||
2020
|
|
103
|
|
|
327,999
|
|
|
2.4
|
%
|
|
$
|
6,991
|
|
|
2.4
|
%
|
|
$
|
21.31
|
|
2021
|
|
145
|
|
|
560,762
|
|
|
4.1
|
%
|
|
12,206
|
|
|
4.2
|
%
|
|
21.77
|
|
||
2022
|
|
111
|
|
|
615,052
|
|
|
4.5
|
%
|
|
14,608
|
|
|
5.0
|
%
|
|
23.75
|
|
||
2023
|
|
111
|
|
|
592,822
|
|
|
4.3
|
%
|
|
13,785
|
|
|
4.7
|
%
|
|
23.25
|
|
||
2024
|
|
98
|
|
|
827,496
|
|
|
6.0
|
%
|
|
18,402
|
|
|
6.3
|
%
|
|
22.24
|
|
||
2025
|
|
149
|
|
|
1,043,501
|
|
|
7.6
|
%
|
|
24,384
|
|
|
8.3
|
%
|
|
23.37
|
|
||
2026
|
|
123
|
|
|
3,417,652
|
|
|
25.0
|
%
|
|
71,064
|
|
|
24.2
|
%
|
|
20.79
|
|
||
2027
|
|
74
|
|
|
1,253,220
|
|
|
9.2
|
%
|
|
26,740
|
|
|
9.1
|
%
|
|
21.34
|
|
||
2028
|
|
63
|
|
|
1,307,598
|
|
|
9.5
|
%
|
|
29,224
|
|
|
10.0
|
%
|
|
22.35
|
|
||
2029
|
|
34
|
|
|
580,833
|
|
|
4.2
|
%
|
|
15,146
|
|
|
5.2
|
%
|
|
26.08
|
|
||
Thereafter
|
|
73
|
|
|
2,534,467
|
|
|
18.6
|
%
|
|
59,469
|
|
|
20.0
|
%
|
|
23.46
|
|
||
Month to month (3)
|
|
41
|
|
|
85,106
|
|
|
0.6
|
%
|
|
1,519
|
|
|
0.6
|
%
|
|
17.84
|
|
||
Vacant
|
|
—
|
|
|
548,747
|
|
|
4.0
|
%
|
|
—
|
|
|
—
|
|
|
—
|
|
||
Total / Weighted average
|
|
1,125
|
|
|
13,695,255
|
|
|
100.0
|
%
|
|
$
|
293,538
|
|
|
100.0
|
%
|
|
$
|
22.33
|
|
(1)
|
Excludes leases related to the Company’s 108,843 square foot corporate office building.
|
(2)
|
Annualized base rent per leased square foot is calculated by dividing (a) annualized base rent as of December 31, 2019 by (b) square footage under executed leases as of December 31, 2019.
|
(3)
|
Includes 9 leases which expired on December 31, 2019, representing 0.2% of portfolio leasable square feet.
|
Tenant
|
|
# of
Properties
|
|
Leased GLA
|
|
% Leased GLA
|
|
Annualized Base
Rent
(thousands)
|
|
% of Portfolio
Annualized Base Rent
|
|||||
CommonSpirit - CHI - Nebraska
|
|
13
|
|
899,129
|
|
|
6.8
|
%
|
|
$
|
16,809
|
|
|
5.7
|
%
|
Northside Hospital
|
|
7
|
|
612,439
|
|
|
4.7
|
%
|
|
13,576
|
|
|
4.6
|
%
|
|
UofL Health - Louisville, Inc.
|
|
9
|
|
596,021
|
|
|
4.5
|
%
|
|
11,859
|
|
|
4.0
|
%
|
|
Baylor Scott and White Health
|
|
2
|
|
268,639
|
|
|
2.0
|
%
|
|
7,770
|
|
|
2.6
|
%
|
|
US Oncology
|
|
8
|
|
285,362
|
|
|
2.2
|
%
|
|
7,563
|
|
|
2.6
|
%
|
|
Ascension - St. Vincent's - Indianapolis
|
|
4
|
|
357,110
|
|
|
2.7
|
%
|
|
7,437
|
|
|
2.5
|
%
|
|
CommonSpirit - CHI - St. Alexius (ND)
|
|
7
|
|
362,284
|
|
|
2.8
|
%
|
|
6,551
|
|
|
2.2
|
%
|
|
HonorHealth
|
|
6
|
|
243,500
|
|
|
1.9
|
%
|
|
6,032
|
|
|
2.1
|
%
|
|
Great Falls Clinic
|
|
3
|
|
185,085
|
|
|
1.4
|
%
|
|
5,421
|
|
|
1.9
|
%
|
|
CommonSpirit - CHI - Franciscan
|
|
7
|
|
280,907
|
|
|
2.1
|
%
|
|
5,146
|
|
|
1.8
|
%
|
|
Total
|
|
66
|
|
4,090,476
|
|
|
31.1
|
%
|
|
$
|
88,164
|
|
|
30.0
|
%
|
|
|
Period Ending
|
|||||||||||||||||||||||||||||
Index
|
|
7/19/2013
|
|
12/31/2013
|
|
12/31/2014
|
12/31/2015
|
|
12/31/2016
|
|
12/31/2017
|
|
12/31/2018
|
|
12/31/2019
|
||||||||||||||||
Physicians Realty Trust
|
|
$
|
100.00
|
|
|
$
|
112.34
|
|
|
$
|
156.36
|
|
$
|
167.72
|
|
|
$
|
197.82
|
|
|
$
|
196.89
|
|
|
$
|
185.68
|
|
|
$
|
234.20
|
|
Standard & Poor’s 500
|
|
$
|
100.00
|
|
|
$
|
110.29
|
|
|
$
|
125.39
|
|
$
|
127.13
|
|
|
$
|
142.33
|
|
|
$
|
173.40
|
|
|
$
|
165.80
|
|
|
$
|
218.01
|
|
MSCI US REIT (RMS)
|
|
$
|
100.00
|
|
|
$
|
91.97
|
|
|
$
|
119.56
|
|
$
|
122.57
|
|
|
$
|
133.11
|
|
|
$
|
139.86
|
|
|
$
|
133.47
|
|
|
$
|
167.96
|
|
Period
|
|
(a) Total Number of Shares (or Units) Purchased
|
|
(b) Average Price Paid per Share (or Unit)
|
|
(c) Total Number of Shares (or Units) Purchased as Part of Publicly Announced Plans or Programs
|
|
(d) Maximum Number (or Approximate Dollar Value) of Shares (or Units) that May Yet Be Purchased Under the Plans or Programs
|
|||||
October 1, 2019 - October 31, 2019
|
|
744,544
|
|
(1)
|
$
|
17.61
|
|
|
N/A
|
|
|
N/A
|
|
November 1, 2019 - November 30, 2019
|
|
—
|
|
|
—
|
|
|
N/A
|
|
|
N/A
|
|
|
December 1, 2019 - December 31, 2019
|
|
—
|
|
|
—
|
|
|
N/A
|
|
|
N/A
|
|
|
Total
|
|
744,544
|
|
|
$
|
17.61
|
|
|
—
|
|
|
—
|
|
(1)
|
Represents OP Units redeemed by holders in exchange for common shares of the Company.
|
|
Year Ended December 31,
|
||||||||||||||||||
(in thousands, except per share data)
|
2019
|
|
2018
|
|
2017
|
|
2016
|
|
2015
|
||||||||||
Statement of Operations Data
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Rental revenues
|
$
|
303,264
|
|
|
$
|
313,006
|
|
|
$
|
259,673
|
|
|
$
|
186,301
|
|
|
$
|
103,974
|
|
Expense recoveries
|
101,115
|
|
|
97,989
|
|
|
75,425
|
|
|
45,875
|
|
|
21,587
|
|
|||||
Interest income on real estate loans and other
|
10,902
|
|
|
11,556
|
|
|
8,486
|
|
|
8,858
|
|
|
3,880
|
|
|||||
Total revenues
|
415,281
|
|
|
422,551
|
|
|
343,584
|
|
|
241,034
|
|
|
129,441
|
|
|||||
Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Interest expense
|
65,022
|
|
|
66,183
|
|
|
47,008
|
|
|
23,864
|
|
|
10,636
|
|
|||||
General and administrative
|
33,099
|
|
|
28,816
|
|
|
22,957
|
|
|
18,397
|
|
|
14,908
|
|
|||||
Operating expenses
|
124,819
|
|
|
122,620
|
|
|
97,035
|
|
|
65,999
|
|
|
31,026
|
|
|||||
Depreciation and amortization
|
146,436
|
|
|
158,389
|
|
|
125,159
|
|
|
86,589
|
|
|
45,471
|
|
|||||
Acquisition expenses
|
—
|
|
|
—
|
|
|
16,744
|
|
|
14,778
|
|
|
14,893
|
|
|||||
Impairment loss
|
—
|
|
|
—
|
|
|
965
|
|
|
—
|
|
|
—
|
|
|||||
Total expenses
|
369,376
|
|
|
376,008
|
|
|
309,868
|
|
|
209,627
|
|
|
116,934
|
|
|||||
Income before equity in income of unconsolidated entities and gain on sale of investment properties, net
|
45,905
|
|
|
46,543
|
|
|
33,716
|
|
|
31,407
|
|
|
12,507
|
|
|||||
Equity in (loss) income of unconsolidated entities
|
(28
|
)
|
|
114
|
|
|
183
|
|
|
115
|
|
|
104
|
|
|||||
Gain on sale of investment properties, net
|
31,309
|
|
|
11,664
|
|
|
5,874
|
|
|
—
|
|
|
130
|
|
|||||
Net income
|
77,186
|
|
|
58,321
|
|
|
39,773
|
|
|
31,522
|
|
|
12,741
|
|
|||||
Net income attributable to noncontrolling interests:
|
|
|
|
|
|
|
|
|
|
||||||||||
Operating Partnership
|
(2,155
|
)
|
|
(1,576
|
)
|
|
(1,136
|
)
|
|
(825
|
)
|
|
(576
|
)
|
|||||
Partially owned properties (1)
|
(548
|
)
|
|
(515
|
)
|
|
(491
|
)
|
|
(716
|
)
|
|
(377
|
)
|
|||||
Net income attributable to controlling interest
|
74,483
|
|
|
56,230
|
|
|
38,146
|
|
|
29,981
|
|
|
11,788
|
|
|||||
Preferred distributions
|
(1,209
|
)
|
|
(1,340
|
)
|
|
(731
|
)
|
|
(1,857
|
)
|
|
(1,189
|
)
|
|||||
Net income attributable to common shareholders
|
$
|
73,274
|
|
|
$
|
54,890
|
|
|
$
|
37,415
|
|
|
$
|
28,124
|
|
|
$
|
10,599
|
|
Net income per share:
|
|
|
|
|
|
|
|
|
|
||||||||||
Basic
|
$
|
0.39
|
|
|
$
|
0.30
|
|
|
$
|
0.23
|
|
|
$
|
0.22
|
|
|
$
|
0.15
|
|
Diluted
|
$
|
0.39
|
|
|
$
|
0.30
|
|
|
$
|
0.23
|
|
|
$
|
0.22
|
|
|
$
|
0.15
|
|
Dividends and distributions declared per common share and OP Unit
|
$
|
0.920
|
|
|
$
|
0.920
|
|
|
$
|
0.915
|
|
|
$
|
0.900
|
|
|
$
|
0.900
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Balance Sheet Data (as of end of period):
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Net real estate investments
|
$
|
4,201,312
|
|
|
$
|
3,970,033
|
|
|
$
|
4,045,388
|
|
|
$
|
2,767,624
|
|
|
$
|
1,579,483
|
|
Cash and cash equivalents
|
2,355
|
|
|
19,161
|
|
|
2,727
|
|
|
15,491
|
|
|
3,143
|
|
|||||
Tenant receivables, net
|
7,972
|
|
|
8,881
|
|
|
9,966
|
|
|
9,790
|
|
|
2,977
|
|
|||||
Other assets
|
134,942
|
|
|
144,759
|
|
|
106,302
|
|
|
95,187
|
|
|
53,283
|
|
|||||
Total assets
|
$
|
4,346,581
|
|
|
$
|
4,142,834
|
|
|
$
|
4,164,383
|
|
|
$
|
2,888,092
|
|
|
$
|
1,638,886
|
|
Liabilities and Equity:
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Credit facility
|
$
|
583,323
|
|
|
$
|
457,388
|
|
|
$
|
324,394
|
|
|
$
|
643,742
|
|
|
$
|
389,375
|
|
Notes payable
|
967,789
|
|
|
966,961
|
|
|
966,603
|
|
|
224,330
|
|
|
—
|
|
|||||
Mortgage debt
|
83,341
|
|
|
108,504
|
|
|
186,471
|
|
|
123,083
|
|
|
94,240
|
|
|||||
Accounts payable
|
6,348
|
|
|
3,886
|
|
|
11,023
|
|
|
4,423
|
|
|
644
|
|
|||||
Distributions and distributions payable
|
46,272
|
|
|
43,821
|
|
|
43,804
|
|
|
32,179
|
|
|
20,783
|
|
|||||
Accrued expenses and other liabilities
|
81,238
|
|
|
76,282
|
|
|
56,405
|
|
|
42,287
|
|
|
24,473
|
|
|||||
Lease liabilities
|
63,290
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Acquired lease intangible, net
|
6,096
|
|
|
13,585
|
|
|
15,702
|
|
|
9,253
|
|
|
5,950
|
|
|||||
Total liabilities
|
1,837,697
|
|
|
1,670,427
|
|
|
1,604,402
|
|
|
1,079,297
|
|
|
535,465
|
|
|||||
Redeemable noncontrolling interest – Series A Preferred Units (2019, 2018, 2016, and 2015) and partially owned properties
|
27,900
|
|
|
24,747
|
|
|
12,347
|
|
|
26,477
|
|
|
26,960
|
|
|||||
Total shareholders’ equity
|
2,408,948
|
|
|
2,379,505
|
|
|
2,473,172
|
|
|
1,738,451
|
|
|
1,021,132
|
|
|||||
Total noncontrolling interests
|
72,036
|
|
|
68,155
|
|
|
74,462
|
|
|
43,867
|
|
|
55,329
|
|
|||||
Total liabilities and equity
|
$
|
4,346,581
|
|
|
$
|
4,142,834
|
|
|
$
|
4,164,383
|
|
|
$
|
2,888,092
|
|
|
$
|
1,638,886
|
|
(1)
|
Includes amounts attributable to redeemable noncontrolling interests for the years ended December 31, 2019, 2018, 2017, and 2016. No such adjustment was required for the year ended December 31, 2015.
|
|
Year Ended December 31,
|
||||||||||||||||||
(in thousands, except per unit data)
|
2019
|
|
2018
|
|
2017
|
|
2016
|
|
2015
|
||||||||||
Statement of Operations Data
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Rental revenues
|
$
|
303,264
|
|
|
$
|
313,006
|
|
|
$
|
259,673
|
|
|
$
|
186,301
|
|
|
$
|
103,974
|
|
Expense recoveries
|
101,115
|
|
|
97,989
|
|
|
75,425
|
|
|
45,875
|
|
|
21,587
|
|
|||||
Interest income on real estate loans and other
|
10,902
|
|
|
11,556
|
|
|
8,486
|
|
|
8,858
|
|
|
3,880
|
|
|||||
Total revenues
|
415,281
|
|
|
422,551
|
|
|
343,584
|
|
|
241,034
|
|
|
129,441
|
|
|||||
Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Interest expense
|
65,022
|
|
|
66,183
|
|
|
47,008
|
|
|
23,864
|
|
|
10,636
|
|
|||||
General and administrative
|
33,099
|
|
|
28,816
|
|
|
22,957
|
|
|
18,397
|
|
|
14,908
|
|
|||||
Operating expenses
|
124,819
|
|
|
122,620
|
|
|
97,035
|
|
|
65,999
|
|
|
31,026
|
|
|||||
Depreciation and amortization
|
146,436
|
|
|
158,389
|
|
|
125,159
|
|
|
86,589
|
|
|
45,471
|
|
|||||
Acquisition expenses
|
—
|
|
|
—
|
|
|
16,744
|
|
|
14,778
|
|
|
14,893
|
|
|||||
Impairment loss
|
—
|
|
|
—
|
|
|
965
|
|
|
—
|
|
|
—
|
|
|||||
Total expenses
|
369,376
|
|
|
376,008
|
|
|
309,868
|
|
|
209,627
|
|
|
116,934
|
|
|||||
Income before equity in income of unconsolidated entities and gain on sale of investment properties, net
|
45,905
|
|
|
46,543
|
|
|
33,716
|
|
|
31,407
|
|
|
12,507
|
|
|||||
Equity in (loss) income of unconsolidated entities
|
(28
|
)
|
|
114
|
|
|
183
|
|
|
115
|
|
|
104
|
|
|||||
Gain on sale of investment properties, net
|
31,309
|
|
|
11,664
|
|
|
5,874
|
|
|
—
|
|
|
130
|
|
|||||
Net income
|
77,186
|
|
|
58,321
|
|
|
39,773
|
|
|
31,522
|
|
|
12,741
|
|
|||||
Net income attributable to noncontrolling interests:
|
|
|
|
|
|
|
|
|
|
||||||||||
Partially owned properties (1)
|
(548
|
)
|
|
(515
|
)
|
|
(491
|
)
|
|
(716
|
)
|
|
(377
|
)
|
|||||
Net income attributable to controlling interest
|
76,638
|
|
|
57,806
|
|
|
39,282
|
|
|
30,806
|
|
|
12,364
|
|
|||||
Preferred distributions
|
(1,209
|
)
|
|
(1,340
|
)
|
|
(731
|
)
|
|
(1,857
|
)
|
|
(1,189
|
)
|
|||||
Net income attributable to common unitholders
|
$
|
75,429
|
|
|
$
|
56,466
|
|
|
$
|
38,551
|
|
|
$
|
28,949
|
|
|
$
|
11,175
|
|
Net income per unit:
|
|
|
|
|
|
|
|
|
|
||||||||||
Basic
|
$
|
0.39
|
|
|
$
|
0.30
|
|
|
$
|
0.23
|
|
|
$
|
0.22
|
|
|
$
|
0.15
|
|
Diluted
|
$
|
0.39
|
|
|
$
|
0.30
|
|
|
$
|
0.23
|
|
|
$
|
0.22
|
|
|
$
|
0.15
|
|
Dividends and distributions declared per common unit
|
$
|
0.920
|
|
|
$
|
0.920
|
|
|
$
|
0.915
|
|
|
$
|
0.900
|
|
|
$
|
0.900
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Balance Sheet Data (as of end of period):
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Net real estate investments
|
$
|
4,201,312
|
|
|
$
|
3,970,033
|
|
|
$
|
4,045,388
|
|
|
$
|
2,767,624
|
|
|
$
|
1,579,483
|
|
Cash and cash equivalents
|
2,355
|
|
|
19,161
|
|
|
2,727
|
|
|
15,491
|
|
|
3,143
|
|
|||||
Tenant receivables, net
|
7,972
|
|
|
8,881
|
|
|
9,966
|
|
|
9,790
|
|
|
2,977
|
|
|||||
Other assets
|
134,942
|
|
|
144,759
|
|
|
106,302
|
|
|
95,187
|
|
|
53,283
|
|
|||||
Total assets
|
$
|
4,346,581
|
|
|
$
|
4,142,834
|
|
|
$
|
4,164,383
|
|
|
$
|
2,888,092
|
|
|
$
|
1,638,886
|
|
Liabilities and Capital:
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Credit facility
|
$
|
583,323
|
|
|
$
|
457,388
|
|
|
$
|
324,394
|
|
|
$
|
643,742
|
|
|
$
|
389,375
|
|
Notes payable
|
967,789
|
|
|
966,961
|
|
|
966,603
|
|
|
224,330
|
|
|
—
|
|
|||||
Mortgage debt
|
83,341
|
|
|
108,504
|
|
|
186,471
|
|
|
123,083
|
|
|
94,240
|
|
|||||
Accounts payable
|
6,348
|
|
|
3,886
|
|
|
11,023
|
|
|
4,423
|
|
|
644
|
|
|||||
Distributions payable
|
46,272
|
|
|
43,821
|
|
|
43,804
|
|
|
32,179
|
|
|
20,783
|
|
|||||
Accrued expenses and other liabilities
|
81,238
|
|
|
76,282
|
|
|
56,405
|
|
|
42,287
|
|
|
24,473
|
|
|||||
Lease liabilities
|
63,290
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Acquired lease intangible, net
|
6,096
|
|
|
13,585
|
|
|
15,702
|
|
|
9,253
|
|
|
5,950
|
|
|||||
Total liabilities
|
1,837,697
|
|
|
1,670,427
|
|
|
1,604,402
|
|
|
1,079,297
|
|
|
535,465
|
|
|||||
Redeemable noncontrolling interest – Series A Preferred Units (2019, 2018, 2016, and 2015) and partially owned properties
|
27,900
|
|
|
24,747
|
|
|
12,347
|
|
|
26,477
|
|
|
26,960
|
|
|||||
Total partners’ capital
|
2,480,645
|
|
|
2,446,982
|
|
|
2,547,016
|
|
|
1,781,593
|
|
|
1,066,583
|
|
|||||
Noncontrolling interest - partially owned properties
|
339
|
|
|
678
|
|
|
618
|
|
|
725
|
|
|
9,878
|
|
|||||
Total liabilities and capital
|
$
|
4,346,581
|
|
|
$
|
4,142,834
|
|
|
$
|
4,164,383
|
|
|
$
|
2,888,092
|
|
|
$
|
1,638,886
|
|
(1)
|
Includes amounts attributable to redeemable noncontrolling interests for the years ended December 31, 2019, 2018, 2017, and 2016. No such adjustment was required for the year ended December 31, 2015.
|
Year
|
|
Portfolio Lease Expirations
|
MTM (1)
|
|
0.6%
|
2020
|
|
2.5%
|
2021
|
|
4.3%
|
2022
|
|
4.7%
|
2023
|
|
4.5%
|
2024
|
|
6.3%
|
2025
|
|
7.9%
|
2026
|
|
26.0%
|
2027
|
|
9.5%
|
2028
|
|
9.9%
|
2029
|
|
4.4%
|
Thereafter
|
|
19.4%
|
Total
|
|
100.0%
|
(1)
|
Includes 9 leases which expired on December 31, 2019, representing 0.2% of portfolio occupied leasable square feet.
|
•
|
medical office buildings;
|
•
|
outpatient treatment and diagnostic facilities;
|
•
|
physician group practice clinics;
|
•
|
ambulatory surgery centers; and
|
•
|
specialty hospitals and treatment centers.
|
|
2019
|
|
2018
|
|
Change
|
|
%
|
|||||||
Revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|||
Rental revenues
|
$
|
303,264
|
|
|
$
|
313,006
|
|
|
$
|
(9,742
|
)
|
|
(3.1
|
)
|
Expense recoveries
|
101,115
|
|
|
97,989
|
|
|
3,126
|
|
|
3.2
|
|
|||
Interest income on real estate loans and other
|
10,902
|
|
|
11,556
|
|
|
(654
|
)
|
|
(5.7
|
)
|
|||
Total revenues
|
415,281
|
|
|
422,551
|
|
|
(7,270
|
)
|
|
(1.7
|
)
|
|||
Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|||
Interest expense
|
65,022
|
|
|
66,183
|
|
|
(1,161
|
)
|
|
(1.8
|
)
|
|||
General and administrative
|
33,099
|
|
|
28,816
|
|
|
4,283
|
|
|
14.9
|
|
|||
Operating expenses
|
124,819
|
|
|
122,620
|
|
|
2,199
|
|
|
1.8
|
|
|||
Depreciation and amortization
|
146,436
|
|
|
158,389
|
|
|
(11,953
|
)
|
|
(7.5
|
)
|
|||
Total expenses
|
369,376
|
|
|
376,008
|
|
|
(6,632
|
)
|
|
(1.8
|
)
|
|||
Income before equity in income of unconsolidated entities and gain on sale of investment properties, net:
|
45,905
|
|
|
46,543
|
|
|
(638
|
)
|
|
(1.4
|
)
|
|||
Equity in (loss) income of unconsolidated entities
|
(28
|
)
|
|
114
|
|
|
(142
|
)
|
|
(124.6
|
)
|
|||
Gain on sale of investment properties, net
|
31,309
|
|
|
11,664
|
|
|
19,645
|
|
|
168.4
|
|
|||
Net income
|
$
|
77,186
|
|
|
$
|
58,321
|
|
|
$
|
18,865
|
|
|
32.3
|
|
|
2018
|
|
2017
|
|
Change
|
|
%
|
|||||||
Revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|||
Rental revenues
|
$
|
313,006
|
|
|
$
|
259,673
|
|
|
$
|
53,333
|
|
|
20.5
|
|
Expense recoveries
|
97,989
|
|
|
75,425
|
|
|
22,564
|
|
|
29.9
|
|
|||
Interest income on real estate loans and other
|
11,556
|
|
|
8,486
|
|
|
3,070
|
|
|
36.2
|
|
|||
Total revenues
|
422,551
|
|
|
343,584
|
|
|
78,967
|
|
|
23.0
|
|
|||
Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|||
Interest expense
|
66,183
|
|
|
47,008
|
|
|
19,175
|
|
|
40.8
|
|
|||
General and administrative
|
28,816
|
|
|
22,957
|
|
|
5,859
|
|
|
25.5
|
|
|||
Operating expenses
|
122,620
|
|
|
97,035
|
|
|
25,585
|
|
|
26.4
|
|
|||
Depreciation and amortization
|
158,389
|
|
|
125,159
|
|
|
33,230
|
|
|
26.6
|
|
|||
Acquisition expenses
|
—
|
|
|
16,744
|
|
|
(16,744
|
)
|
|
(100.0
|
)
|
|||
Impairment loss
|
—
|
|
|
965
|
|
|
(965
|
)
|
|
NM
|
|
|||
Total expenses
|
376,008
|
|
|
309,868
|
|
|
66,140
|
|
|
21.3
|
|
|||
Income before equity in income of unconsolidated entities and gain on sale of investment properties, net:
|
46,543
|
|
|
33,716
|
|
|
12,827
|
|
|
38.0
|
|
|||
Equity in income of unconsolidated entities
|
114
|
|
|
183
|
|
|
(69
|
)
|
|
(37.7
|
)
|
|||
Gain on sale of investment properties, net
|
11,664
|
|
|
5,874
|
|
|
5,790
|
|
|
NM
|
|
|||
Net income
|
$
|
58,321
|
|
|
$
|
39,773
|
|
|
$
|
18,548
|
|
|
46.6
|
|
|
2019
|
|
2018
|
||||
Cash provided by operating activities
|
$
|
201,177
|
|
|
$
|
208,694
|
|
Cash used in investing activities
|
(255,308
|
)
|
|
(77,183
|
)
|
||
Cash provided by (used in) financing activities
|
37,325
|
|
|
(115,077
|
)
|
||
(Decrease) increase in cash and cash equivalents
|
$
|
(16,806
|
)
|
|
$
|
16,434
|
|
|
2018
|
|
2017
|
||||
Net cash provided by operating activities
|
$
|
208,694
|
|
|
$
|
180,471
|
|
Net cash used in investing activities
|
(77,183
|
)
|
|
(1,302,638
|
)
|
||
Net cash (used in) provided by financing activities
|
(115,077
|
)
|
|
1,109,403
|
|
||
Increase (decrease) in cash and cash equivalents
|
$
|
16,434
|
|
|
$
|
(12,764
|
)
|
|
Year Ended December 31,
|
||||||||||
|
2019
|
|
2018
|
|
2017
|
||||||
Net income
|
$
|
77,186
|
|
|
$
|
58,321
|
|
|
$
|
39,773
|
|
Earnings per share - diluted
|
$
|
0.39
|
|
|
$
|
0.30
|
|
|
$
|
0.23
|
|
|
|
|
|
|
|
||||||
Net income
|
$
|
77,186
|
|
|
$
|
58,321
|
|
|
$
|
39,773
|
|
Net income attributable to noncontrolling interests - partially owned properties
|
(548
|
)
|
|
(515
|
)
|
|
(491
|
)
|
|||
Preferred distributions
|
(1,209
|
)
|
|
(1,340
|
)
|
|
(731
|
)
|
|||
Depreciation and amortization expense
|
146,072
|
|
|
158,163
|
|
|
125,022
|
|
|||
Depreciation and amortization expense - partially owned properties
|
(282
|
)
|
|
(336
|
)
|
|
(531
|
)
|
|||
Gain on sale of investment properties, net
|
(31,309
|
)
|
|
(11,664
|
)
|
|
(5,874
|
)
|
|||
Impairment loss
|
—
|
|
|
—
|
|
|
965
|
|
|||
Proportionate share of unconsolidated joint venture adjustments
|
715
|
|
|
—
|
|
|
—
|
|
|||
FFO applicable to common shares and OP Units
|
$
|
190,625
|
|
|
$
|
202,629
|
|
|
$
|
158,133
|
|
FFO per common share and OP Unit
|
$
|
0.99
|
|
|
$
|
1.08
|
|
|
$
|
0.94
|
|
Net change in fair value of derivative
|
1
|
|
|
(6
|
)
|
|
150
|
|
|||
Acquisition expenses
|
—
|
|
|
—
|
|
|
16,744
|
|
|||
Net change in fair value of contingent consideration
|
(37
|
)
|
|
(50
|
)
|
|
(472
|
)
|
|||
Normalized FFO applicable to common shares and OP Units
|
$
|
190,589
|
|
|
$
|
202,573
|
|
|
$
|
174,555
|
|
Normalized FFO per common share and OP Unit
|
$
|
0.99
|
|
|
$
|
1.08
|
|
|
$
|
1.04
|
|
|
|
|
|
|
|
|
|||||
Weighted average number of common shares and OP Units outstanding
|
191,626,320
|
|
|
187,526,762
|
|
|
168,231,299
|
|
|
Year Ended December 31,
|
||||||||||
|
2019
|
|
2018
|
|
2017
|
||||||
Net income
|
$
|
77,186
|
|
|
$
|
58,321
|
|
|
$
|
39,773
|
|
Normalized FFO applicable to common shares and OP Units
|
$
|
190,589
|
|
|
$
|
202,573
|
|
|
$
|
174,555
|
|
|
|
|
|
|
|
||||||
Normalized FFO applicable to common shares and OP Units
|
$
|
190,589
|
|
|
$
|
202,573
|
|
|
$
|
174,555
|
|
Non-cash share compensation expense
|
10,115
|
|
|
8,681
|
|
|
5,073
|
|
|||
Straight-line rent adjustments
|
(9,986
|
)
|
|
(21,860
|
)
|
|
(16,202
|
)
|
|||
Amortization of acquired above/below-market leases/assumed debt
|
3,485
|
|
|
3,287
|
|
|
3,596
|
|
|||
Amortization of lease inducements
|
1,312
|
|
|
1,310
|
|
|
1,309
|
|
|||
Amortization of deferred financing costs
|
2,416
|
|
|
2,428
|
|
|
2,299
|
|
|||
TI/LC and recurring capital expenditures
|
(19,544
|
)
|
|
(19,779
|
)
|
|
(15,319
|
)
|
|||
Seller master lease and rent abatement payments
|
—
|
|
|
229
|
|
|
973
|
|
|||
Proportionate share of unconsolidated joint venture adjustments
|
(36
|
)
|
|
—
|
|
|
—
|
|
|||
Normalized FAD applicable to common shares and OP Units
|
$
|
178,351
|
|
|
$
|
176,869
|
|
|
$
|
156,284
|
|
|
Year Ended December 31,
|
||||||||||
|
2019
|
|
2018
|
|
2017
|
||||||
Net income
|
$
|
77,186
|
|
|
$
|
58,321
|
|
|
$
|
39,773
|
|
General and administrative
|
33,099
|
|
|
28,816
|
|
|
22,957
|
|
|||
Acquisition expenses
|
—
|
|
|
—
|
|
|
16,744
|
|
|||
Depreciation and amortization
|
146,436
|
|
|
158,389
|
|
|
125,159
|
|
|||
Interest expense
|
65,022
|
|
|
66,183
|
|
|
47,008
|
|
|||
Net change in the fair value of derivative
|
1
|
|
|
(6
|
)
|
|
150
|
|
|||
Gain on sale of investment properties, net
|
(31,309
|
)
|
|
(11,664
|
)
|
|
(5,874
|
)
|
|||
Impairment loss
|
—
|
|
|
—
|
|
|
965
|
|
|||
Proportionate share of unconsolidated joint venture adjustments
|
1,048
|
|
|
—
|
|
|
—
|
|
|||
NOI
|
$
|
291,483
|
|
|
$
|
300,039
|
|
|
$
|
246,882
|
|
|
|
|
|
|
|
|
|||||
NOI
|
$
|
291,483
|
|
|
$
|
300,039
|
|
|
$
|
246,882
|
|
Straight-line rent adjustments
|
(9,986
|
)
|
|
(21,860
|
)
|
|
(16,202
|
)
|
|||
Amortization of acquired above/below-market leases/assumed debt
|
3,547
|
|
|
3,287
|
|
|
3,596
|
|
|||
Amortization of lease inducements
|
1,312
|
|
|
1,310
|
|
|
1,309
|
|
|||
Seller master lease and rent abatement payments
|
—
|
|
|
229
|
|
|
973
|
|
|||
Change in fair value of contingent consideration
|
(37
|
)
|
|
(50
|
)
|
|
(472
|
)
|
|||
Proportionate share of unconsolidated joint venture adjustments
|
(36
|
)
|
|
—
|
|
|
—
|
|
|||
Cash NOI
|
$
|
286,283
|
|
|
$
|
282,955
|
|
|
$
|
236,086
|
|
•
|
property expenses;
|
•
|
interest expense and scheduled principal payments on outstanding indebtedness;
|
•
|
general and administrative expenses; and
|
•
|
capital expenditures for tenant improvements and leasing commissions.
|
•
|
existing shareholders may purchase additional common shares by reinvesting all or a portion of the dividends paid on their common shares and by making optional cash payments of not less than $50 and up to a maximum of $10,000 per month;
|
•
|
new investors may join the DRIP by making an initial investment of not less than $1,000 and up to a maximum of $10,000; and
|
•
|
once enrolled in the DRIP, participants may authorize electronic deductions from their bank account for optional cash payments to purchase additional shares.
|
|
|
|
By Period (in thousands)
|
||||||||||||||||
|
Total
|
|
Less than 1
Year
|
|
2021-2022
|
|
2023-2024
|
|
2025 and Thereafter
|
||||||||||
Principal (1)
|
$
|
1,647,478
|
|
|
$
|
25,478
|
|
|
$
|
368,121
|
|
|
$
|
289,677
|
|
|
$
|
964,202
|
|
Interest – fixed rate debt (1)
|
351,187
|
|
|
49,374
|
|
|
97,506
|
|
|
85,666
|
|
|
118,641
|
|
|||||
Interest – variable rate debt (1)
|
22,839
|
|
|
7,941
|
|
|
13,903
|
|
|
423
|
|
|
572
|
|
|||||
Tenant improvements (1)
|
45,924
|
|
|
10,534
|
|
|
10,406
|
|
|
9,048
|
|
|
15,936
|
|
|||||
Ground leases and other operating leases (1)
|
156,925
|
|
|
3,130
|
|
|
6,203
|
|
|
6,106
|
|
|
141,486
|
|
|||||
Total
|
$
|
2,224,353
|
|
|
$
|
96,457
|
|
|
$
|
496,139
|
|
|
$
|
390,920
|
|
|
$
|
1,240,837
|
|
(1)
|
Obligations shown represent 100% of debt service and do not reflect joint venture interests.
|
|
|
Principal
|
|
Fixed/Floating
Rate
|
|
Rate
|
|
Maturity
|
|||
Senior Unsecured Revolving Credit Facility
|
|
$
|
339,000
|
|
|
Floating
|
|
LIBOR + 1.10%
|
|
|
9/18/2022
|
Senior Unsecured Term Loan (1)
|
|
250,000
|
|
|
Fixed
|
|
2.32
|
%
|
|
6/10/2023
|
|
Senior Unsecured Notes
|
|
|
|
|
|
|
|
|
|||
January 2016 - Series A
|
|
15,000
|
|
|
Fixed
|
|
4.03
|
%
|
|
1/7/2023
|
|
January 2016 - Series B
|
|
45,000
|
|
|
Fixed
|
|
4.43
|
%
|
|
1/7/2026
|
|
January 2016 - Series C
|
|
45,000
|
|
|
Fixed
|
|
4.57
|
%
|
|
1/7/2028
|
|
January 2016 - Series D
|
|
45,000
|
|
|
Fixed
|
|
4.74
|
%
|
|
1/7/2031
|
|
August 2016 - Series A
|
|
25,000
|
|
|
Fixed
|
|
4.09
|
%
|
|
8/11/2025
|
|
August 2016 - Series B
|
|
25,000
|
|
|
Fixed
|
|
4.18
|
%
|
|
8/11/2026
|
|
August 2016 - Series C
|
|
25,000
|
|
|
Fixed
|
|
4.24
|
%
|
|
8/11/2027
|
|
March 2017 Notes
|
|
400,000
|
|
|
Fixed
|
|
4.30
|
%
|
|
3/15/2027
|
|
December 2017 Notes
|
|
350,000
|
|
|
Fixed
|
|
3.95
|
%
|
|
1/15/2028
|
|
Peachtree Parking Deck
|
|
8,500
|
|
|
Fixed
|
|
3.00
|
%
|
|
1/5/2020
|
|
Mid Coast Hospital MOB (2)
|
|
6,581
|
|
|
Floating
|
|
LIBOR + 2.75%
|
|
|
11/13/2028
|
|
Foundations Surgical Affiliates MOB
|
|
6,691
|
|
|
Fixed
|
|
4.71
|
%
|
|
1/10/2021
|
|
Savage MOB
|
|
5,109
|
|
|
Fixed
|
|
5.50
|
%
|
|
2/1/2022
|
|
St. Vincent Fishers Medical Center
|
|
15,000
|
|
|
Fixed
|
|
4.00
|
%
|
|
1/10/2020
|
|
CareMount Medical - Lake Katrine MOB
|
|
25,177
|
|
|
Fixed
|
|
4.63
|
%
|
|
11/6/2024
|
|
Gwinnett Physicians Center
|
|
16,420
|
|
|
Fixed
|
|
4.83
|
%
|
|
12/1/2022
|
|
Total principal
|
|
1,647,478
|
|
|
|
|
|
|
|
|
|
Unamortized deferred financing costs
|
|
(7,677
|
)
|
|
|
|
|
|
|
||
Unamortized discounts
|
|
(5,483
|
)
|
|
|
|
|
|
|
||
Unamortized fair value adjustments
|
|
135
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
1,634,453
|
|
|
|
|
|
|
|
|
(1)
|
Our borrowings under the term loan feature of our Credit Agreement bear interest at a rate which is determined by our credit rating, currently equal to LIBOR + 1.25%. We have entered into a pay-fixed receive-variable interest rate swap, fixing the LIBOR component of this rate at 1.07%, resulting in an effective interest rate of 2.32%.
|
(2)
|
We own a 66.3% interest in the joint venture that owns this property. Debt shown in this schedule is the full amount of the mortgage indebtedness on this property.
|
|
|
Page
|
|
|
|
Reports of Independent Registered Public Accounting Firm
|
|
|
|
||
|
||
|
|
|
Report of Independent Registered Public Accounting Firm on Internal Control Over Financial Reporting
|
|
|
|
||
|
|
|
Financial Statements of Physicians Realty Trust
|
|
|
|
||
|
||
|
||
|
||
|
||
|
|
|
Financial Statements of Physicians Realty L.P.
|
|
|
|
||
|
||
|
||
|
||
|
||
|
|
|
Notes for Physicians Realty Trust and Physicians Realty L.P.
|
|
|
|
|
December 31,
|
||||||
ASSETS
|
2019
|
|
2018
|
||||
Investment properties:
|
|
|
|
|
|
||
Land and improvements
|
$
|
225,540
|
|
|
$
|
211,253
|
|
Building and improvements
|
3,700,009
|
|
|
3,623,962
|
|
||
Tenant improvements
|
53,931
|
|
|
36,497
|
|
||
Acquired lease intangibles
|
390,450
|
|
|
452,384
|
|
||
|
4,369,930
|
|
|
4,324,096
|
|
||
Accumulated depreciation
|
(540,928
|
)
|
|
(411,052
|
)
|
||
Net real estate property
|
3,829,002
|
|
|
3,913,044
|
|
||
Right-of-use lease assets, net
|
127,933
|
|
|
—
|
|
||
Real estate loans receivable
|
178,240
|
|
|
55,659
|
|
||
Investment in unconsolidated entities
|
66,137
|
|
|
1,330
|
|
||
Net real estate investments
|
4,201,312
|
|
|
3,970,033
|
|
||
Cash and cash equivalents
|
2,355
|
|
|
19,161
|
|
||
Tenant receivables, net
|
7,972
|
|
|
8,881
|
|
||
Other assets
|
134,942
|
|
|
144,759
|
|
||
Total assets
|
$
|
4,346,581
|
|
|
$
|
4,142,834
|
|
LIABILITIES AND EQUITY
|
|
|
|
|
|
||
Liabilities:
|
|
|
|
|
|
||
Credit facility
|
$
|
583,323
|
|
|
$
|
457,388
|
|
Notes payable
|
967,789
|
|
|
966,961
|
|
||
Mortgage debt
|
83,341
|
|
|
108,504
|
|
||
Accounts payable
|
6,348
|
|
|
3,886
|
|
||
Distributions and distributions payable
|
46,272
|
|
|
43,821
|
|
||
Accrued expenses and other liabilities
|
81,238
|
|
|
76,282
|
|
||
Lease liabilities
|
63,290
|
|
|
—
|
|
||
Acquired lease intangibles, net
|
6,096
|
|
|
13,585
|
|
||
Total liabilities
|
1,837,697
|
|
|
1,670,427
|
|
||
|
|
|
|
||||
Redeemable noncontrolling interest - Series A Preferred Units and partially owned properties
|
27,900
|
|
|
24,747
|
|
||
|
|
|
|
||||
Equity:
|
|
|
|
|
|
||
Common shares, $0.01 par value, 500,000,000 common shares authorized, 189,975,396 and 182,416,007 common shares issued and outstanding as of December 31, 2019 and December 31, 2018, respectively
|
1,900
|
|
|
1,824
|
|
||
Additional paid-in capital
|
2,931,921
|
|
|
2,791,555
|
|
||
Accumulated deficit
|
(529,194
|
)
|
|
(428,307
|
)
|
||
Accumulated other comprehensive income
|
4,321
|
|
|
14,433
|
|
||
Total shareholders’ equity
|
2,408,948
|
|
|
2,379,505
|
|
||
Noncontrolling interests:
|
|
|
|
|
|
||
Operating Partnership
|
71,697
|
|
|
67,477
|
|
||
Partially owned properties
|
339
|
|
|
678
|
|
||
Total noncontrolling interests
|
72,036
|
|
|
68,155
|
|
||
Total equity
|
2,480,984
|
|
|
2,447,660
|
|
||
Total liabilities and equity
|
$
|
4,346,581
|
|
|
$
|
4,142,834
|
|
|
December 31,
|
||||||||||
|
2019
|
|
2018
|
|
2017
|
||||||
Revenues:
|
|
|
|
|
|
|
|
|
|||
Rental revenues
|
$
|
303,264
|
|
|
$
|
313,006
|
|
|
$
|
259,673
|
|
Expense recoveries
|
101,115
|
|
|
97,989
|
|
|
75,425
|
|
|||
Interest income on real estate loans and other
|
10,902
|
|
|
11,556
|
|
|
8,486
|
|
|||
Total revenues
|
415,281
|
|
|
422,551
|
|
|
343,584
|
|
|||
Expenses:
|
|
|
|
|
|
|
|
|
|||
Interest expense
|
65,022
|
|
|
66,183
|
|
|
47,008
|
|
|||
General and administrative
|
33,099
|
|
|
28,816
|
|
|
22,957
|
|
|||
Operating expenses
|
124,819
|
|
|
122,620
|
|
|
97,035
|
|
|||
Depreciation and amortization
|
146,436
|
|
|
158,389
|
|
|
125,159
|
|
|||
Acquisition expenses
|
—
|
|
|
—
|
|
|
16,744
|
|
|||
Impairment loss
|
—
|
|
|
—
|
|
|
965
|
|
|||
Total expenses
|
369,376
|
|
|
376,008
|
|
|
309,868
|
|
|||
Income before equity in income of unconsolidated entities and gain on sale of investment properties, net:
|
45,905
|
|
|
46,543
|
|
|
33,716
|
|
|||
Equity in (loss) income of unconsolidated entities
|
(28
|
)
|
|
114
|
|
|
183
|
|
|||
Gain on sale of investment properties, net
|
31,309
|
|
|
11,664
|
|
|
5,874
|
|
|||
Net income
|
77,186
|
|
|
58,321
|
|
|
39,773
|
|
|||
Net income attributable to noncontrolling interests:
|
|
|
|
|
|
||||||
Operating Partnership
|
(2,155
|
)
|
|
(1,576
|
)
|
|
(1,136
|
)
|
|||
Partially owned properties (1)
|
(548
|
)
|
|
(515
|
)
|
|
(491
|
)
|
|||
Net income attributable to controlling interest
|
74,483
|
|
|
56,230
|
|
|
38,146
|
|
|||
Preferred distributions
|
(1,209
|
)
|
|
(1,340
|
)
|
|
(731
|
)
|
|||
Net income attributable to common shareholders
|
$
|
73,274
|
|
|
$
|
54,890
|
|
|
$
|
37,415
|
|
Net income per share:
|
|
|
|
|
|
|
|
|
|||
Basic
|
$
|
0.39
|
|
|
$
|
0.30
|
|
|
$
|
0.23
|
|
Diluted
|
$
|
0.39
|
|
|
$
|
0.30
|
|
|
$
|
0.23
|
|
Weighted average common shares:
|
|
|
|
|
|
|
|
|
|||
Basic
|
185,770,251
|
|
|
182,064,064
|
|
|
163,123,109
|
|
|||
Diluted
|
191,626,320
|
|
|
187,526,762
|
|
|
168,231,299
|
|
|||
Dividends and distributions declared per common share and OP unit
|
$
|
0.920
|
|
|
$
|
0.920
|
|
|
$
|
0.915
|
|
(1)
|
Includes amounts attributable to redeemable noncontrolling interest.
|
|
December 31,
|
||||||||||
|
2019
|
|
2018
|
|
2017
|
||||||
Net income
|
$
|
77,186
|
|
|
$
|
58,321
|
|
|
$
|
39,773
|
|
Other comprehensive (loss) income:
|
|
|
|
|
|
||||||
Change in fair value of interest rate swap agreements, net
|
(10,112
|
)
|
|
481
|
|
|
244
|
|
|||
Total other comprehensive (loss) income
|
(10,112
|
)
|
|
481
|
|
|
244
|
|
|||
Comprehensive income
|
67,074
|
|
|
58,802
|
|
|
40,017
|
|
|||
Comprehensive income attributable to noncontrolling interests - Operating Partnership
|
(1,863
|
)
|
|
(1,589
|
)
|
|
(1,143
|
)
|
|||
Comprehensive income attributable to noncontrolling interests - partially owned properties
|
(548
|
)
|
|
(515
|
)
|
|
(491
|
)
|
|||
Comprehensive income attributable to common shareholders
|
$
|
64,663
|
|
|
$
|
56,698
|
|
|
$
|
38,383
|
|
|
Par
Value
|
|
Additional
Paid in
Capital
|
|
Accumulated
Deficit
|
|
Accumulated Other Comprehensive Income
|
|
Total
Shareholders’
Equity
|
|
Operating
Partnership
Noncontrolling
interest
|
|
Partially
Owned
Properties
Noncontrolling
Interest
|
|
Total
Noncontrolling
Interests
|
|
Total
Equity
|
||||||||||||||||||
Balance at January 1, 2017
|
$
|
1,360
|
|
|
$
|
1,920,644
|
|
|
$
|
(197,261
|
)
|
|
$
|
13,708
|
|
|
$
|
1,738,451
|
|
|
$
|
43,142
|
|
|
$
|
725
|
|
|
$
|
43,867
|
|
|
$
|
1,782,318
|
|
Net proceeds from sale of common shares
|
451
|
|
|
844,218
|
|
|
—
|
|
|
—
|
|
|
844,669
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
844,669
|
|
|||||||||
Restricted share award grants, net
|
2
|
|
|
4,103
|
|
|
(284
|
)
|
|
—
|
|
|
3,821
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
3,821
|
|
|||||||||
Purchase of OP Units
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(3,886
|
)
|
|
—
|
|
|
(3,886
|
)
|
|
(3,886
|
)
|
|||||||||
Conversion of OP Units
|
1
|
|
|
929
|
|
|
—
|
|
|
—
|
|
|
930
|
|
|
(930
|
)
|
|
—
|
|
|
(930
|
)
|
|
—
|
|
|||||||||
Dividends/distributions declared
|
—
|
|
|
—
|
|
|
(153,970
|
)
|
|
—
|
|
|
(153,970
|
)
|
|
(4,867
|
)
|
|
—
|
|
|
(4,867
|
)
|
|
(158,837
|
)
|
|||||||||
Preferred distribution
|
—
|
|
|
—
|
|
|
(731
|
)
|
|
—
|
|
|
(731
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(731
|
)
|
|||||||||
Issuance of OP Units in connection with acquisition
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
44,259
|
|
|
—
|
|
|
44,259
|
|
|
44,259
|
|
|||||||||
Contributions
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
47
|
|
|
47
|
|
|
47
|
|
|||||||||
Distributions
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(321
|
)
|
|
(321
|
)
|
|
(321
|
)
|
|||||||||
Buyout of Noncontrolling Interest - partially owned properties
|
—
|
|
|
(2,800
|
)
|
|
—
|
|
|
—
|
|
|
(2,800
|
)
|
|
719
|
|
|
(24
|
)
|
|
695
|
|
|
(2,105
|
)
|
|||||||||
Change in fair value of interest rate swap agreements and redeemable equity - property
|
—
|
|
|
—
|
|
|
(1,317
|
)
|
|
244
|
|
|
(1,073
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,073
|
)
|
|||||||||
Net income
|
—
|
|
|
—
|
|
|
38,146
|
|
|
—
|
|
|
38,146
|
|
|
1,136
|
|
|
191
|
|
|
1,327
|
|
|
39,473
|
|
|||||||||
Adjustment for Noncontrolling Interests ownership in Operating Partnership
|
—
|
|
|
5,729
|
|
|
—
|
|
|
—
|
|
|
5,729
|
|
|
(5,729
|
)
|
|
—
|
|
|
(5,729
|
)
|
|
—
|
|
|||||||||
Balance at December 31, 2017
|
1,814
|
|
|
2,772,823
|
|
|
(315,417
|
)
|
|
13,952
|
|
|
2,473,172
|
|
|
73,844
|
|
|
618
|
|
|
74,462
|
|
|
2,547,634
|
|
|||||||||
Net proceeds from sale of common shares
|
6
|
|
|
10,753
|
|
|
—
|
|
|
—
|
|
|
10,759
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
10,759
|
|
|||||||||
Restricted share award grants, net
|
2
|
|
|
6,837
|
|
|
(326
|
)
|
|
—
|
|
|
6,513
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
6,513
|
|
|||||||||
Purchase of OP Units
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2,203
|
)
|
|
—
|
|
|
(2,203
|
)
|
|
(2,203
|
)
|
|||||||||
Conversion of OP Units
|
2
|
|
|
2,523
|
|
|
—
|
|
|
—
|
|
|
2,525
|
|
|
(2,525
|
)
|
|
—
|
|
|
(2,525
|
)
|
|
—
|
|
|||||||||
Dividends/distributions declared
|
—
|
|
|
—
|
|
|
(167,817
|
)
|
|
—
|
|
|
(167,817
|
)
|
|
(4,742
|
)
|
|
—
|
|
|
(4,742
|
)
|
|
(172,559
|
)
|
|||||||||
Preferred distributions
|
—
|
|
|
—
|
|
|
(1,340
|
)
|
|
—
|
|
|
(1,340
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,340
|
)
|
|||||||||
Distributions
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(173
|
)
|
|
(173
|
)
|
|
(173
|
)
|
|||||||||
Change in the market value of redeemable Noncontrolling interest in Operating Partnership
|
—
|
|
|
146
|
|
|
363
|
|
|
—
|
|
|
509
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
509
|
|
|||||||||
Change in fair value of interest rate swap agreements
|
—
|
|
|
—
|
|
|
—
|
|
|
481
|
|
|
481
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
481
|
|
|||||||||
Net income
|
—
|
|
|
—
|
|
|
56,230
|
|
|
—
|
|
|
56,230
|
|
|
1,576
|
|
|
233
|
|
|
1,809
|
|
|
58,039
|
|
|||||||||
Adjustment for Noncontrolling Interests ownership in Operating Partnership
|
—
|
|
|
(1,527
|
)
|
|
—
|
|
|
—
|
|
|
(1,527
|
)
|
|
1,527
|
|
|
—
|
|
|
1,527
|
|
|
—
|
|
|||||||||
Balance at December 31, 2018
|
1,824
|
|
|
2,791,555
|
|
|
(428,307
|
)
|
|
14,433
|
|
|
2,379,505
|
|
|
67,477
|
|
|
678
|
|
|
68,155
|
|
|
2,447,660
|
|
|||||||||
Cumulative effect of changes in accounting standards
|
—
|
|
|
(239
|
)
|
|
—
|
|
|
—
|
|
|
(239
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(239
|
)
|
|||||||||
Net proceeds from sale of common shares
|
74
|
|
|
131,555
|
|
|
—
|
|
|
—
|
|
|
131,629
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
131,629
|
|
|||||||||
Restricted share award grants, net
|
2
|
|
|
7,918
|
|
|
(898
|
)
|
|
—
|
|
|
7,022
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
7,022
|
|
|||||||||
Purchase of OP Units
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(14,023
|
)
|
|
—
|
|
|
(14,023
|
)
|
|
(14,023
|
)
|
|||||||||
Dividends/distributions declared
|
—
|
|
|
—
|
|
|
(172,324
|
)
|
|
—
|
|
|
(172,324
|
)
|
|
(4,947
|
)
|
|
—
|
|
|
(4,947
|
)
|
|
(177,271
|
)
|
|||||||||
Preferred distributions
|
—
|
|
|
—
|
|
|
(1,209
|
)
|
|
—
|
|
|
(1,209
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,209
|
)
|
|||||||||
Issuance of OP Units in connection with acquisition
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
22,598
|
|
|
—
|
|
|
22,598
|
|
|
22,598
|
|
|||||||||
Contributions
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
572
|
|
|
572
|
|
|
572
|
|
|||||||||
Distributions
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(174
|
)
|
|
(174
|
)
|
|
(174
|
)
|
|||||||||
Change in market value of Redeemable Noncontrolling Interest in Operating Partnership
|
—
|
|
|
(309
|
)
|
|
(939
|
)
|
|
—
|
|
|
(1,248
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,248
|
)
|
|||||||||
Buyout of Noncontrolling Interest - partially owned properties
|
—
|
|
|
(122
|
)
|
|
—
|
|
|
—
|
|
|
(122
|
)
|
|
—
|
|
|
(990
|
)
|
|
(990
|
)
|
|
(1,112
|
)
|
|||||||||
Change in fair value of interest rate swap agreements
|
—
|
|
|
—
|
|
|
—
|
|
|
(10,112
|
)
|
|
(10,112
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(10,112
|
)
|
|||||||||
Adjustment for Noncontrolling Interests ownership in Operating Partnership
|
—
|
|
|
1,563
|
|
|
—
|
|
|
—
|
|
|
1,563
|
|
|
(1,563
|
)
|
|
—
|
|
|
(1,563
|
)
|
|
—
|
|
|||||||||
Net income
|
—
|
|
|
—
|
|
|
74,483
|
|
|
—
|
|
|
74,483
|
|
|
2,155
|
|
|
253
|
|
|
2,408
|
|
|
76,891
|
|
|||||||||
Balance at December 31, 2019
|
$
|
1,900
|
|
|
$
|
2,931,921
|
|
|
$
|
(529,194
|
)
|
|
$
|
4,321
|
|
|
$
|
2,408,948
|
|
|
$
|
71,697
|
|
|
$
|
339
|
|
|
$
|
72,036
|
|
|
$
|
2,480,984
|
|
|
Year Ended December 31,
|
||||||||||
|
2019
|
|
2018
|
|
2017
|
||||||
Cash Flows from Operating Activities:
|
|
|
|
|
|
|
|
|
|||
Net income
|
$
|
77,186
|
|
|
$
|
58,321
|
|
|
$
|
39,773
|
|
Adjustments to reconcile net income to net cash provided by operating activities
|
|
|
|
|
|
|
|
|
|||
Depreciation and amortization
|
146,436
|
|
|
158,389
|
|
|
125,159
|
|
|||
Amortization of deferred financing costs
|
2,416
|
|
|
2,428
|
|
|
2,299
|
|
|||
Amortization of lease inducements and above/below-market lease intangibles
|
4,859
|
|
|
4,659
|
|
|
5,083
|
|
|||
Straight-line rental revenue/expense
|
(9,986
|
)
|
|
(21,860
|
)
|
|
(16,202
|
)
|
|||
Amortization of discount on unsecured senior notes
|
603
|
|
|
577
|
|
|
277
|
|
|||
Amortization of above market assumed debt
|
(62
|
)
|
|
(62
|
)
|
|
(178
|
)
|
|||
Gain on sale of investment properties, net
|
(31,309
|
)
|
|
(11,664
|
)
|
|
(5,874
|
)
|
|||
Equity in loss (income) of unconsolidated entities
|
28
|
|
|
(114
|
)
|
|
(183
|
)
|
|||
Distributions from unconsolidated entities
|
119
|
|
|
112
|
|
|
210
|
|
|||
Change in fair value of derivatives
|
1
|
|
|
(6
|
)
|
|
150
|
|
|||
Provision for bad debts
|
2,206
|
|
|
304
|
|
|
123
|
|
|||
Non-cash share compensation
|
10,115
|
|
|
8,681
|
|
|
6,695
|
|
|||
Net change in fair value of contingent consideration
|
(37
|
)
|
|
(50
|
)
|
|
(472
|
)
|
|||
Impairment on investment properties
|
—
|
|
|
—
|
|
|
965
|
|
|||
Change in operating assets and liabilities:
|
|
|
|
|
|
|
|
|
|||
Tenant receivables
|
(5,902
|
)
|
|
230
|
|
|
(2,988
|
)
|
|||
Other assets
|
(2,955
|
)
|
|
(852
|
)
|
|
(533
|
)
|
|||
Accounts payable
|
2,462
|
|
|
(7,137
|
)
|
|
6,600
|
|
|||
Accrued expenses and other liabilities
|
4,997
|
|
|
16,738
|
|
|
19,567
|
|
|||
Net cash provided by operating activities
|
201,177
|
|
|
208,694
|
|
|
180,471
|
|
|||
Cash Flows from Investing Activities:
|
|
|
|
|
|
|
|
|
|||
Proceeds on sale of investment properties
|
20,934
|
|
|
217,222
|
|
|
20,397
|
|
|||
Acquisition of investment properties, net
|
(113,081
|
)
|
|
(236,595
|
)
|
|
(1,268,442
|
)
|
|||
Investment in unconsolidated entities
|
(25,954
|
)
|
|
—
|
|
|
—
|
|
|||
Acquisition of noncontrolling interests
|
(1,112
|
)
|
|
(6,406
|
)
|
|
(8,469
|
)
|
|||
Escrowed cash - acquisition deposits/earnest deposits
|
(10
|
)
|
|
2,780
|
|
|
(1,280
|
)
|
|||
Capital expenditures on investment properties
|
(40,137
|
)
|
|
(34,638
|
)
|
|
(23,243
|
)
|
|||
Pay down of contingent consideration
|
—
|
|
|
—
|
|
|
(156
|
)
|
|||
Issuances of real estate loans receivable
|
(100,744
|
)
|
|
(11,750
|
)
|
|
(39,063
|
)
|
|||
Repayments of real estate loans receivable
|
7,855
|
|
|
15,928
|
|
|
4,711
|
|
|||
Issuances of note receivable
|
—
|
|
|
(20,385
|
)
|
|
—
|
|
|||
Repayments of note receivable
|
—
|
|
|
—
|
|
|
16,423
|
|
|||
Leasing commissions
|
(3,057
|
)
|
|
(3,167
|
)
|
|
(1,449
|
)
|
|||
Lease inducements
|
(2
|
)
|
|
(172
|
)
|
|
(2,067
|
)
|
|||
Net cash used in investing activities
|
(255,308
|
)
|
|
(77,183
|
)
|
|
(1,302,638
|
)
|
|||
Cash Flows from Financing Activities:
|
|
|
|
|
|
|
|
|
|||
Net proceeds from sale of common shares
|
131,629
|
|
|
10,759
|
|
|
844,669
|
|
|||
Proceeds from credit facility borrowings
|
454,000
|
|
|
422,000
|
|
|
927,000
|
|
|||
Repayments on credit facility borrowings
|
(330,000
|
)
|
|
(287,000
|
)
|
|
(1,248,000
|
)
|
|||
Proceeds from issuance of mortgage debt
|
—
|
|
|
—
|
|
|
61,000
|
|
|||
Proceeds from issuance of senior unsecured notes
|
—
|
|
|
—
|
|
|
743,060
|
|
|||
Principal payments on mortgage debt
|
(25,184
|
)
|
|
(78,018
|
)
|
|
(41,503
|
)
|
|||
Debt issuance costs
|
(117
|
)
|
|
(4,540
|
)
|
|
(1,589
|
)
|
|||
Dividends paid - shareholders
|
(170,880
|
)
|
|
(168,060
|
)
|
|
(143,108
|
)
|
|||
Distributions to noncontrolling interests - Operating Partnership
|
(4,838
|
)
|
|
(4,808
|
)
|
|
(4,388
|
)
|
|||
Preferred distributions paid - OP Unit holders
|
(1,176
|
)
|
|
(911
|
)
|
|
(600
|
)
|
|||
Contributions to noncontrolling interests
|
572
|
|
|
—
|
|
|
47
|
|
|||
Distributions to noncontrolling interests - partially owned properties
|
(582
|
)
|
|
(547
|
)
|
|
(748
|
)
|
|||
Payments of employee taxes for withheld stock-based compensation shares
|
(2,076
|
)
|
|
(1,749
|
)
|
|
(2,590
|
)
|
|||
Purchases of Series A Preferred Units
|
—
|
|
|
—
|
|
|
(19,961
|
)
|
|||
Purchases of OP Units
|
(14,023
|
)
|
|
(2,203
|
)
|
|
(3,886
|
)
|
|||
Net cash provided by (used in) financing activities
|
37,325
|
|
|
(115,077
|
)
|
|
1,109,403
|
|
|||
Net (decrease) increase in cash and cash equivalents
|
(16,806
|
)
|
|
16,434
|
|
|
(12,764
|
)
|
|||
Cash and cash equivalents, beginning of year
|
19,161
|
|
|
2,727
|
|
|
15,491
|
|
|||
Cash and cash equivalents, end of year
|
$
|
2,355
|
|
|
$
|
19,161
|
|
|
$
|
2,727
|
|
Supplemental disclosure of cash flow information - interest paid during the year
|
$
|
62,633
|
|
|
$
|
58,705
|
|
|
$
|
38,781
|
|
Supplemental disclosure of noncash activity - change in fair value of interest rate swap agreements and redeemable equity - property
|
$
|
(10,112
|
)
|
|
$
|
481
|
|
|
$
|
244
|
|
Supplemental disclosure of noncash activity - assumed debt
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
43,989
|
|
Supplemental disclosure of noncash activity - issuance of OP Units and Series A Preferred Units in connection with acquisitions
|
$
|
25,200
|
|
|
$
|
22,651
|
|
|
$
|
44,978
|
|
Supplemental disclosure of noncash activity - contingent consideration
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
765
|
|
|
|
|
|
||||
|
December 31,
|
||||||
ASSETS
|
2019
|
|
2018
|
||||
Investment properties:
|
|
|
|
||||
Land and improvements
|
$
|
225,540
|
|
|
$
|
211,253
|
|
Building and improvements
|
3,700,009
|
|
|
3,623,962
|
|
||
Tenant improvements
|
53,931
|
|
|
36,497
|
|
||
Acquired lease intangibles
|
390,450
|
|
|
452,384
|
|
||
|
4,369,930
|
|
|
4,324,096
|
|
||
Accumulated depreciation
|
(540,928
|
)
|
|
(411,052
|
)
|
||
Net real estate property
|
3,829,002
|
|
|
3,913,044
|
|
||
Right-of-use lease assets, net
|
127,933
|
|
|
—
|
|
||
Real estate loans receivable
|
178,240
|
|
|
55,659
|
|
||
Investment in unconsolidated entities
|
66,137
|
|
|
1,330
|
|
||
Net real estate investments
|
4,201,312
|
|
|
3,970,033
|
|
||
Cash and cash equivalents
|
2,355
|
|
|
19,161
|
|
||
Tenant receivables, net
|
7,972
|
|
|
8,881
|
|
||
Other assets
|
134,942
|
|
|
144,759
|
|
||
Total assets
|
$
|
4,346,581
|
|
|
$
|
4,142,834
|
|
LIABILITIES AND CAPITAL
|
|
|
|
||||
Liabilities:
|
|
|
|
||||
Credit facility
|
$
|
583,323
|
|
|
$
|
457,388
|
|
Notes payable
|
967,789
|
|
|
966,961
|
|
||
Mortgage debt
|
83,341
|
|
|
108,504
|
|
||
Accounts payable
|
6,348
|
|
|
3,886
|
|
||
Distributions and distributions payable
|
46,272
|
|
|
43,821
|
|
||
Accrued expenses and other liabilities
|
81,238
|
|
|
76,282
|
|
||
Lease liabilities
|
63,290
|
|
|
—
|
|
||
Acquired lease intangibles, net
|
6,096
|
|
|
13,585
|
|
||
Total liabilities
|
1,837,697
|
|
|
1,670,427
|
|
||
|
|
|
|
||||
Redeemable noncontrolling interest - Series A Preferred Units and partially owned properties
|
27,900
|
|
|
24,747
|
|
||
|
|
|
|
||||
Capital:
|
|
|
|
||||
Partners’ capital:
|
|
|
|
||||
General partners’ capital, 189,975,396 and 182,416,007 units issued and outstanding as of December 31, 2019 and 2018, respectively
|
2,404,627
|
|
|
2,365,072
|
|
||
Limited partners’ capital, 5,666,109 and 5,182,784 units issued and outstanding as of December 31, 2019 and 2018, respectively
|
71,697
|
|
|
67,477
|
|
||
Accumulated other comprehensive income
|
4,321
|
|
|
14,433
|
|
||
Total partners’ capital
|
2,480,645
|
|
|
2,446,982
|
|
||
Noncontrolling interest - partially owned properties
|
339
|
|
|
678
|
|
||
Total capital
|
2,480,984
|
|
|
2,447,660
|
|
||
Total liabilities and capital
|
$
|
4,346,581
|
|
|
$
|
4,142,834
|
|
|
December 31,
|
||||||||||
|
2019
|
|
2018
|
|
2017
|
||||||
Revenues:
|
|
|
|
|
|
|
|
|
|||
Rental revenues
|
$
|
303,264
|
|
|
$
|
313,006
|
|
|
$
|
259,673
|
|
Expense recoveries
|
101,115
|
|
|
97,989
|
|
|
75,425
|
|
|||
Interest income on real estate loans and other
|
10,902
|
|
|
11,556
|
|
|
8,486
|
|
|||
Total revenues
|
415,281
|
|
|
422,551
|
|
|
343,584
|
|
|||
Expenses:
|
|
|
|
|
|
||||||
Interest expense
|
65,022
|
|
|
66,183
|
|
|
47,008
|
|
|||
General and administrative
|
33,099
|
|
|
28,816
|
|
|
22,957
|
|
|||
Operating expenses
|
124,819
|
|
|
122,620
|
|
|
97,035
|
|
|||
Depreciation and amortization
|
146,436
|
|
|
158,389
|
|
|
125,159
|
|
|||
Acquisition expenses
|
—
|
|
|
—
|
|
|
16,744
|
|
|||
Impairment loss
|
—
|
|
|
—
|
|
|
965
|
|
|||
Total expenses
|
369,376
|
|
|
376,008
|
|
|
309,868
|
|
|||
Income before equity in income of unconsolidated entities and gain on sale of investment properties, net:
|
45,905
|
|
|
46,543
|
|
|
33,716
|
|
|||
Equity in (loss) income of unconsolidated entities
|
(28
|
)
|
|
114
|
|
|
183
|
|
|||
Gain on sale of investment properties, net
|
31,309
|
|
|
11,664
|
|
|
5,874
|
|
|||
Net income
|
77,186
|
|
|
58,321
|
|
|
39,773
|
|
|||
Net income attributable to noncontrolling interests - partially owned properties (1)
|
(548
|
)
|
|
(515
|
)
|
|
(491
|
)
|
|||
Net income attributable to controlling interests
|
76,638
|
|
|
57,806
|
|
|
39,282
|
|
|||
Preferred distributions
|
(1,209
|
)
|
|
(1,340
|
)
|
|
(731
|
)
|
|||
Net income attributable to common unitholders
|
$
|
75,429
|
|
|
$
|
56,466
|
|
|
$
|
38,551
|
|
Net income per common unit:
|
|
|
|
|
|
||||||
Basic
|
$
|
0.39
|
|
|
$
|
0.30
|
|
|
$
|
0.23
|
|
Diluted
|
$
|
0.39
|
|
|
$
|
0.30
|
|
|
$
|
0.23
|
|
Weighted average common units:
|
|
|
|
|
|
||||||
Basic
|
191,236,261
|
|
|
187,393,334
|
|
|
167,963,076
|
|
|||
Diluted
|
191,626,320
|
|
|
187,526,762
|
|
|
168,231,299
|
|
|||
Distributions declared per common unit
|
$
|
0.920
|
|
|
$
|
0.920
|
|
|
$
|
0.915
|
|
(1)
|
Includes amounts attributable to redeemable noncontrolling interests.
|
|
December 31,
|
||||||||||
|
2019
|
|
2018
|
|
2017
|
||||||
Net income
|
$
|
77,186
|
|
|
$
|
58,321
|
|
|
$
|
39,773
|
|
Other comprehensive (loss) income:
|
|
|
|
|
|
||||||
Change in fair value of interest rate swap agreements, net
|
(10,112
|
)
|
|
481
|
|
|
244
|
|
|||
Total other comprehensive (loss) income
|
(10,112
|
)
|
|
481
|
|
|
244
|
|
|||
Comprehensive income
|
67,074
|
|
|
58,802
|
|
|
40,017
|
|
|||
Comprehensive income attributable to noncontrolling interests - partially owned properties
|
(548
|
)
|
|
(515
|
)
|
|
(491
|
)
|
|||
Comprehensive income attributable to common unitholders
|
$
|
66,526
|
|
|
$
|
58,287
|
|
|
$
|
39,526
|
|
|
General Partner
|
|
Limited Partner
|
|
Accumulated Other Comprehensive Income
|
|
Total
Partners’ Capital
|
|
Partially
Owned
Properties
Noncontrolling
Interest
|
|
Total
Partners’ Capital
|
||||||||||||
Balance at January 1, 2017
|
$
|
1,724,743
|
|
|
$
|
43,142
|
|
|
$
|
13,708
|
|
|
$
|
1,781,593
|
|
|
$
|
725
|
|
|
$
|
1,782,318
|
|
Net Proceeds from sale of Trust common shares and issuance of common units
|
844,669
|
|
|
—
|
|
|
—
|
|
|
844,669
|
|
|
—
|
|
|
844,669
|
|
||||||
Trust restricted share award grants, net
|
3,821
|
|
|
—
|
|
|
—
|
|
|
3,821
|
|
|
—
|
|
|
3,821
|
|
||||||
Purchase of OP Units
|
—
|
|
|
(3,886
|
)
|
|
—
|
|
|
(3,886
|
)
|
|
—
|
|
|
(3,886
|
)
|
||||||
Conversion of OP Units
|
930
|
|
|
(930
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
OP Units - distributions
|
(153,970
|
)
|
|
(4,867
|
)
|
|
—
|
|
|
(158,837
|
)
|
|
—
|
|
|
(158,837
|
)
|
||||||
Preferred distributions
|
(731
|
)
|
|
—
|
|
|
—
|
|
|
(731
|
)
|
|
—
|
|
|
(731
|
)
|
||||||
Issuance of OP Units in connection with acquisition
|
—
|
|
|
44,259
|
|
|
—
|
|
|
44,259
|
|
|
—
|
|
|
44,259
|
|
||||||
Contributions
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
47
|
|
|
47
|
|
||||||
Distributions
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(321
|
)
|
|
(321
|
)
|
||||||
Buyout of Noncontrolling Interest - partially owned properties
|
(2,800
|
)
|
|
719
|
|
|
—
|
|
|
(2,081
|
)
|
|
(24
|
)
|
|
(2,105
|
)
|
||||||
Change in fair value of interest rate swap agreements and redeemable equity - property
|
(1,317
|
)
|
|
—
|
|
|
244
|
|
|
(1,073
|
)
|
|
—
|
|
|
(1,073
|
)
|
||||||
Net income
|
38,146
|
|
|
1,136
|
|
|
—
|
|
|
39,282
|
|
|
191
|
|
|
39,473
|
|
||||||
Adjustments for Limited Partners ownership in Operating Partnership
|
5,729
|
|
|
(5,729
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Balance at December 31, 2017
|
2,459,220
|
|
|
73,844
|
|
|
13,952
|
|
|
2,547,016
|
|
|
618
|
|
|
2,547,634
|
|
||||||
Net Proceeds from sale of Trust common shares and issuance of common units
|
10,759
|
|
|
—
|
|
|
—
|
|
|
10,759
|
|
|
—
|
|
|
10,759
|
|
||||||
Trust restricted share award grants, net
|
6,513
|
|
|
—
|
|
|
—
|
|
|
6,513
|
|
|
—
|
|
|
6,513
|
|
||||||
Purchase of OP Units
|
—
|
|
|
(2,203
|
)
|
|
—
|
|
|
(2,203
|
)
|
|
—
|
|
|
(2,203
|
)
|
||||||
Conversion of OP Units
|
2,525
|
|
|
(2,525
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
OP Units - distributions
|
(167,817
|
)
|
|
(4,742
|
)
|
|
—
|
|
|
(172,559
|
)
|
|
—
|
|
|
(172,559
|
)
|
||||||
Preferred distributions
|
(1,340
|
)
|
|
—
|
|
|
—
|
|
|
(1,340
|
)
|
|
—
|
|
|
(1,340
|
)
|
||||||
Distributions
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(173
|
)
|
|
(173
|
)
|
||||||
Change in market value of Redeemable Limited Partners
|
146
|
|
|
—
|
|
|
—
|
|
|
146
|
|
|
—
|
|
|
146
|
|
||||||
Change in the market value of Redeemable Noncontrolling Interest in Operating Partnership
|
363
|
|
|
—
|
|
|
—
|
|
|
363
|
|
|
—
|
|
|
363
|
|
||||||
Change in fair value of interest rate swap agreements
|
—
|
|
|
—
|
|
|
481
|
|
|
481
|
|
|
—
|
|
|
481
|
|
||||||
Net income
|
56,230
|
|
|
1,576
|
|
|
—
|
|
|
57,806
|
|
|
233
|
|
|
58,039
|
|
||||||
Adjustments for Limited Partners ownership in Operating Partnership
|
(1,527
|
)
|
|
1,527
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Balance at December 31, 2018
|
2,365,072
|
|
|
67,477
|
|
|
14,433
|
|
|
2,446,982
|
|
|
678
|
|
|
2,447,660
|
|
||||||
Cumulative effect of changes in accounting standard
|
(239
|
)
|
|
—
|
|
|
—
|
|
|
(239
|
)
|
|
—
|
|
|
(239
|
)
|
||||||
Net proceeds from sale of Trust common shares and issuance of common units
|
131,629
|
|
|
—
|
|
|
—
|
|
|
131,629
|
|
|
—
|
|
|
131,629
|
|
||||||
Trust restricted share award grants, net
|
7,022
|
|
|
—
|
|
|
—
|
|
|
7,022
|
|
|
—
|
|
|
7,022
|
|
||||||
Purchase of OP Units
|
—
|
|
|
(14,023
|
)
|
|
—
|
|
|
(14,023
|
)
|
|
—
|
|
|
(14,023
|
)
|
||||||
OP Units - distributions
|
(172,324
|
)
|
|
(4,947
|
)
|
|
—
|
|
|
(177,271
|
)
|
|
—
|
|
|
(177,271
|
)
|
||||||
Preferred distributions
|
(1,209
|
)
|
|
—
|
|
|
—
|
|
|
(1,209
|
)
|
|
—
|
|
|
(1,209
|
)
|
||||||
Issuance of OP Units in connection with acquisitions
|
—
|
|
|
22,598
|
|
|
—
|
|
|
22,598
|
|
|
—
|
|
|
22,598
|
|
||||||
Contributions
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
572
|
|
|
572
|
|
||||||
Distributions
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(174
|
)
|
|
(174
|
)
|
||||||
Change in market value of Redeemable Limited Partners
|
(1,248
|
)
|
|
—
|
|
|
—
|
|
|
(1,248
|
)
|
|
—
|
|
|
(1,248
|
)
|
||||||
Buyout of Noncontrolling Interest - partially owned properties
|
(122
|
)
|
|
—
|
|
|
—
|
|
|
(122
|
)
|
|
(990
|
)
|
|
(1,112
|
)
|
||||||
Change in fair value of interest rate swap agreements
|
—
|
|
|
—
|
|
|
(10,112
|
)
|
|
(10,112
|
)
|
|
—
|
|
|
(10,112
|
)
|
||||||
Net income
|
74,483
|
|
|
2,155
|
|
|
—
|
|
|
76,638
|
|
|
253
|
|
|
76,891
|
|
||||||
Adjustments for Limited Partners ownership in Operating Partnership
|
1,563
|
|
|
(1,563
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Balance at December 31, 2019
|
$
|
2,404,627
|
|
|
$
|
71,697
|
|
|
$
|
4,321
|
|
|
$
|
2,480,645
|
|
|
$
|
339
|
|
|
$
|
2,480,984
|
|
|
Year Ended December 31,
|
||||||||||
|
2019
|
|
2018
|
|
2017
|
||||||
Cash Flows from Operating Activities:
|
|
|
|
|
|
|
|
|
|||
Net income
|
$
|
77,186
|
|
|
$
|
58,321
|
|
|
$
|
39,773
|
|
Adjustments to reconcile net income to net cash provided by operating activities
|
|
|
|
|
|
||||||
Depreciation and amortization
|
146,436
|
|
|
158,389
|
|
|
125,159
|
|
|||
Amortization of deferred financing costs
|
2,416
|
|
|
2,428
|
|
|
2,299
|
|
|||
Amortization of lease inducements and above/below-market lease intangibles
|
4,859
|
|
|
4,659
|
|
|
5,083
|
|
|||
Straight-line rental revenue/expense
|
(9,986
|
)
|
|
(21,860
|
)
|
|
(16,202
|
)
|
|||
Amortization of discount on unsecured senior notes
|
603
|
|
|
577
|
|
|
277
|
|
|||
Amortization of above market assumed debt
|
(62
|
)
|
|
(62
|
)
|
|
(178
|
)
|
|||
Gain on sale of investment properties, net
|
(31,309
|
)
|
|
(11,664
|
)
|
|
(5,874
|
)
|
|||
Equity in loss (income) of unconsolidated entities
|
28
|
|
|
(114
|
)
|
|
(183
|
)
|
|||
Distribution from unconsolidated entities
|
119
|
|
|
112
|
|
|
210
|
|
|||
Change in fair value of derivatives
|
1
|
|
|
(6
|
)
|
|
150
|
|
|||
Provision for bad debts
|
2,206
|
|
|
304
|
|
|
123
|
|
|||
Non-cash share compensation
|
10,115
|
|
|
8,681
|
|
|
6,695
|
|
|||
Net change in fair value of contingent consideration
|
(37
|
)
|
|
(50
|
)
|
|
(472
|
)
|
|||
Impairment on investment properties
|
—
|
|
|
—
|
|
|
965
|
|
|||
Change in operating assets and liabilities:
|
|
|
|
|
|
||||||
Tenant receivables
|
(5,902
|
)
|
|
230
|
|
|
(2,988
|
)
|
|||
Other assets
|
(2,955
|
)
|
|
(852
|
)
|
|
(533
|
)
|
|||
Accounts payable
|
2,462
|
|
|
(7,137
|
)
|
|
6,600
|
|
|||
Accrued expenses and other liabilities
|
4,997
|
|
|
16,738
|
|
|
19,567
|
|
|||
Net cash provided by operating activities
|
201,177
|
|
|
208,694
|
|
|
180,471
|
|
|||
Cash Flows from Investing Activities:
|
|
|
|
|
|
|
|
|
|||
Proceeds on sale of investment properties
|
20,934
|
|
|
217,222
|
|
|
20,397
|
|
|||
Acquisition of investment properties, net
|
(113,081
|
)
|
|
(236,595
|
)
|
|
(1,268,442
|
)
|
|||
Investment in unconsolidated entities
|
(25,954
|
)
|
|
—
|
|
|
—
|
|
|||
Acquisition of non-controlling interests
|
(1,112
|
)
|
|
(6,406
|
)
|
|
(8,469
|
)
|
|||
Escrowed cash - acquisition deposits/earnest deposits
|
(10
|
)
|
|
2,780
|
|
|
(1,280
|
)
|
|||
Capital expenditures on investment properties
|
(40,137
|
)
|
|
(34,638
|
)
|
|
(23,243
|
)
|
|||
Pay down of contingent consideration
|
—
|
|
|
—
|
|
|
(156
|
)
|
|||
Issuance of real estate loans receivable
|
(100,744
|
)
|
|
(11,750
|
)
|
|
(39,063
|
)
|
|||
Repayment of real estate loans receivable
|
7,855
|
|
|
15,928
|
|
|
4,711
|
|
|||
Issuance of note receivable
|
—
|
|
|
(20,385
|
)
|
|
—
|
|
|||
Repayment of note receivable
|
—
|
|
|
—
|
|
|
16,423
|
|
|||
Leasing commissions
|
(3,057
|
)
|
|
(3,167
|
)
|
|
(1,449
|
)
|
|||
Lease inducements
|
(2
|
)
|
|
(172
|
)
|
|
(2,067
|
)
|
|||
Net cash used in investing activities
|
(255,308
|
)
|
|
(77,183
|
)
|
|
(1,302,638
|
)
|
|||
Cash Flows from Financing Activities:
|
|
|
|
|
|
|
|
|
|||
Net proceeds from sale of Trust common shares and issuance of common units
|
131,629
|
|
|
10,759
|
|
|
844,669
|
|
|||
Proceeds from credit facility borrowings
|
454,000
|
|
|
422,000
|
|
|
927,000
|
|
|||
Payment on credit facility borrowings
|
(330,000
|
)
|
|
(287,000
|
)
|
|
(1,248,000
|
)
|
|||
Proceeds from issuance of senior unsecured notes
|
—
|
|
|
—
|
|
|
743,060
|
|
|||
Proceeds from issuance of mortgage debt
|
—
|
|
|
—
|
|
|
61,000
|
|
|||
Principal payments on mortgage debt
|
(25,184
|
)
|
|
(78,018
|
)
|
|
(41,503
|
)
|
|||
Debt issuance costs
|
(117
|
)
|
|
(4,540
|
)
|
|
(1,589
|
)
|
|||
OP Units distributions - General Partner
|
(170,880
|
)
|
|
(168,060
|
)
|
|
(143,108
|
)
|
|||
OP Units distributions - Limited Partner
|
(4,838
|
)
|
|
(4,808
|
)
|
|
(4,388
|
)
|
|||
Preferred OP Units distributions - Limited Partner
|
(1,176
|
)
|
|
(911
|
)
|
|
(600
|
)
|
|||
Contributions to noncontrolling interests
|
572
|
|
|
—
|
|
|
47
|
|
|||
Distributions to noncontrolling interests - partially owned properties
|
(582
|
)
|
|
(547
|
)
|
|
(748
|
)
|
|||
Payments of employee taxes for withheld stock based compensation shares
|
(2,076
|
)
|
|
(1,749
|
)
|
|
(2,590
|
)
|
|||
Purchase of Preferred Limited Partner Units
|
—
|
|
|
—
|
|
|
(19,961
|
)
|
|||
Purchase of Limited Partner Units
|
(14,023
|
)
|
|
(2,203
|
)
|
|
(3,886
|
)
|
|||
Net cash provided by (used in) financing activities
|
37,325
|
|
|
(115,077
|
)
|
|
1,109,403
|
|
|||
Net (decrease) increase in cash and cash equivalents
|
(16,806
|
)
|
|
16,434
|
|
|
(12,764
|
)
|
|||
Cash and cash equivalents, beginning of year
|
19,161
|
|
|
2,727
|
|
|
15,491
|
|
|||
Cash and cash equivalents, end of year
|
$
|
2,355
|
|
|
$
|
19,161
|
|
|
$
|
2,727
|
|
Supplemental disclosure of cash flow information - interest paid during the year
|
$
|
62,633
|
|
|
$
|
58,705
|
|
|
$
|
38,781
|
|
Supplemental disclosure of noncash activity - change in fair value of interest rate swap agreements and redeemable equity - property
|
$
|
(10,112
|
)
|
|
$
|
481
|
|
|
$
|
244
|
|
Supplemental disclosure of noncash activity - assumed debt
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
43,989
|
|
Supplemental disclosure of noncash activity - issuance of OP Units and Series A Preferred Units in connection with acquisitions
|
$
|
25,200
|
|
|
$
|
22,651
|
|
|
$
|
44,978
|
|
Supplemental disclosure of noncash activity - contingent consideration
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
765
|
|
|
2019
|
|
2018
|
||||||||||||||||||
|
Common
shares sold |
|
Weighted
average price |
|
Net
proceeds |
|
Common
shares sold |
|
Weighted
average price |
|
Net
proceeds |
||||||||||
Quarterly period ended March 31
|
1,681,928
|
|
|
$
|
18.61
|
|
|
$
|
30,986
|
|
|
311,786
|
|
|
$
|
17.85
|
|
|
$
|
5,509
|
|
Quarterly period ended June 30
|
971,000
|
|
|
18.66
|
|
|
17,935
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Quarterly period ended September 30
|
3,020,711
|
|
|
17.41
|
|
|
52,070
|
|
|
114,203
|
|
|
17.15
|
|
|
1,947
|
|
||||
Quarterly period ended December 31
|
1,617,500
|
|
|
18.84
|
|
|
30,177
|
|
|
144,562
|
|
|
17.03
|
|
|
2,442
|
|
||||
Year ended December 31
|
7,291,139
|
|
|
$
|
18.17
|
|
|
$
|
131,168
|
|
|
570,551
|
|
|
$
|
17.50
|
|
|
$
|
9,898
|
|
Declaration Date
|
|
Record Date
|
|
Payment Date
|
|
Cash Dividend
per Share/Unit
|
||
December 20, 2019
|
|
January 3, 2020
|
|
January 17, 2020
|
|
$
|
0.230
|
|
September 20, 2019
|
|
October 3, 2019
|
|
October 18, 2019
|
|
$
|
0.230
|
|
June 21, 2019
|
|
July 3, 2019
|
|
July 18, 2019
|
|
$
|
0.230
|
|
March 22, 2019
|
|
April 3, 2019
|
|
April 18, 2019
|
|
$
|
0.230
|
|
December 21, 2018
|
|
January 4, 2019
|
|
January 18, 2019
|
|
$
|
0.230
|
|
September 19, 2018
|
|
October 3, 2018
|
|
October 18, 2018
|
|
$
|
0.230
|
|
June 21, 2018
|
|
July 3, 2018
|
|
July 18, 2018
|
|
$
|
0.230
|
|
March 23, 2018
|
|
April 3, 2018
|
|
April 18, 2018
|
|
$
|
0.230
|
|
December 21, 2017
|
|
January 3, 2018
|
|
January 18, 2018
|
|
$
|
0.230
|
|
September 21, 2017
|
|
October 3, 2017
|
|
October 18, 2017
|
|
$
|
0.230
|
|
June 12, 2017
|
|
July 3, 2017
|
|
July 18, 2017
|
|
$
|
0.230
|
|
March 17, 2017
|
|
April 5, 2017
|
|
April 18, 2017
|
|
$
|
0.225
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2019
|
|
2018
|
|
2017
|
||||||
Per common share and OP Unit:
|
|
|
|
|
|
|
||||||
Ordinary dividends
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
0.4529
|
|
Section 199A Qualified REIT Dividend
|
|
0.4035
|
|
|
0.2825
|
|
|
—
|
|
|||
Qualified dividends
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
Capital gain distributions
|
|
0.0003
|
|
|
—
|
|
|
—
|
|
|||
Non-dividend distributions
|
|
0.5162
|
|
|
0.6375
|
|
|
0.4571
|
|
|||
Total
|
|
$
|
0.9200
|
|
|
$
|
0.9200
|
|
|
$
|
0.9100
|
|
Investment
|
|
|
Location
|
|
Acquisition
Date
|
|
Purchase Price
(in thousands)
|
||
Addition - West TN ASC
|
|
|
Jackson, TN
|
|
January 31, 2019
|
|
$
|
4,271
|
|
Doctors United ASC
|
(1)
|
|
Pasadena, TX
|
|
April 4, 2019
|
|
14,812
|
|
|
NCI Buyout - MN Portfolio
|
|
|
Various
|
|
May 6, 2019
|
|
540
|
|
|
Atlanta Condominium Investments
|
|
|
Atlanta, GA
|
|
June 28, 2019
|
|
8,500
|
|
|
Rockwall II MOB
|
(2)
|
|
Rockwall, TX
|
|
July 26, 2019
|
|
24,006
|
|
|
Shadeland Station Portfolio (2 MOBs)
|
|
|
Indianapolis, IN
|
|
August 2, 2019
|
|
23,296
|
|
|
Noncontrolling Interest Buyout - Rockwall II MOB
|
(2)
|
|
Rockwall, TX
|
|
August 23, 2019
|
|
572
|
|
|
Shell Ridge Portfolio (5 MOBs)
|
(3)
|
|
Walnut Creek, CA
|
|
September 27, 2019
|
|
34,625
|
|
|
ProHealth MOB
|
|
|
Manchester, CT
|
|
October 15, 2019
|
|
11,300
|
|
|
MedCore Realty Eden Hill Joint Venture
|
(4)
|
|
Dover, DE
|
|
October 31, 2019
|
|
8,920
|
|
|
PMAK Joint Venture
|
(5)
|
|
Various
|
|
November 22, 2019
|
|
55,990
|
|
|
Murdock Surgery Center
|
|
|
Port Charlotte, FL
|
|
December 2, 2019
|
|
11,666
|
|
|
Loan Investments
|
|
|
Various
|
|
Various
|
|
128,345
|
|
|
Earn-out Investments
|
(6)
|
|
Various
|
|
Various
|
|
3,208
|
|
|
|
|
|
|
|
|
|
$
|
330,051
|
|
(1)
|
The Operating Partnership partially funded the acquisition by issuing an aggregate 346,989 OP Units valued at approximately $6.5 million on the date of issuance.
|
(2)
|
On July 26, 2019 the Company completed the acquisition of a 97.5% interest in Rockwall II MOB. The Company acquired the remaining interest on August 23, 2019.
|
(3)
|
The Operating Partnership partially funded the acquisition by issuing an aggregate 910,032 OP Units valued at approximately $16.1 million on the date of issuance.
|
(4)
|
The Company purchased a 49% membership interest in this joint venture.
|
(5)
|
The Company purchased a 12% membership interest in this joint venture by contributing 2 properties valued at $39.0 million and paid additional consideration of $17.0 million.
|
(6)
|
The Company completed the settlement of acquisitions related earn-out payments upon execution of leases at two properties. One payment valued at $1.9 million at the time of issuance was funded with the issuance of 8,529 Series A Preferred Units. A second payment valued at $0.7 million at the time of issuance was funded with the issuance of 3,409 Series A Preferred Units. All earn-out payments are considered to be additional purchase price upon each respective property.
|
Property
|
|
|
|
Location
|
|
Acquisition
Date |
|
Purchase Price
(in thousands) |
||
Hazelwood Medical Commons
|
(1)
|
|
|
Maplewood, MN
|
|
January 9, 2018
|
|
$
|
70,702
|
|
Lee's Hill Medical Plaza
|
|
|
|
Fredericksburg, VA
|
|
January 23, 2018
|
|
28,000
|
|
|
Scottsdale, Arizona Land
|
(2)
|
|
|
Scottsdale, AZ
|
|
February 16, 2018
|
|
700
|
|
|
NCI Buyout - Minnesota portfolio
|
(3)
|
|
|
|
|
March 1, 2018
|
|
6,406
|
|
|
HMG Medical Plaza
|
|
|
|
Kingsport, TN
|
|
April 3, 2018
|
|
71,295
|
|
|
Northside Medical Midtown
|
|
|
|
Atlanta, GA
|
|
September 14, 2018
|
|
82,147
|
|
|
Loan Investments
|
(4)
|
|
|
Various
|
|
Various
|
|
11,750
|
|
|
|
|
|
|
|
|
|
|
$
|
271,000
|
|
(1)
|
The Company partially funded the purchase price of this acquisition by issuing a total of 104,172 Series A Preferred Units valued at approximately $22.7 million on the date of issuance.
|
(2)
|
The Company acquired the land beneath a previously acquired facility.
|
(3)
|
The Company acquired an additional 4.2% interest in the Minnesota portfolio joint venture, increasing the Company’s total interest in the joint venture to 99.6%.
|
(4)
|
The Company’s loan investments include 4 separate transactions at a weighted average interest rate of 8.4%.
|
|
December 31, 2019
|
|
December 31, 2018
|
||||
Land
|
$
|
18,394
|
|
|
$
|
17,316
|
|
Building and improvements
|
108,027
|
|
|
217,916
|
|
||
In-place lease intangible
|
14,853
|
|
|
34,358
|
|
||
Above market in-place lease intangible
|
136
|
|
|
1,090
|
|
||
Below market in-place lease intangible
|
(96
|
)
|
|
(959
|
)
|
||
Below market in-place ground lease (1)
|
—
|
|
|
5,329
|
|
||
Right-of-use asset (1)
|
630
|
|
|
—
|
|
||
Receivable
|
54
|
|
|
—
|
|
||
Issuance of OP Units
|
(22,598
|
)
|
|
—
|
|
||
Mortgage escrow
|
(3,718
|
)
|
|
3,790
|
|
||
Prepaid expenses
|
—
|
|
|
(2,628
|
)
|
||
Issuance of Series A Preferred Units
|
(2,602
|
)
|
|
(22,651
|
)
|
||
Net assets acquired
|
$
|
113,080
|
|
|
$
|
253,561
|
|
(1)
|
Effective January 1, 2019, the Company adopted ASC 842, Leases which requires above and below market in-place ground leases to be included in the right-of-use asset.
|
|
Year Ended December 31,
|
||||||||||
|
2019
|
|
2018
|
|
2017
|
||||||
Revenue
|
$
|
3,581
|
|
|
$
|
9,056
|
|
|
$
|
7,197
|
|
|
|
|
|
|
|
||||||
(Loss) income before gain on sale of investment properties, net
|
$
|
(490
|
)
|
|
$
|
3,695
|
|
|
$
|
2,353
|
|
Gain on sale of investment properties, net
|
31,309
|
|
|
—
|
|
|
—
|
|
|||
Net income
|
$
|
30,819
|
|
|
$
|
3,695
|
|
|
$
|
2,353
|
|
|
Year Ended December 31,
|
||||||||||
|
2019
|
|
2018
|
|
2017
|
||||||
Revenue
|
$
|
—
|
|
|
$
|
12,287
|
|
|
$
|
23,960
|
|
|
|
|
|
|
|
||||||
Income before gain on sale of investment properties, net
|
$
|
—
|
|
|
$
|
5,027
|
|
|
$
|
5,765
|
|
Gain on sale of investment properties, net
|
—
|
|
|
11,664
|
|
|
—
|
|
|||
Net income
|
$
|
—
|
|
|
$
|
16,691
|
|
|
$
|
5,765
|
|
|
December 31, 2019
|
|
December 31, 2018
|
||||||||||||||||||||
|
Cost
|
|
Accumulated
Amortization
|
|
Net
|
|
Cost
|
|
Accumulated
Amortization
|
|
Net
|
||||||||||||
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
In-place leases
|
$
|
346,438
|
|
|
$
|
(140,937
|
)
|
|
$
|
205,501
|
|
|
$
|
340,428
|
|
|
$
|
(111,500
|
)
|
|
$
|
228,928
|
|
Above-market leases
|
43,300
|
|
|
(16,856
|
)
|
|
26,444
|
|
|
45,568
|
|
|
(13,621
|
)
|
|
31,947
|
|
||||||
Leasehold interest
|
712
|
|
|
(302
|
)
|
|
410
|
|
|
712
|
|
|
(242
|
)
|
|
470
|
|
||||||
Below-market ground lease (1)
|
—
|
|
|
—
|
|
|
—
|
|
|
65,676
|
|
|
(2,194
|
)
|
|
63,482
|
|
||||||
Right-of-use lease assets
|
129,976
|
|
|
(2,043
|
)
|
|
127,933
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Total
|
$
|
520,426
|
|
|
$
|
(160,138
|
)
|
|
$
|
360,288
|
|
|
$
|
452,384
|
|
|
$
|
(127,557
|
)
|
|
$
|
324,827
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Below-market lease
|
$
|
14,054
|
|
|
$
|
(7,958
|
)
|
|
$
|
6,096
|
|
|
$
|
14,654
|
|
|
$
|
(6,768
|
)
|
|
$
|
7,886
|
|
Above-market ground lease (1)
|
—
|
|
|
—
|
|
|
—
|
|
|
5,965
|
|
|
(266
|
)
|
|
5,699
|
|
||||||
Lease liabilities
|
63,665
|
|
|
(375
|
)
|
|
63,290
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Total
|
$
|
77,719
|
|
|
$
|
(8,333
|
)
|
|
$
|
69,386
|
|
|
$
|
20,619
|
|
|
$
|
(7,034
|
)
|
|
$
|
13,585
|
|
(1)
|
Above- and below-market ground leases are included in the right-of-use asset as of January 1, 2019 due to the implementation of ASU 2016-02, Leases. Further detail is provided in Note 2 (Summary of Significant Accounting Policies).
|
|
December 31,
|
||||||||||
|
2019
|
|
2018
|
|
2017
|
||||||
Amortization expense related to in-place leases
|
$
|
35,984
|
|
|
$
|
50,082
|
|
|
$
|
37,073
|
|
Decrease of rental income related to above-market leases
|
4,354
|
|
|
5,194
|
|
|
5,357
|
|
|||
Decrease of rental income related to leasehold interests
|
59
|
|
|
59
|
|
|
59
|
|
|||
Increase of rental income related to below-market leases
|
1,886
|
|
|
2,718
|
|
|
2,309
|
|
|||
Decrease of operating expense related to above-market ground leases (1)
|
139
|
|
|
139
|
|
|
84
|
|
|||
Increase in operating expense related to below-market ground leases (1)
|
1,219
|
|
|
1,013
|
|
|
810
|
|
(1)
|
Above- and below-market ground leases are included in the right-of-use asset as of January 1, 2019 due to the implementation of ASU 2016-02, Leases. Further detail is provided in Note 2 (Summary of Significant Accounting Policies).
|
|
Net Decrease in
Revenue
|
|
Net Increase in
Expenses
|
||||
2020
|
$
|
2,580
|
|
|
$
|
34,902
|
|
2021
|
2,511
|
|
|
32,371
|
|
||
2022
|
2,059
|
|
|
28,508
|
|
||
2023
|
1,767
|
|
|
25,626
|
|
||
2024
|
1,713
|
|
|
22,392
|
|
||
Thereafter
|
10,128
|
|
|
126,345
|
|
||
Total
|
$
|
20,758
|
|
|
$
|
270,144
|
|
|
December 31,
|
||||||
|
2019
|
|
2018
|
||||
Straight-line rent receivable, net
|
$
|
73,992
|
|
|
$
|
64,245
|
|
Notes receivable
|
22,694
|
|
|
20,628
|
|
||
Lease inducements, net
|
11,415
|
|
|
13,233
|
|
||
Prepaid expenses
|
8,000
|
|
|
16,017
|
|
||
Leasing commissions, net
|
7,986
|
|
|
6,221
|
|
||
Interest rate swap
|
4,933
|
|
|
15,121
|
|
||
Escrows
|
1,886
|
|
|
5,534
|
|
||
Other
|
4,036
|
|
|
3,760
|
|
||
Total
|
$
|
134,942
|
|
|
$
|
144,759
|
|
|
December 31,
|
||||||
|
2019
|
|
2018
|
||||
Fixed interest mortgage notes (1)
|
$
|
76,897
|
|
|
$
|
101,832
|
|
Variable interest mortgage note (2)
|
6,581
|
|
|
6,830
|
|
||
Total mortgage debt
|
83,478
|
|
|
108,662
|
|
||
$850 million unsecured revolving credit facility bearing variable interest of LIBOR plus 1.10%, due September 2022
|
339,000
|
|
|
215,000
|
|
||
$400 million senior unsecured notes bearing fixed interest of 4.30%, due March 2027
|
400,000
|
|
|
400,000
|
|
||
$350 million senior unsecured notes bearing fixed interest of 3.95%, due January 2028
|
350,000
|
|
|
350,000
|
|
||
$250 million unsecured term borrowing bearing fixed interest of 2.32%, due June 2023 (3)
|
250,000
|
|
|
250,000
|
|
||
$150 million senior unsecured notes bearing fixed interest of 4.03% to 4.74%, due January 2023 to 2031
|
150,000
|
|
|
150,000
|
|
||
$75 million senior unsecured notes bearing fixed interest of 4.09% to 4.24%, due August 2025 to 2027
|
75,000
|
|
|
75,000
|
|
||
Total principal
|
1,647,478
|
|
|
1,548,662
|
|
||
Unamortized deferred financing costs
|
(7,677
|
)
|
|
(9,920
|
)
|
||
Unamortized discounts
|
(5,483
|
)
|
|
(6,086
|
)
|
||
Unamortized fair value adjustments
|
135
|
|
|
197
|
|
||
Total debt
|
$
|
1,634,453
|
|
|
$
|
1,532,853
|
|
(1)
|
Fixed interest mortgage notes bearing interest from 3.00% to 5.50%, due in 2020, 2021, 2022, and 2024, with a weighted average interest rate of 4.43% and 4.26% as of December 31, 2019 and December 31, 2018, respectively. The notes are collateralized by five properties with a net book value of $170.2 million and $174.2 million as of December 31, 2019 and December 31, 2018, respectively.
|
(2)
|
Variable interest mortgage note bears variable interest of LIBOR plus 2.75%, for an interest rate of 4.50% and 5.21% as of December 31, 2019 and December 31, 2018, respectively. The note is due in 2028 and is collateralized by one property with a net book value of $8.6 million as of December 31, 2019 and December 31, 2018.
|
(3)
|
The Trust’s borrowings under the term loan feature of the Credit Agreement bear interest at a rate which is determined by the Trust’s credit rating, currently equal to LIBOR + 1.25%. The Trust has entered into a pay-fixed receive-variable interest rate swap, fixing the LIBOR component of this rate at 1.07%.
|
Credit Rating
|
|
Margin for Revolving Loans: Adjusted LIBOR Rate Loans
and Letter of Credit Fee
|
|
Margin for Revolving Loans: Base Rate Loans
|
|
Margin for Term Loans: Adjusted LIBOR Rate Loans
and Letter of Credit Fee
|
|
Margin for Term Loans: Base Rate Loans
|
||
At Least A- or A3
|
|
LIBOR + 0.775%
|
|
—
|
%
|
|
LIBOR + 0.85%
|
|
—
|
%
|
At Least BBB+ or Baa1
|
|
LIBOR + 0.825%
|
|
—
|
%
|
|
LIBOR + 0.90%
|
|
—
|
%
|
At Least BBB or Baa2
|
|
LIBOR + 0.90%
|
|
—
|
%
|
|
LIBOR + 1.00%
|
|
—
|
%
|
At Least BBB- or Baa3
|
|
LIBOR + 1.10%
|
|
0.10
|
%
|
|
LIBOR + 1.25%
|
|
0.25
|
%
|
Below BBB- or Baa3
|
|
LIBOR + 1.45%
|
|
0.45
|
%
|
|
LIBOR + 1.65%
|
|
0.65
|
%
|
2020
|
$
|
25,478
|
|
2021
|
8,296
|
|
|
2022
|
359,825
|
|
|
2023
|
266,008
|
|
|
2024
|
23,669
|
|
|
Thereafter
|
964,202
|
|
|
Total Payments
|
$
|
1,647,478
|
|
Total notional amount
|
|
$
|
250,000
|
|
Effective fixed interest rate
|
(1)
|
2.32
|
%
|
|
Effective date
|
|
7/7/2016
|
|
|
Maturity date
|
|
6/10/2023
|
|
|
Asset balance at December 31, 2019 (included in Other assets)
|
|
$
|
4,933
|
|
Asset balance at December 31, 2018 (included in Other assets)
|
|
$
|
15,121
|
|
(1)
|
1.07% effective swap rate plus 1.25% spread per Credit Agreement.
|
|
December 31,
|
||||||
|
2019
|
|
2018
|
||||
Real estate taxes payable
|
$
|
21,483
|
|
|
$
|
21,043
|
|
Prepaid rent
|
21,037
|
|
|
18,745
|
|
||
Accrued interest
|
16,038
|
|
|
16,038
|
|
||
Accrued expenses
|
4,882
|
|
|
5,122
|
|
||
Embedded derivative
|
4,290
|
|
|
3,673
|
|
||
Security deposits
|
3,472
|
|
|
3,118
|
|
||
Accrued incentive compensation
|
2,248
|
|
|
1,323
|
|
||
Tenant improvement allowance
|
2,155
|
|
|
2,784
|
|
||
Contingent consideration
|
715
|
|
|
753
|
|
||
Other
|
4,918
|
|
|
3,683
|
|
||
Total
|
$
|
81,238
|
|
|
$
|
76,282
|
|
|
Common Shares
|
|
Weighted
Average Grant
Date Fair Value
|
|||
Non-vested at December 31, 2016
|
296,785
|
|
|
$
|
16.16
|
|
Granted
|
143,593
|
|
|
19.74
|
|
|
Vested
|
(266,552
|
)
|
|
16.00
|
|
|
Forfeited
|
(550
|
)
|
|
18.78
|
|
|
Non-vested at December 31, 2017
|
173,276
|
|
|
19.36
|
|
|
Granted
|
206,446
|
|
|
14.87
|
|
|
Vested
|
(153,325
|
)
|
|
19.32
|
|
|
Forfeited
|
(1,258
|
)
|
|
16.27
|
|
|
Non-vested at December 31, 2018
|
225,139
|
|
|
15.29
|
|
|
Granted
|
194,413
|
|
|
17.80
|
|
|
Vested
|
(200,104
|
)
|
|
15.13
|
|
|
Forfeited
|
(2,571
|
)
|
|
16.96
|
|
|
Non-vested at December 31, 2019
|
216,877
|
|
|
$
|
17.67
|
|
|
2019
|
|
2018
|
|
2017
|
||||||
Volatility
|
21.8
|
%
|
|
21.7
|
%
|
|
21.5
|
%
|
|||
Dividend assumption
|
reinvested
|
|
|
reinvested
|
|
|
reinvested
|
|
|||
Expected term in years
|
2.8 years
|
|
|
2.8 years
|
|
|
2.8 years
|
|
|||
Risk-free rate
|
2.53
|
%
|
|
2.40
|
%
|
|
1.68
|
%
|
|||
Stock price (per share)
|
$
|
17.89
|
|
|
$
|
14.78
|
|
|
$
|
19.80
|
|
|
Executive Awards
|
|
Trustee Awards
|
||||||||||
|
Restricted Share
Units
|
|
Weighted
Average Grant
Date Fair Value
|
|
Restricted Share
Units |
|
Weighted
Average Grant Date Fair Value |
||||||
Non-vested at December 31, 2016
|
235,483
|
|
|
$
|
21.84
|
|
|
57,260
|
|
|
$
|
17.03
|
|
Granted
|
174,320
|
|
|
29.34
|
|
|
32,831
|
|
|
19.80
|
|
||
Vested
|
(55,680
|
)
|
(1)
|
16.94
|
|
|
(38,871
|
)
|
|
16.72
|
|
||
Non-vested at December 31, 2017
|
354,123
|
|
|
26.30
|
|
|
51,220
|
|
|
19.04
|
|
||
Granted
|
254,282
|
|
|
16.58
|
|
|
50,745
|
|
|
14.78
|
|
||
Vested
|
(75,250
|
)
|
(2)
|
19.22
|
|
|
(34,807
|
)
|
|
18.67
|
|
||
Non-vested at December 31, 2018
|
533,155
|
|
|
22.66
|
|
|
67,158
|
|
|
16.01
|
|
||
Granted
|
229,884
|
|
|
25.27
|
|
|
41,925
|
|
|
17.89
|
|
||
Vested
|
(104,553
|
)
|
(3)
|
26.33
|
|
|
(41,786
|
)
|
|
16.75
|
|
||
Forfeited
|
(3,734
|
)
|
|
23.08
|
|
|
—
|
|
|
—
|
|
||
Non-vested at December 31, 2019
|
654,752
|
|
|
$
|
22.99
|
|
|
67,297
|
|
|
$
|
16.72
|
|
(1)
|
Restricted units vested by Company executives in 2017 resulted in the issuance of 105,792 common shares, less 50,582 common shares withheld to cover minimum withholding tax obligations, for multiple employees.
|
(2)
|
Restricted units vested by Company executives in 2018 resulted in the issuance of 126,108 common shares, less 56,502 common shares withheld to cover minimum withholding tax obligations, for multiple employees.
|
(3)
|
Restricted units vested by Company executives in 2019 resulted in the issuance of 87,805 common shares, less 35,265 common shares withheld to cover minimum withholding tax obligations, for multiple employees.
|
|
December 31,
|
||||||||||||||
|
2019
|
|
2018
|
||||||||||||
|
Carrying
Amount
|
|
Fair
Value
|
|
Carrying
Amount
|
|
Fair
Value
|
||||||||
Assets:
|
|
|
|
|
|
|
|
||||||||
Real estate loans receivable
|
$
|
178,240
|
|
|
$
|
178,095
|
|
|
$
|
55,659
|
|
|
$
|
54,782
|
|
Notes receivable
|
$
|
22,694
|
|
|
$
|
22,694
|
|
|
$
|
20,628
|
|
|
$
|
20,628
|
|
Derivative assets
|
$
|
4,933
|
|
|
$
|
4,933
|
|
|
$
|
15,121
|
|
|
$
|
15,121
|
|
Liabilities:
|
|
|
|
|
|
|
|
||||||||
Credit facility
|
$
|
(589,000
|
)
|
|
$
|
(589,000
|
)
|
|
$
|
(465,000
|
)
|
|
$
|
(465,000
|
)
|
Notes payable
|
$
|
(975,000
|
)
|
|
$
|
(1,003,385
|
)
|
|
$
|
(975,000
|
)
|
|
$
|
(914,918
|
)
|
Mortgage debt
|
$
|
(83,613
|
)
|
|
$
|
(85,110
|
)
|
|
$
|
(108,859
|
)
|
|
$
|
(107,131
|
)
|
Derivative liabilities
|
$
|
(4,290
|
)
|
|
$
|
(4,290
|
)
|
|
$
|
(3,673
|
)
|
|
$
|
(3,673
|
)
|
2020
|
$
|
294,810
|
|
2021
|
291,816
|
|
|
2022
|
284,665
|
|
|
2023
|
275,541
|
|
|
2024
|
264,209
|
|
|
Thereafter
|
1,046,962
|
|
|
Total
|
$
|
2,458,003
|
|
2020
|
$
|
3,130
|
|
2021
|
3,119
|
|
|
2022
|
3,084
|
|
|
2023
|
3,066
|
|
|
2024
|
3,040
|
|
|
Thereafter
|
141,486
|
|
|
Total undiscounted lease payments
|
$
|
156,925
|
|
Less: Interest
|
(93,635
|
)
|
|
Present value of lease liabilities
|
$
|
63,290
|
|
2019
|
$
|
3,058
|
|
2020
|
3,013
|
|
|
2021
|
3,037
|
|
|
2022
|
3,030
|
|
|
2023
|
3,017
|
|
|
Thereafter
|
143,094
|
|
|
Total
|
$
|
158,249
|
|
|
Year Ended
December 31, 2019 |
||
Operating lease cost
|
$
|
1,896
|
|
Variable lease cost
|
973
|
|
|
Total lease cost
|
$
|
2,869
|
|
Tenant
|
|
Total ABR
|
|
Percent of ABR
|
|||
CommonSpirit - CHI - Nebraska
|
|
$
|
16,809
|
|
|
5.7
|
%
|
Northside Hospital
|
|
13,576
|
|
|
4.6
|
%
|
|
UofL Health - Louisville, Inc.
|
|
11,859
|
|
|
4.0
|
%
|
|
Baylor Scott and White Health
|
|
7,770
|
|
|
2.6
|
%
|
|
US Oncology
|
|
7,563
|
|
|
2.6
|
%
|
|
Remaining portfolio
|
|
235,961
|
|
|
80.5
|
%
|
|
Total
|
|
$
|
293,538
|
|
|
100.0
|
%
|
State
|
|
Total ABR
|
|
Percent of ABR
|
|||
Texas
|
|
$
|
45,602
|
|
|
15.5
|
%
|
Georgia
|
|
25,658
|
|
|
8.7
|
%
|
|
Indiana
|
|
21,372
|
|
|
7.3
|
%
|
|
Nebraska
|
|
18,052
|
|
|
6.2
|
%
|
|
Minnesota
|
|
17,520
|
|
|
6.0
|
%
|
|
Other
|
|
165,334
|
|
|
56.3
|
%
|
|
Total
|
|
$
|
293,538
|
|
|
100.0
|
%
|
|
Year Ended December 31,
|
||||||||||
|
2019
|
|
2018
|
|
2017
|
||||||
Numerator for earnings per share - basic:
|
|
|
|
|
|
||||||
Net income
|
$
|
77,186
|
|
|
$
|
58,321
|
|
|
$
|
39,773
|
|
Net income attributable to noncontrolling interests:
|
|
|
|
|
|
||||||
Operating Partnership
|
(2,155
|
)
|
|
(1,576
|
)
|
|
(1,136
|
)
|
|||
Partially owned properties
|
(548
|
)
|
|
(515
|
)
|
|
(491
|
)
|
|||
Preferred distributions
|
(1,209
|
)
|
|
(1,340
|
)
|
|
(731
|
)
|
|||
Numerator for earnings per share - basic:
|
$
|
73,274
|
|
|
$
|
54,890
|
|
|
$
|
37,415
|
|
Numerator for earnings per share - diluted:
|
|
|
|
|
|
||||||
Numerator for earnings per share - basic:
|
73,274
|
|
|
54,890
|
|
|
37,415
|
|
|||
Operating Partnership net income
|
2,155
|
|
|
1,576
|
|
|
1,136
|
|
|||
Numerator for earnings per share - diluted
|
$
|
75,429
|
|
|
$
|
56,466
|
|
|
$
|
38,551
|
|
Denominator for earnings per share - basic and diluted:
|
|
|
|
|
|
||||||
Weighted average number of shares outstanding - basic
|
185,770,251
|
|
|
182,064,064
|
|
|
163,123,109
|
|
|||
Effect of dilutive securities:
|
|
|
|
|
|
|
|||||
Noncontrolling interest - Operating Partnership units
|
5,466,010
|
|
|
5,329,270
|
|
|
4,839,967
|
|
|||
Restricted common shares
|
103,293
|
|
|
99,129
|
|
|
89,497
|
|
|||
Restricted share units
|
286,766
|
|
|
34,299
|
|
|
178,726
|
|
|||
Denominator for earnings per share - diluted
|
191,626,320
|
|
|
187,526,762
|
|
|
168,231,299
|
|
|||
Earnings per share - basic
|
$
|
0.39
|
|
|
$
|
0.30
|
|
|
$
|
0.23
|
|
Earnings per share - diluted
|
$
|
0.39
|
|
|
$
|
0.30
|
|
|
$
|
0.23
|
|
|
Year Ended December 31,
|
||||||||||
|
2019
|
|
2018
|
|
2017
|
||||||
Numerator for earnings per unit - basic and diluted:
|
|
|
|
|
|
||||||
Net income
|
$
|
77,186
|
|
|
$
|
58,321
|
|
|
$
|
39,773
|
|
Net income attributable to noncontrolling interests -
partially owned properties
|
(548
|
)
|
|
(515
|
)
|
|
(491
|
)
|
|||
Preferred distributions
|
(1,209
|
)
|
|
(1,340
|
)
|
|
(731
|
)
|
|||
Numerator for earnings per unit - basic and diluted
|
$
|
75,429
|
|
|
$
|
56,466
|
|
|
$
|
38,551
|
|
Denominator for earnings per unit - basic and diluted:
|
|
|
|
|
|
||||||
Weighted average number of units outstanding - basic
|
191,236,261
|
|
|
187,393,334
|
|
|
167,963,076
|
|
|||
Effect of dilutive securities:
|
|
|
|
|
|
|
|||||
Restricted common shares
|
103,293
|
|
|
99,129
|
|
|
89,497
|
|
|||
Restricted share units
|
286,766
|
|
|
34,299
|
|
|
178,726
|
|
|||
Denominator for earnings per unit - diluted
|
191,626,320
|
|
|
187,526,762
|
|
|
168,231,299
|
|
|||
Earnings per unit - basic
|
$
|
0.39
|
|
|
$
|
0.30
|
|
|
$
|
0.23
|
|
Earnings per unit - diluted
|
$
|
0.39
|
|
|
$
|
0.30
|
|
|
$
|
0.23
|
|
|
|
Quarter Ended
|
||||||||||||||
2019 (1)
|
|
March 31
|
|
June 30
|
|
September 30
|
|
December 31
|
||||||||
Total revenues
|
|
$
|
105,368
|
|
|
$
|
94,903
|
|
|
$
|
107,593
|
|
|
$
|
107,417
|
|
Net income
|
|
11,500
|
|
|
7,316
|
|
|
15,619
|
|
|
42,751
|
|
||||
Net income attributable to common shareholders
|
|
10,773
|
|
|
6,686
|
|
|
14,735
|
|
|
41,080
|
|
||||
Earnings per share – basic:
|
|
|
|
|
|
|
|
|
||||||||
Net income available to common shareholders
|
|
$
|
0.06
|
|
|
$
|
0.04
|
|
|
$
|
0.08
|
|
|
$
|
0.22
|
|
Weighted average number of shares outstanding
|
|
182,672,863
|
|
|
185,239,471
|
|
|
186,328,500
|
|
|
188,767,069
|
|
||||
Earnings per share – diluted:
|
|
|
|
|
|
|
|
|
||||||||
Net income available to common shareholders
|
|
$
|
0.06
|
|
|
$
|
0.04
|
|
|
$
|
0.08
|
|
|
$
|
0.22
|
|
Weighted average number of shares outstanding
|
|
188,497,308
|
|
|
190,815,892
|
|
|
191,980,222
|
|
|
194,961,039
|
|
|
|
Quarter Ended
|
||||||||||||||
2018 (1)
|
|
March 31
|
|
June 30
|
|
September 30
|
|
December 31
|
||||||||
Total revenues
|
|
$
|
105,223
|
|
|
$
|
106,989
|
|
|
$
|
105,028
|
|
|
$
|
105,311
|
|
Net income
|
|
11,332
|
|
|
12,062
|
|
|
23,771
|
|
|
11,156
|
|
||||
Net income available to common shareholders
|
|
10,421
|
|
|
11,303
|
|
|
22,712
|
|
|
10,454
|
|
||||
Earnings per share – basic:
|
|
|
|
|
|
|
|
|
|
|||||||
Net income available to common shareholders
|
|
$
|
0.06
|
|
|
$
|
0.06
|
|
|
$
|
0.12
|
|
|
$
|
0.06
|
|
Weighted average number of shares outstanding
|
|
181,809,570
|
|
|
182,002,062
|
|
|
182,076,513
|
|
|
182,361,904
|
|
||||
Earnings per share – diluted:
|
|
|
|
|
|
|
|
|
|
|||||||
Net income available to common shareholders
|
|
$
|
0.06
|
|
|
$
|
0.06
|
|
|
$
|
0.12
|
|
|
$
|
0.06
|
|
Weighted average number of shares outstanding
|
|
187,317,243
|
|
|
187,431,132
|
|
|
187,473,230
|
|
|
187,847,406
|
|
|
|
Quarter Ended
|
||||||||||||||
2019 (1)
|
|
March 31
|
|
June 30
|
|
September 30
|
|
December 31
|
||||||||
Total revenues
|
|
$
|
105,368
|
|
|
$
|
94,903
|
|
|
$
|
107,593
|
|
|
$
|
107,417
|
|
Net income
|
|
11,500
|
|
|
7,316
|
|
|
15,619
|
|
|
42,751
|
|
||||
Net income attributable to common unitholders
|
|
11,078
|
|
|
6,886
|
|
|
15,169
|
|
|
42,296
|
|
||||
Earnings per unit – basic:
|
|
|
|
|
|
|
|
|
||||||||
Net income available to common unitholders
|
|
$
|
0.06
|
|
|
$
|
0.04
|
|
|
$
|
0.08
|
|
|
$
|
0.22
|
|
Weighted average number of units outstanding
|
|
187,850,775
|
|
|
190,717,713
|
|
|
191,864,611
|
|
|
194,432,714
|
|
||||
Earnings per unit – diluted:
|
|
|
|
|
|
|
|
|
||||||||
Net income available to common unitholders
|
|
$
|
0.06
|
|
|
$
|
0.04
|
|
|
$
|
0.08
|
|
|
$
|
0.22
|
|
Weighted average number of units outstanding
|
|
188,497,308
|
|
|
190,815,892
|
|
|
191,980,222
|
|
|
194,961,039
|
|
|
|
Quarter Ended
|
||||||||||||||
2018 (1)
|
|
March 31
|
|
June 30
|
|
September 30
|
|
December 31
|
||||||||
Total revenues
|
|
$
|
105,223
|
|
|
$
|
106,989
|
|
|
$
|
105,028
|
|
|
$
|
105,311
|
|
Net income
|
|
11,332
|
|
|
12,062
|
|
|
23,771
|
|
|
11,156
|
|
||||
Net income attributable to common unitholders
|
|
10,734
|
|
|
11,634
|
|
|
23,368
|
|
|
10,730
|
|
||||
Earnings per unit – basic:
|
|
|
|
|
|
|
|
|
||||||||
Net income available to common unitholders
|
|
$
|
0.06
|
|
|
$
|
0.06
|
|
|
$
|
0.12
|
|
|
$
|
0.06
|
|
Weighted average number of units outstanding
|
|
187,264,064
|
|
|
187,394,619
|
|
|
187,367,538
|
|
|
187,544,319
|
|
||||
Earnings per unit – diluted:
|
|
|
|
|
|
|
|
|
|
|||||||
Net income available to common unitholders
|
|
$
|
0.06
|
|
|
$
|
0.06
|
|
|
$
|
0.12
|
|
|
$
|
0.06
|
|
Weighted average number of units outstanding
|
|
187,317,243
|
|
|
187,431,132
|
|
|
187,473,230
|
|
|
187,847,406
|
|
|
|
|
|
|
|
Initial Cost to Company
|
|
|
|
Gross Amount at Which Carried as of Close of Period
|
|
|
|
|
|
|
||||||||||||||||||||||||
Description
|
|
Location
|
|
Encumbrances
|
|
Land
|
|
Buildings and
Improvements
|
|
Cost Capitalized
Subsequent to
Acquisitions
|
|
Land
|
|
Buildings and
Improvements
|
|
Total (1)
|
|
Accumulated
Depreciation
|
|
Year
Built
|
|
Date
Acquired
|
|
Life on Which Building
Depreciation in
Income Statement
is Computed
|
||||||||||||||||
Arrowhead Commons
|
|
Phoenix, AZ
|
|
$
|
—
|
|
|
$
|
740
|
|
|
$
|
2,551
|
|
|
$
|
748
|
|
|
$
|
740
|
|
|
$
|
3,299
|
|
|
$
|
4,039
|
|
|
$
|
(830
|
)
|
|
2004
|
|
5/31/2008
|
|
46
|
Aurora MOB - Shawano
|
|
Green Bay, WI
|
|
—
|
|
|
500
|
|
|
1,566
|
|
|
—
|
|
|
500
|
|
|
1,566
|
|
|
2,066
|
|
|
(305
|
)
|
|
2010
|
|
4/15/2010
|
|
50
|
||||||||
Del Sol Medical Center MOB
|
|
El Paso, TX
|
|
—
|
|
|
860
|
|
|
2,866
|
|
|
461
|
|
|
860
|
|
|
3,327
|
|
|
4,187
|
|
|
(2,142
|
)
|
|
1987
|
|
8/24/2006
|
|
21
|
||||||||
Firehouse Square
|
|
Milwaukee, WI
|
|
—
|
|
|
1,120
|
|
|
2,768
|
|
|
10
|
|
|
1,120
|
|
|
2,778
|
|
|
3,898
|
|
|
(1,146
|
)
|
|
2002
|
|
8/15/2007
|
|
30
|
||||||||
Hackley MOB
|
|
Grand Rapids, MI
|
|
—
|
|
|
1,840
|
|
|
6,402
|
|
|
208
|
|
|
1,840
|
|
|
6,610
|
|
|
8,450
|
|
|
(2,866
|
)
|
|
1968
|
|
12/22/2006
|
|
30
|
||||||||
MeadowView Professional
|
|
Kingsport, TN
|
|
—
|
|
|
2,270
|
|
|
11,344
|
|
|
1,017
|
|
|
2,270
|
|
|
12,361
|
|
|
14,631
|
|
|
(4,830
|
)
|
|
2005
|
|
5/10/2007
|
|
30
|
||||||||
Mid Coast Hospital MOB
|
|
Portland, ME
|
|
6,581
|
|
|
—
|
|
|
11,247
|
|
|
117
|
|
|
—
|
|
|
11,364
|
|
|
11,364
|
|
|
(4,383
|
)
|
|
2008
|
|
5/1/2008
|
|
42
|
||||||||
New Albany MOB
|
|
Columbus, OH
|
|
—
|
|
|
237
|
|
|
2,767
|
|
|
590
|
|
|
237
|
|
|
3,357
|
|
|
3,594
|
|
|
(1,052
|
)
|
|
2000
|
|
1/4/2008
|
|
42
|
||||||||
Remington Medical Commons
|
|
Chicago, IL
|
|
—
|
|
|
895
|
|
|
6,499
|
|
|
403
|
|
|
895
|
|
|
6,902
|
|
|
7,797
|
|
|
(2,741
|
)
|
|
2008
|
|
6/1/2008
|
|
30
|
||||||||
Valley West Hospital MOB
|
|
Chicago, IL
|
|
—
|
|
|
—
|
|
|
6,275
|
|
|
785
|
|
|
—
|
|
|
7,060
|
|
|
7,060
|
|
|
(2,805
|
)
|
|
2007
|
|
11/1/2007
|
|
30
|
||||||||
East El Paso Physicians Medical Center
|
|
El Paso, TX
|
|
—
|
|
|
710
|
|
|
4,500
|
|
|
33
|
|
|
710
|
|
|
4,533
|
|
|
5,243
|
|
|
(815
|
)
|
|
2004
|
|
8/30/2013
|
|
35
|
||||||||
LifeCare 2.0 - Plano
|
|
Plano, TX
|
|
—
|
|
|
3,370
|
|
|
11,689
|
|
|
455
|
|
|
3,370
|
|
|
12,144
|
|
|
15,514
|
|
|
(3,123
|
)
|
|
1987
|
|
9/18/2013
|
|
25
|
||||||||
Crescent City Surgical Centre
|
|
New Orleans, LA
|
|
—
|
|
|
—
|
|
|
34,208
|
|
|
—
|
|
|
—
|
|
|
34,208
|
|
|
34,208
|
|
|
(4,454
|
)
|
|
2010
|
|
9/30/2013
|
|
48
|
||||||||
Foundations Surgical Affiliates MOB
|
|
Oklahoma City, OK
|
|
6,691
|
|
|
1,300
|
|
|
12,724
|
|
|
—
|
|
|
1,300
|
|
|
12,724
|
|
|
14,024
|
|
|
(1,849
|
)
|
|
2004
|
|
9/30/2013
|
|
43
|
||||||||
Eastwind Surgical Center
|
|
Columbus, OH
|
|
—
|
|
|
981
|
|
|
7,620
|
|
|
—
|
|
|
981
|
|
|
7,620
|
|
|
8,601
|
|
|
(1,054
|
)
|
|
2007
|
|
11/27/2013
|
|
44
|
||||||||
Great Falls ASC
|
|
Great Falls, MT
|
|
—
|
|
|
203
|
|
|
3,224
|
|
|
85
|
|
|
203
|
|
|
3,309
|
|
|
3,512
|
|
|
(613
|
)
|
|
1999
|
|
12/11/2013
|
|
33
|
||||||||
Foundation Surgical Hospital of San Antonio
|
|
San Antonio, TX
|
|
—
|
|
|
2,230
|
|
|
23,346
|
|
|
43
|
|
|
2,230
|
|
|
23,389
|
|
|
25,619
|
|
|
(4,443
|
)
|
|
2007
|
|
2/19/2014
|
|
35
|
||||||||
21st Century Radiation Oncology - Sarasota
|
|
Sarasota, FL
|
|
—
|
|
|
633
|
|
|
6,557
|
|
|
—
|
|
|
633
|
|
|
6,557
|
|
|
7,190
|
|
|
(1,475
|
)
|
|
1975
|
|
2/26/2014
|
|
27
|
||||||||
21st Century Radiation Oncology - Venice
|
|
Venice, FL
|
|
—
|
|
|
814
|
|
|
2,952
|
|
|
—
|
|
|
814
|
|
|
2,952
|
|
|
3,766
|
|
|
(555
|
)
|
|
1987
|
|
2/26/2014
|
|
35
|
||||||||
21st Century Radiation Oncology - Englewood
|
|
Englewood, FL
|
|
—
|
|
|
350
|
|
|
1,878
|
|
|
—
|
|
|
350
|
|
|
1,878
|
|
|
2,228
|
|
|
(318
|
)
|
|
1992
|
|
2/26/2014
|
|
38
|
||||||||
Foundation Healthplex of San Antonio
|
|
San Antonio, TX
|
|
—
|
|
|
911
|
|
|
4,189
|
|
|
—
|
|
|
911
|
|
|
4,189
|
|
|
5,100
|
|
|
(730
|
)
|
|
2007
|
|
2/28/2014
|
|
35
|
||||||||
Peachtree Dunwoody Medical Center
|
|
Atlanta, GA
|
|
8,500
|
|
|
—
|
|
|
52,481
|
|
|
142
|
|
|
—
|
|
|
52,623
|
|
|
52,623
|
|
|
(9,966
|
)
|
|
1987
|
|
2/28/2014
|
|
25
|
||||||||
LifeCare 2.0 - Fort Worth
|
|
Fort Worth, TX
|
|
—
|
|
|
2,730
|
|
|
24,639
|
|
|
—
|
|
|
2,730
|
|
|
24,639
|
|
|
27,369
|
|
|
(4,849
|
)
|
|
1985
|
|
3/28/2014
|
|
30
|
||||||||
LifeCare 2.0 - Pittsburgh
|
|
Pittsburgh, PA
|
|
—
|
|
|
1,142
|
|
|
11,737
|
|
|
—
|
|
|
1,142
|
|
|
11,737
|
|
|
12,879
|
|
|
(2,414
|
)
|
|
1987
|
|
3/28/2014
|
|
30
|
||||||||
Pinnacle Health MOB - Wormleysburg
|
|
Harrisburg, PA
|
|
—
|
|
|
795
|
|
|
4,601
|
|
|
31
|
|
|
795
|
|
|
4,632
|
|
|
5,427
|
|
|
(1,132
|
)
|
|
1990
|
|
4/22/2014
|
|
25
|
||||||||
Pinnacle Health MOB - Carlisle
|
|
Carlisle, PA
|
|
—
|
|
|
424
|
|
|
2,232
|
|
|
—
|
|
|
424
|
|
|
2,232
|
|
|
2,656
|
|
|
(394
|
)
|
|
2002
|
|
4/22/2014
|
|
35
|
||||||||
South Bend Orthopaedics MOB
|
|
Mishawaka, IN
|
|
—
|
|
|
2,418
|
|
|
11,355
|
|
|
—
|
|
|
2,418
|
|
|
11,355
|
|
|
13,773
|
|
|
(1,846
|
)
|
|
2007
|
|
4/30/2014
|
|
40
|
||||||||
Grenada Medical Complex
|
|
Grenada, MS
|
|
—
|
|
|
185
|
|
|
5,820
|
|
|
144
|
|
|
185
|
|
|
5,964
|
|
|
6,149
|
|
|
(1,349
|
)
|
|
1975
|
|
4/30/2014
|
|
30
|
||||||||
Mississippi Sports Medicine & Orthopedics
|
|
Jackson, MS
|
|
—
|
|
|
1,272
|
|
|
14,177
|
|
|
626
|
|
|
1,272
|
|
|
14,803
|
|
|
16,075
|
|
|
(2,588
|
)
|
|
1987
|
|
5/23/2014
|
|
35
|
||||||||
Carmel Medical Pavilion
|
|
Carmel, IN
|
|
—
|
|
|
—
|
|
|
3,917
|
|
|
281
|
|
|
—
|
|
|
4,198
|
|
|
4,198
|
|
|
(944
|
)
|
|
1993
|
|
5/28/2014
|
|
25
|
||||||||
Renaissance ASC
|
|
Oshkosh, WI
|
|
—
|
|
|
228
|
|
|
7,658
|
|
|
17
|
|
|
228
|
|
|
7,675
|
|
|
7,903
|
|
|
(1,098
|
)
|
|
2007
|
|
6/30/2014
|
|
40
|
||||||||
Summit Urology
|
|
Bloomington, IN
|
|
—
|
|
|
125
|
|
|
4,792
|
|
|
—
|
|
|
125
|
|
|
4,792
|
|
|
4,917
|
|
|
(901
|
)
|
|
1996
|
|
6/30/2014
|
|
30
|
||||||||
IU Health - 500 Landmark
|
|
Bloomington, IN
|
|
—
|
|
|
627
|
|
|
3,549
|
|
|
—
|
|
|
627
|
|
|
3,549
|
|
|
4,176
|
|
|
(581
|
)
|
|
2000
|
|
7/1/2014
|
|
35
|
||||||||
IU Health - 550 Landmark
|
|
Bloomington, IN
|
|
—
|
|
|
2,717
|
|
|
15,224
|
|
|
—
|
|
|
2,717
|
|
|
15,224
|
|
|
17,941
|
|
|
(2,492
|
)
|
|
2000
|
|
7/1/2014
|
|
35
|
||||||||
IU Health - 574 Landmark
|
|
Bloomington, IN
|
|
—
|
|
|
418
|
|
|
1,493
|
|
|
—
|
|
|
418
|
|
|
1,493
|
|
|
1,911
|
|
|
(250
|
)
|
|
2004
|
|
7/1/2014
|
|
35
|
||||||||
Carlisle II MOB
|
|
Carlisle, PA
|
|
—
|
|
|
412
|
|
|
3,962
|
|
|
—
|
|
|
412
|
|
|
3,962
|
|
|
4,374
|
|
|
(502
|
)
|
|
1996
|
|
7/25/2014
|
|
45
|
||||||||
Surgical Institute of Monroe
|
|
Monroe, MI
|
|
—
|
|
|
410
|
|
|
5,743
|
|
|
—
|
|
|
410
|
|
|
5,743
|
|
|
6,153
|
|
|
(1,045
|
)
|
|
2010
|
|
7/28/2014
|
|
35
|
||||||||
Oaks Medical Building
|
|
Lady Lake, FL
|
|
—
|
|
|
1,065
|
|
|
8,642
|
|
|
—
|
|
|
1,065
|
|
|
8,642
|
|
|
9,707
|
|
|
(1,126
|
)
|
|
2011
|
|
7/31/2014
|
|
42
|
||||||||
Mansfield ASC
|
|
Mansfield, TX
|
|
—
|
|
|
1,491
|
|
|
6,471
|
|
|
—
|
|
|
1,491
|
|
|
6,471
|
|
|
7,962
|
|
|
(827
|
)
|
|
2010
|
|
9/2/2014
|
|
46
|
||||||||
Eye Center of Southern Indiana
|
|
Bloomington, IN
|
|
—
|
|
|
910
|
|
|
11,477
|
|
|
—
|
|
|
910
|
|
|
11,477
|
|
|
12,387
|
|
|
(1,814
|
)
|
|
1995
|
|
9/5/2014
|
|
35
|
||||||||
Zangmeister Cancer Center
|
|
Columbus, OH
|
|
—
|
|
|
1,610
|
|
|
31,120
|
|
|
4
|
|
|
1,610
|
|
|
31,124
|
|
|
32,734
|
|
|
(4,272
|
)
|
|
2007
|
|
9/30/2014
|
|
40
|
||||||||
Orthopedic One - Columbus
|
|
Columbus, OH
|
|
—
|
|
|
—
|
|
|
16,234
|
|
|
37
|
|
|
—
|
|
|
16,271
|
|
|
16,271
|
|
|
(2,115
|
)
|
|
2009
|
|
9/30/2014
|
|
45
|
||||||||
Orthopedic One - Westerville
|
|
Columbus, OH
|
|
—
|
|
|
362
|
|
|
3,944
|
|
|
—
|
|
|
362
|
|
|
3,944
|
|
|
4,306
|
|
|
(530
|
)
|
|
2007
|
|
9/30/2014
|
|
43
|
||||||||
South Point Medical Center
|
|
Columbus, OH
|
|
—
|
|
|
—
|
|
|
5,950
|
|
|
—
|
|
|
—
|
|
|
5,950
|
|
|
5,950
|
|
|
(906
|
)
|
|
2007
|
|
9/30/2014
|
|
38
|
||||||||
3100 Lee Trevino Drive
|
|
El Paso, TX
|
|
—
|
|
|
2,294
|
|
|
11,316
|
|
|
487
|
|
|
2,294
|
|
|
11,803
|
|
|
14,097
|
|
|
(2,200
|
)
|
|
1983
|
|
9/30/2014
|
|
30
|
||||||||
1755 Curie
|
|
El Paso, TX
|
|
—
|
|
|
2,283
|
|
|
24,543
|
|
|
659
|
|
|
2,283
|
|
|
25,202
|
|
|
27,485
|
|
|
(4,510
|
)
|
|
1970
|
|
9/30/2014
|
|
30
|
||||||||
9999 Kenworthy
|
|
El Paso, TX
|
|
—
|
|
|
728
|
|
|
2,178
|
|
|
492
|
|
|
728
|
|
|
2,670
|
|
|
3,398
|
|
|
(408
|
)
|
|
1983
|
|
9/30/2014
|
|
35
|
||||||||
32 Northeast MOB
|
|
Harrisburg, PA
|
|
—
|
|
|
408
|
|
|
3,232
|
|
|
147
|
|
|
408
|
|
|
3,379
|
|
|
3,787
|
|
|
(582
|
)
|
|
1994
|
|
10/29/2014
|
|
33
|
||||||||
4518 Union Deposit MOB
|
|
Harrisburg, PA
|
|
—
|
|
|
617
|
|
|
7,305
|
|
|
15
|
|
|
617
|
|
|
7,320
|
|
|
7,937
|
|
|
(1,312
|
)
|
|
2000
|
|
10/29/2014
|
|
31
|
||||||||
4520 Union Deposit MOB
|
|
Harrisburg, PA
|
|
—
|
|
|
169
|
|
|
2,055
|
|
|
29
|
|
|
169
|
|
|
2,084
|
|
|
2,253
|
|
|
(400
|
)
|
|
1997
|
|
10/29/2014
|
|
28
|
||||||||
240 Grandview MOB
|
|
Harrisburg, PA
|
|
—
|
|
|
321
|
|
|
4,242
|
|
|
175
|
|
|
321
|
|
|
4,417
|
|
|
4,738
|
|
|
(674
|
)
|
|
1980
|
|
10/29/2014
|
|
35
|
||||||||
Market Place Way MOB
|
|
Harrisburg, PA
|
|
—
|
|
|
808
|
|
|
2,383
|
|
|
32
|
|
|
808
|
|
|
2,415
|
|
|
3,223
|
|
|
(508
|
)
|
|
2004
|
|
10/29/2014
|
|
35
|
||||||||
Middletown Medical - Maltese
|
|
Middletown, NY
|
|
—
|
|
|
670
|
|
|
9,921
|
|
|
37
|
|
|
670
|
|
|
9,958
|
|
|
10,628
|
|
|
(1,499
|
)
|
|
1988
|
|
11/28/2014
|
|
35
|
||||||||
Middletown Medical - Edgewater
|
|
Middletown, NY
|
|
—
|
|
|
200
|
|
|
2,966
|
|
|
11
|
|
|
200
|
|
|
2,977
|
|
|
3,177
|
|
|
(448
|
)
|
|
1992
|
|
11/28/2014
|
|
35
|
||||||||
Napoleon MOB
|
|
New Orleans, LA
|
|
—
|
|
|
1,202
|
|
|
7,412
|
|
|
1,280
|
|
|
1,202
|
|
|
8,692
|
|
|
9,894
|
|
|
(1,830
|
)
|
|
1974
|
|
12/19/2014
|
|
25
|
||||||||
West Tennessee ASC
|
|
Jackson, TN
|
|
—
|
|
|
1,661
|
|
|
2,960
|
|
|
7,116
|
|
|
1,661
|
|
|
10,076
|
|
|
11,737
|
|
|
(835
|
)
|
|
1991
|
|
12/30/2014
|
|
44
|
||||||||
Southdale Place
|
|
Edina MN
|
|
—
|
|
|
504
|
|
|
10,006
|
|
|
1,694
|
|
|
504
|
|
|
11,700
|
|
|
12,204
|
|
|
(2,625
|
)
|
|
1979
|
|
1/22/2015
|
|
24
|
||||||||
Crystal MOB
|
|
Crystal, MN
|
|
—
|
|
|
945
|
|
|
11,862
|
|
|
51
|
|
|
945
|
|
|
11,913
|
|
|
12,858
|
|
|
(1,485
|
)
|
|
2012
|
|
1/22/2015
|
|
47
|
|
|
|
|
|
|
Initial Cost to Company
|
|
|
|
Gross Amount at Which Carried as of Close of Period
|
|
|
|
|
|
|
||||||||||||||||||||||||
Description
|
|
Location
|
|
Encumbrances
|
|
Land
|
|
Buildings and
Improvements
|
|
Cost Capitalized
Subsequent to
Acquisitions
|
|
Land
|
|
Buildings and
Improvements
|
|
Total (1)
|
|
Accumulated
Depreciation
|
|
Year
Built
|
|
Date
Acquired
|
|
Life on Which Building
Depreciation in
Income Statement
is Computed
|
||||||||||||||||
Savage MOB
|
|
Savage, MN
|
|
5,109
|
|
|
1,281
|
|
|
10,021
|
|
|
—
|
|
|
1,281
|
|
|
10,021
|
|
|
11,302
|
|
|
(1,299
|
)
|
|
2011
|
|
1/22/2015
|
|
48
|
||||||||
Dell MOB
|
|
Chanhassen, MN
|
|
—
|
|
|
800
|
|
|
4,520
|
|
|
178
|
|
|
800
|
|
|
4,698
|
|
|
5,498
|
|
|
(676
|
)
|
|
2008
|
|
1/22/2015
|
|
43
|
||||||||
Methodist Sports
|
|
Greenwood, IN
|
|
—
|
|
|
1,050
|
|
|
8,556
|
|
|
—
|
|
|
1,050
|
|
|
8,556
|
|
|
9,606
|
|
|
(1,339
|
)
|
|
2008
|
|
1/28/2015
|
|
33
|
||||||||
Vadnais Heights MOB
|
|
Vadnais Heights, MN
|
|
—
|
|
|
2,751
|
|
|
12,233
|
|
|
—
|
|
|
2,751
|
|
|
12,233
|
|
|
14,984
|
|
|
(1,802
|
)
|
|
2013
|
|
1/29/2015
|
|
43
|
||||||||
Minnetonka MOB
|
|
Minnetonka, MN
|
|
—
|
|
|
1,770
|
|
|
19,797
|
|
|
—
|
|
|
1,770
|
|
|
19,797
|
|
|
21,567
|
|
|
(2,454
|
)
|
|
2014
|
|
2/5/2015
|
|
49
|
||||||||
Jamestown
|
|
Jamestown, ND
|
|
—
|
|
|
656
|
|
|
9,440
|
|
|
298
|
|
|
656
|
|
|
9,738
|
|
|
10,394
|
|
|
(1,457
|
)
|
|
2013
|
|
2/5/2015
|
|
43
|
||||||||
Indiana American 3
|
|
Greenwood, IN
|
|
—
|
|
|
862
|
|
|
6,901
|
|
|
1,071
|
|
|
862
|
|
|
7,972
|
|
|
8,834
|
|
|
(1,290
|
)
|
|
2008
|
|
2/13/2015
|
|
38
|
||||||||
Indiana American 2
|
|
Greenwood, IN
|
|
—
|
|
|
741
|
|
|
1,846
|
|
|
550
|
|
|
741
|
|
|
2,396
|
|
|
3,137
|
|
|
(488
|
)
|
|
2001
|
|
2/13/2015
|
|
31
|
||||||||
Indiana American 4
|
|
Greenwood, IN
|
|
—
|
|
|
771
|
|
|
1,928
|
|
|
287
|
|
|
771
|
|
|
2,215
|
|
|
2,986
|
|
|
(402
|
)
|
|
2001
|
|
2/13/2015
|
|
31
|
||||||||
8920 Southpointe
|
|
Indianapolis, IN
|
|
—
|
|
|
563
|
|
|
1,741
|
|
|
473
|
|
|
563
|
|
|
2,214
|
|
|
2,777
|
|
|
(578
|
)
|
|
1993
|
|
2/13/2015
|
|
27
|
||||||||
Minnesota Eye MOB
|
|
Minnetonka, MN
|
|
—
|
|
|
1,143
|
|
|
7,470
|
|
|
—
|
|
|
1,143
|
|
|
7,470
|
|
|
8,613
|
|
|
(1,010
|
)
|
|
2014
|
|
2/17/2015
|
|
44
|
||||||||
Baylor Cancer Center- Carrollton
|
|
Dallas, TX
|
|
—
|
|
|
855
|
|
|
6,007
|
|
|
57
|
|
|
855
|
|
|
6,064
|
|
|
6,919
|
|
|
(733
|
)
|
|
2001
|
|
2/27/2015
|
|
43
|
||||||||
Bridgeport Medical Center
|
|
Lakewood, WA
|
|
—
|
|
|
1,397
|
|
|
10,435
|
|
|
238
|
|
|
1,397
|
|
|
10,673
|
|
|
12,070
|
|
|
(1,543
|
)
|
|
2004
|
|
2/27/2015
|
|
35
|
||||||||
Renaissance Office Building
|
|
Milwaukee, WI
|
|
—
|
|
|
1,379
|
|
|
4,182
|
|
|
6,745
|
|
|
1,379
|
|
|
10,927
|
|
|
12,306
|
|
|
(2,252
|
)
|
|
1896
|
|
3/27/2015
|
|
15
|
||||||||
Calkins 125
|
|
Rochester, NY
|
|
—
|
|
|
534
|
|
|
10,164
|
|
|
779
|
|
|
534
|
|
|
10,943
|
|
|
11,477
|
|
|
(1,873
|
)
|
|
1997
|
|
3/31/2015
|
|
32
|
||||||||
Calkins 200
|
|
Rochester, NY
|
|
—
|
|
|
210
|
|
|
3,317
|
|
|
58
|
|
|
210
|
|
|
3,375
|
|
|
3,585
|
|
|
(594
|
)
|
|
2000
|
|
3/31/2015
|
|
38
|
||||||||
Calkins 300
|
|
Rochester, NY
|
|
—
|
|
|
372
|
|
|
6,645
|
|
|
42
|
|
|
372
|
|
|
6,687
|
|
|
7,059
|
|
|
(1,003
|
)
|
|
2002
|
|
3/31/2015
|
|
39
|
||||||||
Calkins 400
|
|
Rochester, NY
|
|
—
|
|
|
353
|
|
|
8,226
|
|
|
159
|
|
|
353
|
|
|
8,385
|
|
|
8,738
|
|
|
(1,319
|
)
|
|
2007
|
|
3/31/2015
|
|
39
|
||||||||
Calkins 500
|
|
Rochester, NY
|
|
—
|
|
|
282
|
|
|
7,074
|
|
|
56
|
|
|
282
|
|
|
7,130
|
|
|
7,412
|
|
|
(1,021
|
)
|
|
2008
|
|
3/31/2015
|
|
41
|
||||||||
Premier Surgery Center of Louisville
|
|
Louisville, KY
|
|
—
|
|
|
1,106
|
|
|
5,437
|
|
|
—
|
|
|
1,106
|
|
|
5,437
|
|
|
6,543
|
|
|
(645
|
)
|
|
2013
|
|
4/10/2015
|
|
43
|
||||||||
Baton Rouge Surgery Center
|
|
Baton Rouge, LA
|
|
—
|
|
|
711
|
|
|
7,720
|
|
|
13
|
|
|
711
|
|
|
7,733
|
|
|
8,444
|
|
|
(1,098
|
)
|
|
2003
|
|
4/15/2015
|
|
35
|
||||||||
Healthpark Surgery Center
|
|
Grand Blanc, MI
|
|
—
|
|
|
—
|
|
|
17,624
|
|
|
52
|
|
|
—
|
|
|
17,676
|
|
|
17,676
|
|
|
(2,514
|
)
|
|
2006
|
|
4/30/2015
|
|
36
|
||||||||
Northern Ohio Medical Center
|
|
Sheffield, OH
|
|
—
|
|
|
644
|
|
|
9,162
|
|
|
—
|
|
|
644
|
|
|
9,162
|
|
|
9,806
|
|
|
(2,174
|
)
|
|
1999
|
|
5/28/2015
|
|
20
|
||||||||
University of Michigan Center for Specialty Care
|
|
Livonia, MI
|
|
—
|
|
|
2,200
|
|
|
8,627
|
|
|
205
|
|
|
2,200
|
|
|
8,832
|
|
|
11,032
|
|
|
(1,450
|
)
|
|
1988
|
|
5/29/2015
|
|
30
|
||||||||
Coon Rapids Medical Center
|
|
Coon Rapids, MN
|
|
—
|
|
|
607
|
|
|
5,857
|
|
|
14
|
|
|
607
|
|
|
5,871
|
|
|
6,478
|
|
|
(831
|
)
|
|
2007
|
|
6/1/2015
|
|
35
|
||||||||
Premier RPM
|
|
Bloomington, IN
|
|
—
|
|
|
872
|
|
|
10,537
|
|
|
—
|
|
|
872
|
|
|
10,537
|
|
|
11,409
|
|
|
(1,295
|
)
|
|
2008
|
|
6/5/2015
|
|
39
|
||||||||
Palm Beach ASC
|
|
Palm Beach, FL
|
|
—
|
|
|
2,576
|
|
|
7,675
|
|
|
—
|
|
|
2,576
|
|
|
7,675
|
|
|
10,251
|
|
|
(912
|
)
|
|
2003
|
|
6/26/2015
|
|
40
|
||||||||
Brookstone Physician Center
|
|
Jacksonville, AL
|
|
—
|
|
|
—
|
|
|
1,913
|
|
|
—
|
|
|
—
|
|
|
1,913
|
|
|
1,913
|
|
|
(299
|
)
|
|
2007
|
|
6/30/2015
|
|
31
|
||||||||
Hillside Medical Center
|
|
Hanover, PA
|
|
—
|
|
|
812
|
|
|
13,217
|
|
|
358
|
|
|
812
|
|
|
13,575
|
|
|
14,387
|
|
|
(1,811
|
)
|
|
2003
|
|
6/30/2015
|
|
35
|
||||||||
Randall Road MOB
|
|
Elgin, IL
|
|
—
|
|
|
1,124
|
|
|
15,404
|
|
|
1,127
|
|
|
1,124
|
|
|
16,531
|
|
|
17,655
|
|
|
(1,954
|
)
|
|
2006
|
|
6/30/2015
|
|
38
|
||||||||
JFK Medical Center MOB
|
|
Atlantis, FL
|
|
—
|
|
|
—
|
|
|
7,560
|
|
|
6
|
|
|
—
|
|
|
7,566
|
|
|
7,566
|
|
|
(989
|
)
|
|
2002
|
|
7/24/2015
|
|
37
|
||||||||
Grove City Health Center
|
|
Grove City, OH
|
|
—
|
|
|
1,363
|
|
|
8,516
|
|
|
—
|
|
|
1,363
|
|
|
8,516
|
|
|
9,879
|
|
|
(1,164
|
)
|
|
2001
|
|
7/31/2015
|
|
37
|
||||||||
Trios Health MOB
|
|
Kennewick, WA
|
|
—
|
|
|
1,492
|
|
|
55,178
|
|
|
3,795
|
|
|
1,492
|
|
|
58,973
|
|
|
60,465
|
|
|
(5,864
|
)
|
|
2015
|
|
7/31/2015
|
|
45
|
||||||||
Abrazo Scottsdale MOB
|
|
Phoenix, AZ
|
|
—
|
|
|
—
|
|
|
25,893
|
|
|
367
|
|
|
—
|
|
|
26,260
|
|
|
26,260
|
|
|
(3,000
|
)
|
|
2004
|
|
8/14/2015
|
|
43
|
||||||||
Avondale MOB
|
|
Avondale, AZ
|
|
—
|
|
|
1,818
|
|
|
18,108
|
|
|
65
|
|
|
1,818
|
|
|
18,173
|
|
|
19,991
|
|
|
(1,898
|
)
|
|
2006
|
|
8/19/2015
|
|
45
|
||||||||
Palm Valley MOB
|
|
Goodyear, AZ
|
|
—
|
|
|
2,666
|
|
|
28,655
|
|
|
121
|
|
|
2,666
|
|
|
28,776
|
|
|
31,442
|
|
|
(3,142
|
)
|
|
2006
|
|
8/19/2015
|
|
43
|
||||||||
North Mountain MOB
|
|
Phoenix, AZ
|
|
—
|
|
|
—
|
|
|
42,877
|
|
|
953
|
|
|
—
|
|
|
43,830
|
|
|
43,830
|
|
|
(4,496
|
)
|
|
2008
|
|
8/31/2015
|
|
47
|
||||||||
Katy Medical Complex
|
|
Katy, TX
|
|
—
|
|
|
822
|
|
|
6,797
|
|
|
42
|
|
|
822
|
|
|
6,839
|
|
|
7,661
|
|
|
(822
|
)
|
|
2005
|
|
9/1/2015
|
|
39
|
||||||||
Katy Medical Complex Surgery Center
|
|
Katy, TX
|
|
—
|
|
|
1,560
|
|
|
25,601
|
|
|
281
|
|
|
1,560
|
|
|
25,882
|
|
|
27,442
|
|
|
(2,940
|
)
|
|
2006
|
|
9/1/2015
|
|
40
|
||||||||
New Albany Medical Center
|
|
New Albany, OH
|
|
—
|
|
|
1,600
|
|
|
8,505
|
|
|
981
|
|
|
1,600
|
|
|
9,486
|
|
|
11,086
|
|
|
(1,257
|
)
|
|
2005
|
|
9/9/2015
|
|
37
|
||||||||
Fountain Hills Medical Campus
|
|
Fountain Hills, AZ
|
|
—
|
|
|
2,593
|
|
|
7,635
|
|
|
744
|
|
|
2,593
|
|
|
8,379
|
|
|
10,972
|
|
|
(998
|
)
|
|
1995
|
|
9/30/2015
|
|
39
|
||||||||
Fairhope MOB
|
|
Fairhope, AL
|
|
—
|
|
|
640
|
|
|
5,227
|
|
|
872
|
|
|
640
|
|
|
6,099
|
|
|
6,739
|
|
|
(789
|
)
|
|
2005
|
|
10/13/2015
|
|
38
|
||||||||
Foley MOB
|
|
Foley, AL
|
|
—
|
|
|
365
|
|
|
732
|
|
|
—
|
|
|
365
|
|
|
732
|
|
|
1,097
|
|
|
(91
|
)
|
|
1997
|
|
10/13/2015
|
|
40
|
||||||||
Foley Venture
|
|
Foley, AL
|
|
—
|
|
|
420
|
|
|
1,118
|
|
|
—
|
|
|
420
|
|
|
1,118
|
|
|
1,538
|
|
|
(139
|
)
|
|
2002
|
|
10/13/2015
|
|
38
|
||||||||
North Okaloosa MOB
|
|
Crestview, FL
|
|
—
|
|
|
190
|
|
|
1,010
|
|
|
—
|
|
|
190
|
|
|
1,010
|
|
|
1,200
|
|
|
(115
|
)
|
|
2005
|
|
10/13/2015
|
|
41
|
||||||||
Commons on North Davis
|
|
Pensacola, FL
|
|
—
|
|
|
380
|
|
|
1,237
|
|
|
—
|
|
|
380
|
|
|
1,237
|
|
|
1,617
|
|
|
(142
|
)
|
|
2009
|
|
10/13/2015
|
|
41
|
||||||||
Sorrento Road MOB
|
|
Pensacola, FL
|
|
—
|
|
|
170
|
|
|
894
|
|
|
—
|
|
|
170
|
|
|
894
|
|
|
1,064
|
|
|
(104
|
)
|
|
2010
|
|
10/13/2015
|
|
41
|
||||||||
Panama City Beach MOB
|
|
Panama City, FL
|
|
—
|
|
|
—
|
|
|
739
|
|
|
—
|
|
|
—
|
|
|
739
|
|
|
739
|
|
|
(79
|
)
|
|
2012
|
|
10/13/2015
|
|
42
|
||||||||
Perdido Medical Park
|
|
Pensacola, FL
|
|
—
|
|
|
100
|
|
|
1,147
|
|
|
—
|
|
|
100
|
|
|
1,147
|
|
|
1,247
|
|
|
(130
|
)
|
|
2010
|
|
10/13/2015
|
|
41
|
||||||||
Ft. Walton Beach MOB
|
|
Ft. Walton Beach, FL
|
|
—
|
|
|
230
|
|
|
914
|
|
|
—
|
|
|
230
|
|
|
914
|
|
|
1,144
|
|
|
(119
|
)
|
|
1979
|
|
10/13/2015
|
|
35
|
||||||||
Panama City MOB
|
|
Panama City, FL
|
|
—
|
|
|
—
|
|
|
661
|
|
|
39
|
|
|
—
|
|
|
700
|
|
|
700
|
|
|
(81
|
)
|
|
2003
|
|
10/13/2015
|
|
38
|
||||||||
Pensacola MOB
|
|
Pensacola, FL
|
|
—
|
|
|
220
|
|
|
1,685
|
|
|
78
|
|
|
220
|
|
|
1,763
|
|
|
1,983
|
|
|
(200
|
)
|
|
2001
|
|
10/13/2015
|
|
39
|
||||||||
Arete Surgical Center
|
|
Johnstown, CO
|
|
—
|
|
|
399
|
|
|
6,667
|
|
|
—
|
|
|
399
|
|
|
6,667
|
|
|
7,066
|
|
|
(648
|
)
|
|
2013
|
|
10/19/2015
|
|
45
|
||||||||
Cambridge Professional Center
|
|
Waldorf, MD
|
|
—
|
|
|
590
|
|
|
8,520
|
|
|
591
|
|
|
590
|
|
|
9,111
|
|
|
9,701
|
|
|
(1,169
|
)
|
|
1999
|
|
10/30/2015
|
|
35
|
||||||||
HonorHealth - 44th Street MOB
|
|
Phoenix, AZ
|
|
—
|
|
|
515
|
|
|
3,884
|
|
|
1,320
|
|
|
515
|
|
|
5,204
|
|
|
5,719
|
|
|
(865
|
)
|
|
1988
|
|
11/13/2015
|
|
28
|
||||||||
Mercy Medical Center
|
|
Fenton, MO
|
|
—
|
|
|
1,201
|
|
|
6,778
|
|
|
—
|
|
|
1,201
|
|
|
6,778
|
|
|
7,979
|
|
|
(762
|
)
|
|
1999
|
|
12/1/2015
|
|
40
|
||||||||
8 C1TY Blvd
|
|
Nashville, TN
|
|
—
|
|
|
1,555
|
|
|
39,713
|
|
|
273
|
|
|
1,555
|
|
|
39,986
|
|
|
41,541
|
|
|
(3,590
|
)
|
|
2015
|
|
12/17/2015
|
|
45
|
||||||||
Great Falls Clinic
|
|
Great Falls, MT
|
|
—
|
|
|
1,687
|
|
|
27,402
|
|
|
441
|
|
|
1,687
|
|
|
27,843
|
|
|
29,530
|
|
|
(3,005
|
)
|
|
2004
|
|
12/29/2015
|
|
40
|
||||||||
Great Falls Hospital
|
|
Great Falls, MT
|
|
—
|
|
|
1,026
|
|
|
25,262
|
|
|
—
|
|
|
1,026
|
|
|
25,262
|
|
|
26,288
|
|
|
(2,643
|
)
|
|
2015
|
|
1/25/2016
|
|
40
|
||||||||
Treasure Coast Center for Surgery
|
|
Stuart, FL
|
|
—
|
|
|
380
|
|
|
5,064
|
|
|
—
|
|
|
380
|
|
|
5,064
|
|
|
5,444
|
|
|
(490
|
)
|
|
2013
|
|
2/1/2016
|
|
42
|
||||||||
Park Nicollet Clinic
|
|
Chanhassen, MN
|
|
—
|
|
|
1,941
|
|
|
14,555
|
|
|
—
|
|
|
1,941
|
|
|
14,555
|
|
|
16,496
|
|
|
(1,549
|
)
|
|
2005
|
|
2/8/2016
|
|
40
|
|
|
|
|
|
|
Initial Cost to Company
|
|
|
|
Gross Amount at Which Carried as of Close of Period
|
|
|
|
|
|
|
||||||||||||||||||||||||
Description
|
|
Location
|
|
Encumbrances
|
|
Land
|
|
Buildings and
Improvements
|
|
Cost Capitalized
Subsequent to
Acquisitions
|
|
Land
|
|
Buildings and
Improvements
|
|
Total (1)
|
|
Accumulated
Depreciation
|
|
Year
Built
|
|
Date
Acquired
|
|
Life on Which Building
Depreciation in
Income Statement
is Computed
|
||||||||||||||||
HEB Cancer Center
|
|
Bedford, TX
|
|
—
|
|
|
—
|
|
|
11,839
|
|
|
11
|
|
|
—
|
|
|
11,850
|
|
|
11,850
|
|
|
(1,119
|
)
|
|
2014
|
|
2/12/2016
|
|
44
|
||||||||
Riverview Medical Center
|
|
Lancaster, OH
|
|
—
|
|
|
1,313
|
|
|
10,243
|
|
|
443
|
|
|
1,313
|
|
|
10,686
|
|
|
11,999
|
|
|
(1,347
|
)
|
|
1997
|
|
2/26/2016
|
|
33
|
||||||||
St. Luke's Cornwall MOB
|
|
Cornwall, NY
|
|
—
|
|
|
—
|
|
|
13,017
|
|
|
8
|
|
|
—
|
|
|
13,025
|
|
|
13,025
|
|
|
(1,555
|
)
|
|
2006
|
|
2/26/2016
|
|
35
|
||||||||
HonorHealth - Glendale
|
|
Glendale, AZ
|
|
—
|
|
|
1,770
|
|
|
8,089
|
|
|
—
|
|
|
1,770
|
|
|
8,089
|
|
|
9,859
|
|
|
(736
|
)
|
|
2015
|
|
3/15/2016
|
|
45
|
||||||||
Columbia MOB
|
|
Hudson, NY
|
|
—
|
|
|
—
|
|
|
16,550
|
|
|
36
|
|
|
—
|
|
|
16,586
|
|
|
16,586
|
|
|
(1,815
|
)
|
|
2006
|
|
3/21/2016
|
|
35
|
||||||||
St Vincent POB 1
|
|
Birmingham, AL
|
|
—
|
|
|
—
|
|
|
10,172
|
|
|
370
|
|
|
—
|
|
|
10,542
|
|
|
10,542
|
|
|
(2,732
|
)
|
|
1975
|
|
3/23/2016
|
|
15
|
||||||||
Emerson Medical Building
|
|
Creve Coeur, MO
|
|
—
|
|
|
1,590
|
|
|
9,853
|
|
|
277
|
|
|
1,590
|
|
|
10,130
|
|
|
11,720
|
|
|
(1,154
|
)
|
|
1989
|
|
3/24/2016
|
|
35
|
||||||||
Eye Associates of NM - Santa Fe
|
|
Santa Fe, NM
|
|
—
|
|
|
900
|
|
|
6,604
|
|
|
—
|
|
|
900
|
|
|
6,604
|
|
|
7,504
|
|
|
(765
|
)
|
|
2002
|
|
3/31/2016
|
|
35
|
||||||||
Eye Associates of NM - Albuquerque
|
|
Albuquerque, NM
|
|
—
|
|
|
1,020
|
|
|
7,832
|
|
|
13
|
|
|
1,020
|
|
|
7,845
|
|
|
8,865
|
|
|
(806
|
)
|
|
2007
|
|
3/31/2016
|
|
40
|
||||||||
Gardendale Surgery Center
|
|
Gardendale, AL
|
|
—
|
|
|
200
|
|
|
5,732
|
|
|
—
|
|
|
200
|
|
|
5,732
|
|
|
5,932
|
|
|
(536
|
)
|
|
2011
|
|
4/11/2016
|
|
42
|
||||||||
HealthEast - Curve Crest
|
|
Stillwater, MN
|
|
—
|
|
|
409
|
|
|
3,279
|
|
|
—
|
|
|
409
|
|
|
3,279
|
|
|
3,688
|
|
|
(317
|
)
|
|
2011
|
|
4/14/2016
|
|
43
|
||||||||
HealthEast - Victor Gardens
|
|
Hugo, MN
|
|
—
|
|
|
572
|
|
|
4,400
|
|
|
62
|
|
|
572
|
|
|
4,462
|
|
|
5,034
|
|
|
(457
|
)
|
|
2008
|
|
4/14/2016
|
|
41
|
||||||||
NOMS - Clyde
|
|
Clyde, OH
|
|
—
|
|
|
440
|
|
|
5,948
|
|
|
—
|
|
|
440
|
|
|
5,948
|
|
|
6,388
|
|
|
(527
|
)
|
|
2015
|
|
5/10/2016
|
|
44
|
||||||||
Cardwell Professional Building
|
|
Lufkin, TX
|
|
—
|
|
|
—
|
|
|
8,348
|
|
|
234
|
|
|
—
|
|
|
8,582
|
|
|
8,582
|
|
|
(820
|
)
|
|
1999
|
|
5/11/2016
|
|
42
|
||||||||
Dacono Neighborhood Health Clinic
|
|
Dacono, CO
|
|
—
|
|
|
2,258
|
|
|
2,911
|
|
|
20
|
|
|
2,258
|
|
|
2,931
|
|
|
5,189
|
|
|
(384
|
)
|
|
2014
|
|
5/11/2016
|
|
44
|
||||||||
Grand Island Specialty Clinic
|
|
Grand Island, NE
|
|
—
|
|
|
102
|
|
|
2,802
|
|
|
163
|
|
|
102
|
|
|
2,965
|
|
|
3,067
|
|
|
(315
|
)
|
|
1978
|
|
5/11/2016
|
|
42
|
||||||||
Hot Springs Village Office Building
|
|
Hot Springs Village, AR
|
|
—
|
|
|
305
|
|
|
3,309
|
|
|
95
|
|
|
305
|
|
|
3,404
|
|
|
3,709
|
|
|
(473
|
)
|
|
1988
|
|
5/11/2016
|
|
30
|
||||||||
UofL Health - East
|
|
Louisville, KY
|
|
—
|
|
|
—
|
|
|
81,248
|
|
|
126
|
|
|
—
|
|
|
81,374
|
|
|
81,374
|
|
|
(6,922
|
)
|
|
2003
|
|
5/11/2016
|
|
45
|
||||||||
UofL Health - South
|
|
Shepherdsville, KY
|
|
—
|
|
|
—
|
|
|
15,861
|
|
|
235
|
|
|
—
|
|
|
16,096
|
|
|
16,096
|
|
|
(1,758
|
)
|
|
2005
|
|
5/11/2016
|
|
39
|
||||||||
UofL Health - Plaza I
|
|
Louisville, KY
|
|
—
|
|
|
—
|
|
|
8,808
|
|
|
707
|
|
|
—
|
|
|
9,515
|
|
|
9,515
|
|
|
(1,055
|
)
|
|
1970
|
|
5/11/2016
|
|
35
|
||||||||
UofL Health - Plaza II
|
|
Louisville, KY
|
|
—
|
|
|
—
|
|
|
5,216
|
|
|
1,873
|
|
|
—
|
|
|
7,089
|
|
|
7,089
|
|
|
(1,395
|
)
|
|
1964
|
|
5/11/2016
|
|
15
|
||||||||
UofL Health - OCC
|
|
Louisville, KY
|
|
—
|
|
|
—
|
|
|
35,703
|
|
|
230
|
|
|
—
|
|
|
35,933
|
|
|
35,933
|
|
|
(3,902
|
)
|
|
1985
|
|
5/11/2016
|
|
34
|
||||||||
Lexington Surgery Center
|
|
Lexington, KY
|
|
—
|
|
|
1,229
|
|
|
18,914
|
|
|
503
|
|
|
1,229
|
|
|
19,417
|
|
|
20,646
|
|
|
(2,415
|
)
|
|
2000
|
|
5/11/2016
|
|
30
|
||||||||
Medical Arts Pavilion
|
|
Lufkin, TX
|
|
—
|
|
|
—
|
|
|
6,215
|
|
|
606
|
|
|
—
|
|
|
6,821
|
|
|
6,821
|
|
|
(785
|
)
|
|
2004
|
|
5/11/2016
|
|
33
|
||||||||
Memorial Outpatient Therapy Center
|
|
Lufkin, TX
|
|
—
|
|
|
—
|
|
|
4,808
|
|
|
100
|
|
|
—
|
|
|
4,908
|
|
|
4,908
|
|
|
(462
|
)
|
|
1990
|
|
5/11/2016
|
|
45
|
||||||||
Midlands Two Professional Center
|
|
Papillion, NE
|
|
—
|
|
|
—
|
|
|
587
|
|
|
225
|
|
|
—
|
|
|
812
|
|
|
812
|
|
|
(487
|
)
|
|
1976
|
|
5/11/2016
|
|
5
|
||||||||
Parkview MOB
|
|
Little Rock, AR
|
|
—
|
|
|
705
|
|
|
4,343
|
|
|
76
|
|
|
705
|
|
|
4,419
|
|
|
5,124
|
|
|
(516
|
)
|
|
1988
|
|
5/11/2016
|
|
35
|
||||||||
Peak One ASC
|
|
Frisco, CO
|
|
—
|
|
|
—
|
|
|
5,763
|
|
|
317
|
|
|
—
|
|
|
6,080
|
|
|
6,080
|
|
|
(541
|
)
|
|
2006
|
|
5/11/2016
|
|
44
|
||||||||
Physicians Medical Center
|
|
Tacoma, WA
|
|
—
|
|
|
—
|
|
|
5,862
|
|
|
2,934
|
|
|
—
|
|
|
8,796
|
|
|
8,796
|
|
|
(896
|
)
|
|
1977
|
|
5/11/2016
|
|
27
|
||||||||
St. Alexius - Minot Medical Plaza
|
|
Minot, ND
|
|
—
|
|
|
—
|
|
|
26,078
|
|
|
18
|
|
|
—
|
|
|
26,096
|
|
|
26,096
|
|
|
(2,251
|
)
|
|
2015
|
|
5/11/2016
|
|
49
|
||||||||
St. Clare Medical Pavilion
|
|
Lakewood, WA
|
|
—
|
|
|
—
|
|
|
9,005
|
|
|
200
|
|
|
—
|
|
|
9,205
|
|
|
9,205
|
|
|
(1,183
|
)
|
|
1989
|
|
5/11/2016
|
|
33
|
||||||||
St. Joseph Medical Pavilion
|
|
Tacoma, WA
|
|
—
|
|
|
—
|
|
|
11,497
|
|
|
105
|
|
|
—
|
|
|
11,602
|
|
|
11,602
|
|
|
(1,315
|
)
|
|
1989
|
|
5/11/2016
|
|
35
|
||||||||
St. Joseph Office Park
|
|
Lexington, KY
|
|
—
|
|
|
3,722
|
|
|
12,675
|
|
|
4,312
|
|
|
3,722
|
|
|
16,987
|
|
|
20,709
|
|
|
(3,855
|
)
|
|
1992
|
|
5/11/2016
|
|
14
|
||||||||
UofL Health - Mary & Elizabeth MOB II
|
|
Louisville, KY
|
|
—
|
|
|
—
|
|
|
5,587
|
|
|
90
|
|
|
—
|
|
|
5,677
|
|
|
5,677
|
|
|
(636
|
)
|
|
1979
|
|
5/11/2016
|
|
34
|
||||||||
UofL Health - Mary & Elizabeth MOB III
|
|
Louisville, KY
|
|
—
|
|
|
—
|
|
|
383
|
|
|
275
|
|
|
—
|
|
|
658
|
|
|
658
|
|
|
(424
|
)
|
|
1974
|
|
5/11/2016
|
|
2
|
||||||||
Thornton Neighborhood Health Clinic
|
|
Thornton, CO
|
|
—
|
|
|
1,609
|
|
|
2,287
|
|
|
—
|
|
|
1,609
|
|
|
2,287
|
|
|
3,896
|
|
|
(290
|
)
|
|
2014
|
|
5/11/2016
|
|
43
|
||||||||
St. Francis MOB
|
|
Federal Way, WA
|
|
—
|
|
|
—
|
|
|
12,817
|
|
|
74
|
|
|
—
|
|
|
12,891
|
|
|
12,891
|
|
|
(1,399
|
)
|
|
1987
|
|
6/2/2016
|
|
38
|
||||||||
Children's Wisconsin - Brookfield
|
|
Milwaukee, WI
|
|
—
|
|
|
476
|
|
|
4,897
|
|
|
—
|
|
|
476
|
|
|
4,897
|
|
|
5,373
|
|
|
(445
|
)
|
|
2016
|
|
6/3/2016
|
|
45
|
||||||||
UofL Health - South MOB
|
|
Shepherdsville, KY
|
|
—
|
|
|
27
|
|
|
3,827
|
|
|
—
|
|
|
27
|
|
|
3,827
|
|
|
3,854
|
|
|
(346
|
)
|
|
2006
|
|
6/8/2016
|
|
40
|
||||||||
Good Samaritan North Annex Building
|
|
Kearney, NE
|
|
—
|
|
|
—
|
|
|
2,734
|
|
|
—
|
|
|
—
|
|
|
2,734
|
|
|
2,734
|
|
|
(308
|
)
|
|
1984
|
|
6/28/2016
|
|
37
|
||||||||
NE Heart Institute Medical Building
|
|
Lincoln, NE
|
|
—
|
|
|
—
|
|
|
19,738
|
|
|
—
|
|
|
—
|
|
|
19,738
|
|
|
19,738
|
|
|
(1,476
|
)
|
|
2004
|
|
6/28/2016
|
|
47
|
||||||||
St. Vincent West MOB
|
|
Little Rock, AR
|
|
—
|
|
|
—
|
|
|
13,453
|
|
|
—
|
|
|
—
|
|
|
13,453
|
|
|
13,453
|
|
|
(1,044
|
)
|
|
2012
|
|
6/29/2016
|
|
49
|
||||||||
Meridan
|
|
Englewood, CO
|
|
—
|
|
|
1,608
|
|
|
15,774
|
|
|
137
|
|
|
1,608
|
|
|
15,911
|
|
|
17,519
|
|
|
(1,687
|
)
|
|
2002
|
|
6/29/2016
|
|
38
|
||||||||
UofL Health - Mary & Elizabeth MOB I
|
|
Louisville, KY
|
|
—
|
|
|
—
|
|
|
8,774
|
|
|
414
|
|
|
—
|
|
|
9,188
|
|
|
9,188
|
|
|
(1,298
|
)
|
|
1991
|
|
6/29/2016
|
|
25
|
||||||||
St. Alexius - Medical Arts Pavilion
|
|
Bismarck, ND
|
|
—
|
|
|
—
|
|
|
12,902
|
|
|
249
|
|
|
—
|
|
|
13,151
|
|
|
13,151
|
|
|
(1,472
|
)
|
|
1974
|
|
6/29/2016
|
|
32
|
||||||||
St. Alexius - Mandan Clinic
|
|
Mandan, ND
|
|
—
|
|
|
708
|
|
|
7,700
|
|
|
224
|
|
|
708
|
|
|
7,924
|
|
|
8,632
|
|
|
(717
|
)
|
|
2014
|
|
6/29/2016
|
|
43
|
||||||||
St. Alexius - Orthopaedic Center
|
|
Bismarck, ND
|
|
—
|
|
|
—
|
|
|
13,881
|
|
|
557
|
|
|
—
|
|
|
14,438
|
|
|
14,438
|
|
|
(1,355
|
)
|
|
1997
|
|
6/29/2016
|
|
39
|
||||||||
St. Alexius - Rehab Center
|
|
Bismarck, ND
|
|
—
|
|
|
—
|
|
|
5,920
|
|
|
134
|
|
|
—
|
|
|
6,054
|
|
|
6,054
|
|
|
(898
|
)
|
|
1997
|
|
6/29/2016
|
|
25
|
||||||||
St. Alexius - Tech & Ed
|
|
Bismarck, ND
|
|
—
|
|
|
—
|
|
|
16,688
|
|
|
128
|
|
|
—
|
|
|
16,816
|
|
|
16,816
|
|
|
(1,591
|
)
|
|
2011
|
|
6/29/2016
|
|
38
|
||||||||
Good Samaritan MOB
|
|
Kearney, NE
|
|
—
|
|
|
—
|
|
|
24,154
|
|
|
443
|
|
|
—
|
|
|
24,597
|
|
|
24,597
|
|
|
(1,981
|
)
|
|
1999
|
|
6/29/2016
|
|
45
|
||||||||
Lakeside Two Professional Center
|
|
Omaha, NE
|
|
—
|
|
|
—
|
|
|
13,358
|
|
|
772
|
|
|
—
|
|
|
14,130
|
|
|
14,130
|
|
|
(1,301
|
)
|
|
2000
|
|
6/29/2016
|
|
38
|
||||||||
Lakeside Wellness Center
|
|
Omaha, NE
|
|
—
|
|
|
—
|
|
|
10,177
|
|
|
397
|
|
|
—
|
|
|
10,574
|
|
|
10,574
|
|
|
(952
|
)
|
|
2000
|
|
6/29/2016
|
|
39
|
||||||||
McAuley Center
|
|
Omaha, NE
|
|
—
|
|
|
1,427
|
|
|
17,020
|
|
|
618
|
|
|
1,427
|
|
|
17,638
|
|
|
19,065
|
|
|
(2,199
|
)
|
|
1988
|
|
6/29/2016
|
|
30
|
||||||||
Memorial Health Center
|
|
Grand Island, NE
|
|
—
|
|
|
—
|
|
|
33,967
|
|
|
1,305
|
|
|
—
|
|
|
35,272
|
|
|
35,272
|
|
|
(3,631
|
)
|
|
1955
|
|
6/29/2016
|
|
35
|
||||||||
Missionary Ridge MOB
|
|
Chattanooga, TN
|
|
—
|
|
|
—
|
|
|
7,223
|
|
|
3,075
|
|
|
—
|
|
|
10,298
|
|
|
10,298
|
|
|
(2,753
|
)
|
|
1976
|
|
6/29/2016
|
|
10
|
||||||||
Pilot Medical Center
|
|
Birmingham, AL
|
|
—
|
|
|
1,419
|
|
|
14,528
|
|
|
55
|
|
|
1,419
|
|
|
14,583
|
|
|
16,002
|
|
|
(1,554
|
)
|
|
2005
|
|
6/29/2016
|
|
35
|
||||||||
St. Joseph Medical Clinic
|
|
Tacoma, WA
|
|
—
|
|
|
—
|
|
|
16,427
|
|
|
72
|
|
|
—
|
|
|
16,499
|
|
|
16,499
|
|
|
(1,941
|
)
|
|
1991
|
|
6/30/2016
|
|
30
|
||||||||
Woodlands Medical Arts Center
|
|
The Woodlands, TX
|
|
—
|
|
|
—
|
|
|
19,168
|
|
|
2,411
|
|
|
—
|
|
|
21,579
|
|
|
21,579
|
|
|
(2,167
|
)
|
|
2001
|
|
6/30/2016
|
|
35
|
||||||||
FESC MOB
|
|
Tacoma, WA
|
|
—
|
|
|
—
|
|
|
12,702
|
|
|
202
|
|
|
—
|
|
|
12,904
|
|
|
12,904
|
|
|
(2,256
|
)
|
|
1980
|
|
6/30/2016
|
|
22
|
||||||||
PrairieCare MOB
|
|
Maplewood, MN
|
|
—
|
|
|
525
|
|
|
3,099
|
|
|
—
|
|
|
525
|
|
|
3,099
|
|
|
3,624
|
|
|
(265
|
)
|
|
2016
|
|
7/6/2016
|
|
45
|
|
|
|
|
|
|
Initial Cost to Company
|
|
|
|
Gross Amount at Which Carried as of Close of Period
|
|
|
|
|
|
|
||||||||||||||||||||||||
Description
|
|
Location
|
|
Encumbrances
|
|
Land
|
|
Buildings and
Improvements
|
|
Cost Capitalized
Subsequent to
Acquisitions
|
|
Land
|
|
Buildings and
Improvements
|
|
Total (1)
|
|
Accumulated
Depreciation
|
|
Year
Built
|
|
Date
Acquired
|
|
Life on Which Building
Depreciation in
Income Statement
is Computed
|
||||||||||||||||
Springwoods MOB
|
|
Spring, TX
|
|
—
|
|
|
3,821
|
|
|
14,830
|
|
|
4,728
|
|
|
3,821
|
|
|
19,558
|
|
|
23,379
|
|
|
(2,192
|
)
|
|
2015
|
|
7/21/2016
|
|
44
|
||||||||
Unity ASC, Imaging & MOB
|
|
West Lafayette, IN
|
|
—
|
|
|
960
|
|
|
9,991
|
|
|
—
|
|
|
960
|
|
|
9,991
|
|
|
10,951
|
|
|
(1,036
|
)
|
|
2001
|
|
8/8/2016
|
|
35
|
||||||||
Unity Medical Pavilion
|
|
West Lafayette, IN
|
|
—
|
|
|
1,070
|
|
|
12,454
|
|
|
—
|
|
|
1,070
|
|
|
12,454
|
|
|
13,524
|
|
|
(1,290
|
)
|
|
2001
|
|
8/8/2016
|
|
35
|
||||||||
Unity Faith, Hope & Love
|
|
West Lafayette, IN
|
|
—
|
|
|
280
|
|
|
1,862
|
|
|
—
|
|
|
280
|
|
|
1,862
|
|
|
2,142
|
|
|
(194
|
)
|
|
2001
|
|
8/8/2016
|
|
35
|
||||||||
Unity Immediate Care and OCC
|
|
West Lafayette, IN
|
|
—
|
|
|
300
|
|
|
1,833
|
|
|
—
|
|
|
300
|
|
|
1,833
|
|
|
2,133
|
|
|
(182
|
)
|
|
2004
|
|
8/8/2016
|
|
37
|
||||||||
Medical Village at Maitland
|
|
Orlando, FL
|
|
—
|
|
|
2,393
|
|
|
18,543
|
|
|
48
|
|
|
2,393
|
|
|
18,591
|
|
|
20,984
|
|
|
(1,533
|
)
|
|
2006
|
|
8/23/2016
|
|
44
|
||||||||
Tri-State Orthopaedics MOB
|
|
Evansville, IN
|
|
—
|
|
|
1,580
|
|
|
14,162
|
|
|
—
|
|
|
1,580
|
|
|
14,162
|
|
|
15,742
|
|
|
(1,383
|
)
|
|
2004
|
|
8/30/2016
|
|
37
|
||||||||
Maury Regional Health Complex
|
|
Spring Hill, TN
|
|
—
|
|
|
—
|
|
|
15,619
|
|
|
335
|
|
|
—
|
|
|
15,954
|
|
|
15,954
|
|
|
(1,361
|
)
|
|
2012
|
|
9/30/2016
|
|
41
|
||||||||
Spring Ridge Medical Center
|
|
Wyomissing, PA
|
|
—
|
|
|
28
|
|
|
4,943
|
|
|
—
|
|
|
28
|
|
|
4,943
|
|
|
4,971
|
|
|
(461
|
)
|
|
2002
|
|
9/30/2016
|
|
37
|
||||||||
Doctors Community Hospital POB
|
|
Lanham, MD
|
|
—
|
|
|
—
|
|
|
23,034
|
|
|
14
|
|
|
—
|
|
|
23,048
|
|
|
23,048
|
|
|
(1,565
|
)
|
|
2009
|
|
9/30/2016
|
|
48
|
||||||||
Gig Harbor Medical Pavilion
|
|
Gig Harbor, WA
|
|
—
|
|
|
—
|
|
|
4,791
|
|
|
2,245
|
|
|
—
|
|
|
7,036
|
|
|
7,036
|
|
|
(879
|
)
|
|
1991
|
|
9/30/2016
|
|
30
|
||||||||
Midlands One Professional Center
|
|
Papillion, NE
|
|
—
|
|
|
—
|
|
|
14,922
|
|
|
34
|
|
|
—
|
|
|
14,956
|
|
|
14,956
|
|
|
(1,318
|
)
|
|
2010
|
|
9/30/2016
|
|
37
|
||||||||
Northwest Michigan Surgery Center
|
|
Traverse City, MI
|
|
—
|
|
|
2,748
|
|
|
30,005
|
|
|
—
|
|
|
2,748
|
|
|
30,005
|
|
|
32,753
|
|
|
(2,467
|
)
|
|
2004
|
|
10/28/2016
|
|
40
|
||||||||
Northeast Medical Center
|
|
Fayetteville, NY
|
|
—
|
|
|
4,011
|
|
|
25,564
|
|
|
953
|
|
|
4,011
|
|
|
26,517
|
|
|
30,528
|
|
|
(2,985
|
)
|
|
1998
|
|
11/23/2016
|
|
33
|
||||||||
North Medical Center
|
|
Liverpool, NY
|
|
—
|
|
|
1,337
|
|
|
18,680
|
|
|
915
|
|
|
1,337
|
|
|
19,595
|
|
|
20,932
|
|
|
(1,930
|
)
|
|
1989
|
|
11/23/2016
|
|
35
|
||||||||
Cincinnati Eye Institute
|
|
Cincinnati, OH
|
|
—
|
|
|
2,050
|
|
|
32,546
|
|
|
—
|
|
|
2,050
|
|
|
32,546
|
|
|
34,596
|
|
|
(3,076
|
)
|
|
1985
|
|
11/23/2016
|
|
35
|
||||||||
HonorHealth - Scottsdale MOB
|
|
Scottsdale, AZ
|
|
—
|
|
|
3,340
|
|
|
4,288
|
|
|
1,702
|
|
|
3,340
|
|
|
5,990
|
|
|
9,330
|
|
|
(520
|
)
|
|
2000
|
|
12/2/2016
|
|
45
|
||||||||
Fox Valley Hematology & Oncology
|
|
Appleton, WI
|
|
—
|
|
|
1,590
|
|
|
26,666
|
|
|
—
|
|
|
1,590
|
|
|
26,666
|
|
|
28,256
|
|
|
(1,968
|
)
|
|
2015
|
|
12/8/2016
|
|
44
|
||||||||
Northern Vision Eye Center
|
|
Traverse City, MI
|
|
—
|
|
|
490
|
|
|
2,132
|
|
|
—
|
|
|
490
|
|
|
2,132
|
|
|
2,622
|
|
|
(203
|
)
|
|
2006
|
|
12/15/2016
|
|
35
|
||||||||
Flower Mound MOB
|
|
Flower Mound, TX
|
|
—
|
|
|
1,945
|
|
|
8,312
|
|
|
17
|
|
|
1,945
|
|
|
8,329
|
|
|
10,274
|
|
|
(651
|
)
|
|
2011
|
|
12/16/2016
|
|
43
|
||||||||
Carrollton MOB
|
|
Flower Mound, TX
|
|
—
|
|
|
2,183
|
|
|
10,461
|
|
|
60
|
|
|
2,183
|
|
|
10,521
|
|
|
12,704
|
|
|
(875
|
)
|
|
2002
|
|
12/16/2016
|
|
40
|
||||||||
HonorHealth - Scottsdale IRF
|
|
Scottsdale, AZ
|
|
—
|
|
|
—
|
|
|
19,331
|
|
|
—
|
|
|
—
|
|
|
19,331
|
|
|
19,331
|
|
|
(1,444
|
)
|
|
2000
|
|
12/22/2016
|
|
42
|
||||||||
Orthopedic Associates
|
|
Flower Mound, TX
|
|
—
|
|
|
2,915
|
|
|
12,791
|
|
|
—
|
|
|
2,915
|
|
|
12,791
|
|
|
15,706
|
|
|
(956
|
)
|
|
2011
|
|
1/5/2017
|
|
43
|
||||||||
Medical Arts Center at Hartford
|
|
Plainville, CT
|
|
—
|
|
|
1,499
|
|
|
24,627
|
|
|
499
|
|
|
1,499
|
|
|
25,126
|
|
|
26,625
|
|
|
(1,782
|
)
|
|
2015
|
|
1/11/2017
|
|
44
|
||||||||
CareMount Medical - Lake Katrine MOB
|
|
Lake Katrine, NY
|
|
25,177
|
|
|
1,941
|
|
|
27,434
|
|
|
—
|
|
|
1,941
|
|
|
27,434
|
|
|
29,375
|
|
|
(2,024
|
)
|
|
2013
|
|
2/14/2017
|
|
42
|
||||||||
CareMount Medical - Rhinebeck MOB
|
|
Rhinebeck, NY
|
|
—
|
|
|
869
|
|
|
12,220
|
|
|
—
|
|
|
869
|
|
|
12,220
|
|
|
13,089
|
|
|
(940
|
)
|
|
1965
|
|
2/14/2017
|
|
41
|
||||||||
Monterey Medical Center
|
|
Stuart, FL
|
|
—
|
|
|
2,292
|
|
|
13,376
|
|
|
135
|
|
|
2,292
|
|
|
13,511
|
|
|
15,803
|
|
|
(1,102
|
)
|
|
2003
|
|
3/7/2017
|
|
37
|
||||||||
Creighton University Medical Center
|
|
Omaha, NE
|
|
—
|
|
|
—
|
|
|
32,487
|
|
|
—
|
|
|
—
|
|
|
32,487
|
|
|
32,487
|
|
|
(1,956
|
)
|
|
2017
|
|
3/28/2017
|
|
49
|
||||||||
Strictly Pediatrics Specialty Center
|
|
Austin, TX
|
|
—
|
|
|
4,457
|
|
|
62,527
|
|
|
303
|
|
|
4,457
|
|
|
62,830
|
|
|
67,287
|
|
|
(4,500
|
)
|
|
2006
|
|
3/31/2017
|
|
40
|
||||||||
MedStar Stephen's Crossing
|
|
Brandywine, MD
|
|
—
|
|
|
1,975
|
|
|
14,810
|
|
|
—
|
|
|
1,975
|
|
|
14,810
|
|
|
16,785
|
|
|
(952
|
)
|
|
2015
|
|
6/16/2017
|
|
43
|
||||||||
Health Clinic Building
|
|
Omaha, NE
|
|
—
|
|
|
—
|
|
|
50,177
|
|
|
—
|
|
|
—
|
|
|
50,177
|
|
|
50,177
|
|
|
(2,579
|
)
|
|
2017
|
|
6/29/2017
|
|
49
|
||||||||
Family Medical Center
|
|
Little Falls, MN
|
|
—
|
|
|
—
|
|
|
4,944
|
|
|
7,950
|
|
|
—
|
|
|
12,894
|
|
|
12,894
|
|
|
(539
|
)
|
|
1990
|
|
6/29/2017
|
|
25
|
||||||||
Craven-Hagan Clinic
|
|
Williston, ND
|
|
—
|
|
|
—
|
|
|
8,739
|
|
|
750
|
|
|
—
|
|
|
9,489
|
|
|
9,489
|
|
|
(619
|
)
|
|
1984
|
|
6/29/2017
|
|
40
|
||||||||
Chattanooga Heart Institute
|
|
Chattanooga, TN
|
|
—
|
|
|
—
|
|
|
18,639
|
|
|
519
|
|
|
—
|
|
|
19,158
|
|
|
19,158
|
|
|
(1,321
|
)
|
|
1993
|
|
6/29/2017
|
|
37
|
||||||||
St. Vincent Mercy Heart and Vascular Center
|
|
Hot Springs, AR
|
|
—
|
|
|
—
|
|
|
11,688
|
|
|
6
|
|
|
—
|
|
|
11,694
|
|
|
11,694
|
|
|
(726
|
)
|
|
1998
|
|
6/29/2017
|
|
45
|
||||||||
South Campus MOB
|
|
Hot Springs, AR
|
|
—
|
|
|
—
|
|
|
13,369
|
|
|
52
|
|
|
—
|
|
|
13,421
|
|
|
13,421
|
|
|
(862
|
)
|
|
2009
|
|
6/29/2017
|
|
42
|
||||||||
St. Vincent Mercy Cancer Center
|
|
Hot Springs, AR
|
|
—
|
|
|
—
|
|
|
5,090
|
|
|
51
|
|
|
—
|
|
|
5,141
|
|
|
5,141
|
|
|
(367
|
)
|
|
2001
|
|
6/29/2017
|
|
39
|
||||||||
St. Joseph Professional Office Building
|
|
Bryan, TX
|
|
—
|
|
|
—
|
|
|
11,169
|
|
|
175
|
|
|
—
|
|
|
11,344
|
|
|
11,344
|
|
|
(656
|
)
|
|
1996
|
|
6/29/2017
|
|
46
|
||||||||
St. Vincent Carmel Women's Center
|
|
Carmel, IN
|
|
—
|
|
|
—
|
|
|
31,720
|
|
|
182
|
|
|
—
|
|
|
31,902
|
|
|
31,902
|
|
|
(1,719
|
)
|
|
2014
|
|
6/29/2017
|
|
48
|
||||||||
St. Vincent Fishers Medical Center
|
|
Fishers, IN
|
|
15,000
|
|
|
—
|
|
|
62,870
|
|
|
276
|
|
|
—
|
|
|
63,146
|
|
|
63,146
|
|
|
(3,750
|
)
|
|
2008
|
|
6/29/2017
|
|
45
|
||||||||
Baylor Charles A. Sammons Cancer Center
|
|
Dallas, TX
|
|
—
|
|
|
—
|
|
|
256,886
|
|
|
716
|
|
|
—
|
|
|
257,602
|
|
|
257,602
|
|
|
(15,503
|
)
|
|
2011
|
|
6/30/2017
|
|
43
|
||||||||
Orthopedic & Sports Institute of the Fox Valley
|
|
Appleton, WI
|
|
—
|
|
|
2,003
|
|
|
26,394
|
|
|
100
|
|
|
2,003
|
|
|
26,494
|
|
|
28,497
|
|
|
(1,799
|
)
|
|
2005
|
|
6/30/2017
|
|
40
|
||||||||
Clearview Cancer Institute
|
|
Huntsville, AL
|
|
—
|
|
|
2,736
|
|
|
43,220
|
|
|
—
|
|
|
2,736
|
|
|
43,220
|
|
|
45,956
|
|
|
(3,212
|
)
|
|
2006
|
|
8/4/2017
|
|
34
|
||||||||
Northside Cherokee-Town Lake MOB
|
|
Atlanta, GA
|
|
—
|
|
|
—
|
|
|
30,627
|
|
|
1,667
|
|
|
—
|
|
|
32,294
|
|
|
32,294
|
|
|
(1,918
|
)
|
|
2013
|
|
8/15/2017
|
|
46
|
||||||||
HonorHealth - Mesa
|
|
Mesa, AZ
|
|
—
|
|
|
362
|
|
|
3,059
|
|
|
8
|
|
|
362
|
|
|
3,067
|
|
|
3,429
|
|
|
(188
|
)
|
|
2013
|
|
8/15/2017
|
|
43
|
||||||||
Little Falls Orthopedics
|
|
Little Falls, MN
|
|
—
|
|
|
246
|
|
|
1,977
|
|
|
146
|
|
|
246
|
|
|
2,123
|
|
|
2,369
|
|
|
(281
|
)
|
|
1999
|
|
8/24/2017
|
|
28
|
||||||||
Unity Specialty Center
|
|
Little Falls, MN
|
|
—
|
|
|
—
|
|
|
2,885
|
|
|
891
|
|
|
—
|
|
|
3,776
|
|
|
3,776
|
|
|
(583
|
)
|
|
1959
|
|
8/24/2017
|
|
15
|
||||||||
Immanuel One Professional Center
|
|
Omaha, NE
|
|
—
|
|
|
—
|
|
|
16,598
|
|
|
737
|
|
|
—
|
|
|
17,335
|
|
|
17,335
|
|
|
(1,251
|
)
|
|
1993
|
|
8/24/2017
|
|
35
|
||||||||
SJRHC Cancer Center
|
|
Bryan, TX
|
|
—
|
|
|
—
|
|
|
5,065
|
|
|
776
|
|
|
—
|
|
|
5,841
|
|
|
5,841
|
|
|
(391
|
)
|
|
1997
|
|
8/24/2017
|
|
40
|
||||||||
St. Vincent Women's Center
|
|
Hot Springs, AR
|
|
—
|
|
|
—
|
|
|
4,789
|
|
|
225
|
|
|
—
|
|
|
5,014
|
|
|
5,014
|
|
|
(304
|
)
|
|
2001
|
|
8/31/2017
|
|
40
|
||||||||
Legends Park MOB & ASC
|
|
Midland, TX
|
|
—
|
|
|
1,658
|
|
|
24,178
|
|
|
—
|
|
|
1,658
|
|
|
24,178
|
|
|
25,836
|
|
|
(1,360
|
)
|
|
2003
|
|
9/27/2017
|
|
44
|
||||||||
Franklin MOB & ASC
|
|
Franklin, TN
|
|
—
|
|
|
1,001
|
|
|
7,902
|
|
|
—
|
|
|
1,001
|
|
|
7,902
|
|
|
8,903
|
|
|
(439
|
)
|
|
2014
|
|
10/12/2017
|
|
42
|
||||||||
Eagle Point MOB
|
|
Lake Elmo, MN
|
|
—
|
|
|
1,011
|
|
|
9,009
|
|
|
—
|
|
|
1,011
|
|
|
9,009
|
|
|
10,020
|
|
|
(468
|
)
|
|
2015
|
|
10/31/2017
|
|
48
|
||||||||
Edina East MOB
|
|
Edina, MN
|
|
—
|
|
|
2,360
|
|
|
4,135
|
|
|
436
|
|
|
2,360
|
|
|
4,571
|
|
|
6,931
|
|
|
(388
|
)
|
|
1962
|
|
10/31/2017
|
|
30
|
||||||||
Northside Center Pointe
|
|
Atlanta, GA
|
|
—
|
|
|
—
|
|
|
118,430
|
|
|
4,354
|
|
|
—
|
|
|
122,784
|
|
|
122,784
|
|
|
(8,318
|
)
|
|
2009
|
|
11/10/2017
|
|
31
|
||||||||
Gwinnett 500 Building
|
|
Lawrenceville, GA
|
|
—
|
|
|
—
|
|
|
22,753
|
|
|
88
|
|
|
—
|
|
|
22,841
|
|
|
22,841
|
|
|
(1,187
|
)
|
|
1995
|
|
11/17/2017
|
|
45
|
||||||||
Hudgens Professional Building
|
|
Duluth, GA
|
|
—
|
|
|
—
|
|
|
21,779
|
|
|
58
|
|
|
—
|
|
|
21,837
|
|
|
21,837
|
|
|
(1,304
|
)
|
|
1994
|
|
11/17/2017
|
|
40
|
||||||||
St. Vincent Building
|
|
Indianapolis, IN
|
|
—
|
|
|
5,854
|
|
|
42,382
|
|
|
5,718
|
|
|
5,854
|
|
|
48,100
|
|
|
53,954
|
|
|
(2,941
|
)
|
|
2007
|
|
11/17/2017
|
|
45
|
||||||||
Gwinnett Physicians Center
|
|
Lawrenceville, GA
|
|
16,420
|
|
|
—
|
|
|
48,304
|
|
|
64
|
|
|
—
|
|
|
48,368
|
|
|
48,368
|
|
|
(2,258
|
)
|
|
2010
|
|
12/1/2017
|
|
47
|
||||||||
Apple Valley Medical Center
|
|
Apple Valley, MN
|
|
—
|
|
|
1,587
|
|
|
14,929
|
|
|
2,529
|
|
|
1,587
|
|
|
17,458
|
|
|
19,045
|
|
|
(1,221
|
)
|
|
1974
|
|
12/18/2017
|
|
33
|
|
|
|
|
|
|
Initial Cost to Company
|
|
|
|
Gross Amount at Which Carried as of Close of Period
|
|
|
|
|
|
|
||||||||||||||||||||||||
Description
|
|
Location
|
|
Encumbrances
|
|
Land
|
|
Buildings and
Improvements
|
|
Cost Capitalized
Subsequent to
Acquisitions
|
|
Land
|
|
Buildings and
Improvements
|
|
Total (1)
|
|
Accumulated
Depreciation
|
|
Year
Built
|
|
Date
Acquired
|
|
Life on Which Building
Depreciation in
Income Statement
is Computed
|
||||||||||||||||
Desert Cove MOB
|
|
Scottsdale, AZ
|
|
—
|
|
|
1,689
|
|
|
5,207
|
|
|
—
|
|
|
1,689
|
|
|
5,207
|
|
|
6,896
|
|
|
(303
|
)
|
|
1991
|
|
12/18/2017
|
|
38
|
||||||||
Westgate MOB
|
|
Glendale, AZ
|
|
—
|
|
|
—
|
|
|
13,379
|
|
|
2,052
|
|
|
—
|
|
|
15,431
|
|
|
15,431
|
|
|
(760
|
)
|
|
2016
|
|
12/21/2017
|
|
45
|
||||||||
Hazelwood Medical Commons
|
|
Maplewood, MN
|
|
—
|
|
|
3,292
|
|
|
57,390
|
|
|
3,681
|
|
|
3,292
|
|
|
61,071
|
|
|
64,363
|
|
|
(2,714
|
)
|
|
2017
|
|
1/9/2018
|
|
45
|
||||||||
Lee's Hill Medical Plaza
|
|
Fredericksburg, VA
|
|
—
|
|
|
1,052
|
|
|
24,790
|
|
|
—
|
|
|
1,052
|
|
|
24,790
|
|
|
25,842
|
|
|
(1,308
|
)
|
|
2006
|
|
1/23/2018
|
|
40
|
||||||||
HMG Medical Plaza
|
|
Kingsport, TN
|
|
—
|
|
|
—
|
|
|
64,204
|
|
|
—
|
|
|
—
|
|
|
64,204
|
|
|
64,204
|
|
|
(2,941
|
)
|
|
2010
|
|
4/3/2018
|
|
40
|
||||||||
Jacksonville MedPlex (Building B)
|
|
Jacksonville, FL
|
|
—
|
|
|
3,259
|
|
|
5,988
|
|
|
168
|
|
|
3,259
|
|
|
6,156
|
|
|
9,415
|
|
|
(280
|
)
|
|
2010
|
|
7/26/2018
|
|
37
|
||||||||
Jacksonville MedPlex (Building C)
|
|
Jacksonville, FL
|
|
—
|
|
|
2,168
|
|
|
6,467
|
|
|
13
|
|
|
2,168
|
|
|
6,480
|
|
|
8,648
|
|
|
(261
|
)
|
|
2010
|
|
7/26/2018
|
|
40
|
||||||||
Northside Medical Midtown
|
|
Atlanta, GA
|
|
—
|
|
|
—
|
|
|
55,483
|
|
|
8,677
|
|
|
—
|
|
|
64,160
|
|
|
64,160
|
|
|
(1,753
|
)
|
|
2018
|
|
9/14/2018
|
|
50
|
||||||||
Doctors United ASC
|
|
Pasadena, TX
|
|
—
|
|
|
1,603
|
|
|
11,827
|
|
|
—
|
|
|
1,603
|
|
|
11,827
|
|
|
13,430
|
|
|
(196
|
)
|
|
2018
|
|
4/4/2019
|
|
54
|
||||||||
Atlanta Condominium Investments
|
|
Atlanta, GA
|
|
—
|
|
|
3,888
|
|
|
2,201
|
|
|
—
|
|
|
3,888
|
|
|
2,201
|
|
|
6,089
|
|
|
(100
|
)
|
|
1986
|
|
6/28/2019
|
|
30
|
||||||||
Rockwall II MOB
|
|
Rockwall, TX
|
|
—
|
|
|
—
|
|
|
19,904
|
|
|
—
|
|
|
—
|
|
|
19,904
|
|
|
19,904
|
|
|
(246
|
)
|
|
2017
|
|
7/26/2019
|
|
44
|
||||||||
Community Health 7240
|
|
Indianapolis, IN
|
|
—
|
|
|
1,017
|
|
|
8,052
|
|
|
—
|
|
|
1,017
|
|
|
8,052
|
|
|
9,069
|
|
|
(97
|
)
|
|
1985
|
|
8/2/2019
|
|
40
|
||||||||
Community Health 7330
|
|
Indianapolis, IN
|
|
—
|
|
|
1,216
|
|
|
7,633
|
|
|
—
|
|
|
1,216
|
|
|
7,633
|
|
|
8,849
|
|
|
(92
|
)
|
|
1988
|
|
8/2/2019
|
|
40
|
||||||||
Shell Ridge Plaza - Bldg 106
|
|
Walnut Creek, CA
|
|
—
|
|
|
1,296
|
|
|
9,007
|
|
|
16
|
|
|
1,296
|
|
|
9,023
|
|
|
10,319
|
|
|
(107
|
)
|
|
1984
|
|
9/27/2019
|
|
30
|
||||||||
Shell Ridge Plaza - Bldg 108
|
|
Walnut Creek, CA
|
|
—
|
|
|
1,105
|
|
|
2,600
|
|
|
—
|
|
|
1,105
|
|
|
2,600
|
|
|
3,705
|
|
|
(31
|
)
|
|
1984
|
|
9/27/2019
|
|
30
|
||||||||
Shell Ridge Plaza - Bldg 110
|
|
Walnut Creek, CA
|
|
—
|
|
|
1,105
|
|
|
2,786
|
|
|
—
|
|
|
1,105
|
|
|
2,786
|
|
|
3,891
|
|
|
(34
|
)
|
|
1984
|
|
9/27/2019
|
|
30
|
||||||||
Shell Ridge Plaza - Bldg 112
|
|
Walnut Creek, CA
|
|
—
|
|
|
3,097
|
|
|
9,639
|
|
|
—
|
|
|
3,097
|
|
|
9,639
|
|
|
12,736
|
|
|
(136
|
)
|
|
1984
|
|
9/27/2019
|
|
25
|
||||||||
Shell Ridge Plaza - Bldg 114
|
|
Walnut Creek, CA
|
|
—
|
|
|
1,392
|
|
|
4,624
|
|
|
—
|
|
|
1,392
|
|
|
4,624
|
|
|
6,016
|
|
|
(43
|
)
|
|
1984
|
|
9/27/2019
|
|
40
|
||||||||
ProHealth MOB
|
|
Manchester, CT
|
|
—
|
|
|
1,032
|
|
|
9,418
|
|
|
—
|
|
|
1,032
|
|
|
9,418
|
|
|
10,450
|
|
|
(66
|
)
|
|
2012
|
|
10/15/2019
|
|
38
|
||||||||
Murdock Surgery Center
|
|
Port Charlotte, FL
|
|
—
|
|
|
1,643
|
|
|
9,527
|
|
|
—
|
|
|
1,643
|
|
|
9,527
|
|
|
11,170
|
|
|
(24
|
)
|
|
2006
|
|
12/2/2019
|
|
35
|
||||||||
|
|
|
|
$
|
83,478
|
|
|
$
|
225,540
|
|
|
$
|
3,630,750
|
|
|
$
|
123,191
|
|
|
$
|
225,540
|
|
|
$
|
3,753,941
|
|
|
$
|
3,979,481
|
|
|
$
|
(382,833
|
)
|
|
|
|
|
|
|
|
Year Ended December 31,
|
||||||||||
|
2019
|
|
2018
|
|
2017
|
||||||
Balance as of the beginning of the year
|
$
|
3,871,712
|
|
|
$
|
3,809,609
|
|
|
$
|
2,606,536
|
|
Acquisitions
|
126,407
|
|
|
235,232
|
|
|
1,207,098
|
|
|||
Additions
|
35,531
|
|
|
8,821
|
|
|
12,243
|
|
|||
Impairment
|
—
|
|
|
—
|
|
|
(965
|
)
|
|||
Dispositions
|
(54,169
|
)
|
|
(181,950
|
)
|
|
(15,303
|
)
|
|||
Balance as of the end of the year
|
$
|
3,979,481
|
|
|
$
|
3,871,712
|
|
|
$
|
3,809,609
|
|
|
Year Ended December 31,
|
||||||||||
|
2019
|
|
2018
|
|
2017
|
||||||
Balance as of the beginning of the year
|
$
|
283,495
|
|
|
$
|
201,527
|
|
|
$
|
118,609
|
|
Depreciation
|
109,030
|
|
|
106,300
|
|
|
87,531
|
|
|||
Dispositions
|
(9,692
|
)
|
|
(24,332
|
)
|
|
(4,613
|
)
|
|||
Balance as of the end of the year
|
$
|
382,833
|
|
|
$
|
283,495
|
|
|
$
|
201,527
|
|
|
|
Page
|
|
|
|
Reports of Independent Registered Public Accounting Firm
|
|
|
|
||
|
||
|
|
|
Report of Independent Registered Public Accounting Firm on Internal Control Over Financial Reporting
|
|
|
|
||
|
|
|
Financial Statements of Physicians Realty Trust
|
|
|
|
||
|
||
|
||
|
||
|
||
|
|
|
Financial Statements of Physicians Realty L.P.
|
|
|
|
||
|
||
|
||
|
||
|
||
|
|
|
Notes for Physicians Realty Trust and Physicians Realty L.P.
|
|
|
|
|
|
PHYSICIANS REALTY TRUST
|
|
|
|
Dated:
|
February 27, 2020
|
/s/ John T. Thomas
|
|
|
John T. Thomas
|
|
|
Chief Executive Officer and President
|
|
|
(Principal Executive Officer)
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
/s/ JOHN T. THOMAS
|
|
Chief Executive Officer and
|
|
February 27, 2020
|
John T. Thomas
|
|
President and Trustee (Principal Executive Officer)
|
|
|
|
|
|
|
|
/s/ JEFFREY N. THEILER
|
|
Executive Vice President and
|
|
February 27, 2020
|
Jeffrey N. Theiler
|
|
Chief Financial Officer (Principal Financial Officer)
|
|
|
|
|
|
|
|
/s/ JOHN W. LUCEY
|
|
Chief Accounting and Administrative Officer
|
|
February 27, 2020
|
John W. Lucey
|
|
(Principal Accounting Officer)
|
|
|
|
|
|
|
|
/s/ STANTON D. ANDERSON
|
|
Trustee
|
|
February 27, 2020
|
Stanton D. Anderson
|
|
|
|
|
|
|
|
|
|
/s/ MARK A. BAUMGARTNER
|
|
Trustee
|
|
February 27, 2020
|
Mark A. Baumgartner
|
|
|
|
|
|
|
|
|
|
/s/ ALBERT C. BLACK, JR.
|
|
Trustee
|
|
February 27, 2020
|
Albert C. Black, Jr.
|
|
|
|
|
|
|
|
|
|
/s/ WILLIAM A. EBINGER, M.D.
|
|
Trustee
|
|
February 27, 2020
|
William A. Ebinger, M.D.
|
|
|
|
|
|
|
|
|
|
/s/ PAMELA J. KESSLER
|
|
Trustee
|
|
February 27, 2020
|
Pamela J. Kessler
|
|
|
|
|
|
|
|
|
|
/s/ TOMMY G. THOMPSON
|
|
Chairman
|
|
February 27, 2020
|
Tommy G. Thompson
|
|
|
|
|
|
|
|
|
|
/s/ RICHARD A. WEISS
|
|
Trustee
|
|
February 27, 2020
|
Richard A. Weiss
|
|
|
|
|
|
|
PHYSICIANS REALTY L.P.
by: Physicians Realty Trust, its general partner
|
|
|
|
Dated:
|
February 27, 2020
|
/s/ John T. Thomas
|
|
|
John T. Thomas
|
|
|
Chief Executive Officer and President
|
|
|
(Principal Executive Officer)
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
/s/ JOHN T. THOMAS
|
|
Chief Executive Officer and
|
|
February 27, 2020
|
John T. Thomas
|
|
President and Trustee (Principal Executive Officer) of Physicians Realty Trust, the general partner of Physicians Realty L.P.
|
|
|
|
|
|
|
|
/s/ JEFFREY N. THEILER
|
|
Executive Vice President and
|
|
February 27, 2020
|
Jeffrey N. Theiler
|
|
Chief Financial Officer (Principal Financial Officer) of Physicians Realty Trust, the general partner of Physicians Realty L.P.
|
|
|
|
|
|
|
|
/s/ JOHN W. LUCEY
|
|
Chief Accounting and Administrative Officer
|
|
February 27, 2020
|
John W. Lucey
|
|
(Principal Accounting Officer) of Physicians Realty Trust, the general partner of Physicians Realty L.P.
|
|
|
|
|
|
|
|
/s/ STANTON D. ANDERSON
|
|
Trustee of Physicians Realty Trust, the general partner
|
|
February 27, 2020
|
Stanton D. Anderson
|
|
of Physicians Realty L.P.
|
|
|
|
|
|
|
|
/s/ MARK A. BAUMGARTNER
|
|
Trustee of Physicians Realty Trust, the general partner
|
|
February 27, 2020
|
Mark A. Baumgartner
|
|
of Physicians Realty L.P.
|
|
|
|
|
|
|
|
/s/ ALBERT C. BLACK, JR.
|
|
Trustee of Physicians Realty Trust, the general partner
|
|
February 27, 2020
|
Albert C. Black, Jr.
|
|
of Physicians Realty L.P.
|
|
|
|
|
|
|
|
/s/ WILLIAM A. EBINGER, M.D.
|
|
Trustee of Physicians Realty Trust, the general partner
|
|
February 27, 2020
|
William A. Ebinger, M.D.
|
|
of Physicians Realty L.P.
|
|
|
|
|
|
|
|
/s/ PAMELA J. KESSLER
|
|
Trustee of Physicians Realty Trust, the general partner
|
|
February 27, 2020
|
Pamela J. Kessler
|
|
of Physicians Realty L.P.
|
|
|
|
|
|
|
|
/s/ TOMMY G. THOMPSON
|
|
Chairman of the Board of Trustees of Physicians Realty
|
|
February 27, 2020
|
Tommy G. Thompson
|
|
Trust, the general partner of Physicians Realty L.P.
|
|
|
|
|
|
|
|
/s/ RICHARD A. WEISS
|
|
Trustee of Physicians Realty Trust, the general partner
|
|
February 27, 2020
|
Richard A. Weiss
|
|
of Physicians Realty L.P.
|
|
|
†
|
Users of this data are advised pursuant to Rule 406T of Regulation S-T that this interactive data file is deemed not filed or part of a registration statement for purposes of Section 11 or 12 of the Securities Act, is deemed not filed for purposes of Section 18 of the Exchange Act, and otherwise is not subject to liability under these sections.
|
(1)
|
Incorporated by reference to Amendment No. 2 to the Registrant’s Registration Statement on Form S-11 filed with the SEC on June 14, 2013 (File No. 333-188862).
|
(2)
|
Incorporated by reference to the Registrant’s Current Report on Form 8-K filed with the SEC on February 24, 2017 (File No. 001-36007).
|
(3)
|
Incorporated by reference to the Registrant’s Registration Statement on Form S-3 filed with the SEC on June 17, 2015 (File No. 333-205034).
|
(4)
|
Incorporated by reference to the Registrant’s Current Report on Form 8-K filed with the SEC on March 7, 2017 (File No. 001-36007).
|
(5)
|
Incorporated by reference to the Registrant’s Current Report on Form 8-K filed with the SEC on December 1, 2017 (File No. 001-36007).
|
(6)
|
Incorporated by reference to the Registrant’s Current Report on Form 8-K filed with the SEC on February 6, 2015.
|
(7)
|
Incorporated by reference to Amendment No. 3 to the Registrant’s Registration Statement on Form S-11 filed with the SEC on June 20, 2013 (File No. 333-188862).
|
(8)
|
Incorporated by reference to the Registrant’s Current Report on Form 8-K filed with the SEC on November 7, 2019 (File No. 001-36007).
|
(9)
|
Incorporated by reference to the Registrant’s Current Report on Form 8-K filed with the SEC on May 7, 2014 (File No. 001-36007).
|
(10)
|
Incorporated by reference to the Registrant’s Current Report on Form 8-K filed with the SEC on April 30, 2019 (File No. 001-36007).
|
(11)
|
Incorporated by reference to the Registrant’s Annual Report on Form 10-K filed with the SEC on March 12, 2015 (File No. 001-36007).
|
(12)
|
Incorporated by reference to the Registrant’s Current Report on Form 8-K filed with the SEC on June 13, 2016 (File No. 001-36007).
|
(13)
|
Incorporated by reference to the Registrant’s Current Report on Form 8-K filed with the SEC on January 12, 2016 (File No. 001-36007).
|
(14)
|
Incorporated by reference to the Registrant’s Current Report on Form 8-K filed with the SEC on August 11, 2016 (File No. 001-36007).
|
(15)
|
Incorporated by reference to the Registrant’s Current Report on Form 8-K filed with the SEC on July 7, 2017 (File No. 001-36007).
|
(16)
|
Incorporated by reference to the Registrant’s Current Report on Form 8-K filed with the SEC on August 7, 2018 (File No. 001-36007).
|
(17)
|
Incorporated by reference to the Registrant’s Annual Report on Form 10-K filed with the SEC on February 28, 2019 (File No. 001-36007).
|
|
/s/ Ernst & Young LLP
|
|
Ernst & Young LLP
|
|
/s/ Ernst & Young LLP
|
|
Ernst & Young LLP
|
1.
|
I have reviewed this Annual Report on Form 10-K for the fiscal year ended December 31, 2019, of Physicians Realty Trust;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a.
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date: February 27, 2020
|
/s/ John T. Thomas
|
|
John T. Thomas
|
|
Chief Executive Officer and President
|
1.
|
I have reviewed this Annual Report on Form 10-K for the fiscal year ended December 31, 2019, of Physicians Realty Trust;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a.
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date: February 27, 2020
|
/s/ Jeffrey N. Theiler
|
|
Jeffrey N. Theiler
|
|
Executive Vice President and Chief Financial Officer
|
1.
|
I have reviewed this Annual Report on Form 10-K for the fiscal year ended December 31, 2019, of Physicians Realty L.P.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a.
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date: February 27, 2020
|
/s/ John T. Thomas
|
|
John T. Thomas
|
|
Chief Executive Officer and President of Physicians Realty Trust, the general partner of the registrant
|
1.
|
I have reviewed this Annual Report on Form 10-K for the fiscal year ended December 31, 2019, of Physicians Realty L.P.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a.
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date: February 27, 2020
|
/s/ Jeffrey N. Theiler
|
|
Jeffrey N. Theiler
|
|
Executive Vice President and Chief Financial Officer of Physicians Realty Trust, the general partner of the registrant
|
a.
|
the Annual Report on Form 10-K of the Company for the fiscal year ended December 31, 2019, as filed with the Securities and Exchange Commission (the “Report”), fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and
|
b.
|
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
/s/ John T. Thomas
|
|
John T. Thomas
|
|
Chief Executive Officer and President
|
|
|
|
|
|
/s/ Jeffrey N. Theiler
|
|
Jeffrey N. Theiler
|
|
Executive Vice President and Chief Financial Officer
|
|
a.
|
the Annual Report on Form 10-K of the Operating Partnership for the fiscal year ended December 31, 2019, as filed with the Securities and Exchange Commission (the “Report”), fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and
|
b.
|
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Operating Partnership.
|
/s/ John T. Thomas
|
|
John T. Thomas
|
|
Chief Executive Officer and President of Physicians Realty Trust, the general partner of the registrant
|
|
|
|
|
|
/s/ Jeffrey N. Theiler
|
|
Jeffrey N. Theiler
|
|
Executive Vice President and Chief Financial Officer of Physicians Realty Trust, the general partner of the registrant
|
|